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Résumé de la thèse  
Brucella abortus, est une bactérie pathogène appartenant au genre Brucella et responsable 
d’une zoonose ré-émergente appelée brucellose. Cette bactérie est capable d’infecter de 
nombreux types cellulaires. A l’intérieur de la cellule, Brucella est retrouvée dans une 
vacuole appelée Brucella-containing vacuole (BCV). Cette vacuole interagit partiellement 
avec les différents compartiments endosomaux et lysosomaux jusqu’à atteindre le réticulum 
endoplasmique où la bactérie va établir sa niche réplicative. Une fois sa réplication achevée, 
Brucella va alors modifier sa BCV afin de sortir de la cellule et amorcer son processus de 
réinfection. Il a été démontré qu’un des acteurs clé dans la virulence de B. abortus est le 
système de sécrétion de type IV (SST4). Ce sont les protéines injectées (ou effecteurs) par ce 
système de sécrétion qui permettent à Brucella de contrôler les différentes voies cellulaires de 
son hôte. Mon projet de thèse a consisté à caractériser un nouvel effecteur de ce système de 
sécrétion appelé « Brucella secreted protein L » (BspL). Nous avons observé la localisation 
de cet effecteur au sein du réticulum endoplasmique et l’induction de stress par celui-ci dans 
la cellule. En parallèle nous avons identifié la protéine « Homocysteine-responsive 
endoplasmic reticulum-resident ubiquitin-like domain member 1 » (Herp) comme cible de 
BspL. Herp est impliquée dans de nombreux processus de régulations physiologiques du 
réticulum comme la dégradation associée au réticulum (ERAD). Nous avons démontré que 
BspL stimule cette capacité d’action de l’ERAD au sein de la cellule. Par la suite nous avons 
découvert que l’ERAD et BspL sont impliqués dans la formation des vésicules de sortie de 
Brucella. En effet nous avons pu voir que BspL ralentissait la formation de ces vacuoles de 
sortie et dépendamment de Herp. Ces résultats sont synthétisés dans un manuscrit en cours de 
soumission dans lequel je suis le premier auteur. 
En parallèle, nous avons observé que BspL fragmentait les mitochondries en réduisant leur 
connectivité dans différentes lignées cellulaires. Nous avons néanmoins vu que ce processus 
de fragmentation des mitochondries était indépendant du stress induit par BspL dans le 
réticulum et de Herp ce qui suggèrerait que BspL cible les mitochondries indépendamment du 
réticulum. Ces phénotypes nécessitent une caractérisation plus approfondie afin d’élucider les 
conséquences de cette fragmentation. 
En conclusion, nous avons identifié un nouvel effecteur de Brucella qui participe à la 
formation des vésicules de sortie aBCVs en modulant l’ERAD. Par ailleurs BspL cible 
également les mitochondries ce qui indique que l’effecteur pourrait avoir un rôle différentiel 
au cours du temps pendant l’infection.  
? ???
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Objectives  
The objective of this thesis was to characterize a novel Brucella effector called BspL by 
combining different experimental approaches. We aimed mainly at determining the role of 
BspL in the virulence of Brucella abortus, identify its cellular target and its impact on the 
infected eukaryotic cell. We have found that this effector impacts endoplasmic reticulum 
functions as well as mitochondrial integrity. Therefore, to introduce the context of this work 
the introduction is composed of 3 chapters. The first chapter describes in great detail the 
functions of the endoplasmic reticulum particularly regarding ER stress and quality control; 
the second chapter is focused on mitochondria and the last chapter summarizes the most 
important information regarding Brucella abortus pathogenesis. The manuscript then has 2 
results chapters, describing all the data that I have obtained during my thesis. The first chapter 
of results deals with the impact of BspL on the endoplasmic reticulum and the second one its 
impact on mitochondria. A general conclusion about my work is included at the end to 
explain how it contributes to improve our knowledge on the virulence mechanisms of 
Brucella. Finally, I included a final chapter that sums up my contributions in other 
collaborative projects, on Pseudomonas aeruginosa and Acinetobacter baumannii. 
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Chapter 1 Endoplasmic reticulum 
I-) Endoplasmic reticulum: structure, functions and the secretory pathway. 
 
The endoplasmic reticulum (ER) is a dynamic organelle, a specialized membranous 
network of elongated tubules and flattened discs which covers a huge surface of the 
cytoplasm [1]. The ER is classically divided into rough ER (RER) and smooth ER (SER), 
depending on the presence or absence of ribosomes on the cytosolic face of the membrane 
respectively. The SER and RER can be found as spatially distinct compartments or highly 
interconnected and each of them is specialized in specific biological processes [2]. The RER 
is contiguous to the nuclear membrane and specializes mostly in protein synthesis whereas the 
more tubular SER is production and metabolism of lipids and associated molecules. The ER 
spans a large area of the cell ensuring many contacts with other cellular organelles as the 
Golgi apparatus. Together with other organelles, the ER can sense intrinsic and extrinsic 
perturbations enabling its central role as a coordinator of cellular homeostasis. Another 
important organelle association is the ER-mitochondria interconnectivity. This forms physical 
contact sites between the ER and mitochondria, named mitochondria-associated membranes 
(MAMs), which play a pivotal role in several cellular processes such as the control of calcium 
(Ca2+) homeostasis and metabolic processes [3].  
 
One of the most well-known functions of the ER is maintaining cellular homeostasis by 
controlling protein biosynthesis. Indeed, a significant proportion of the mammalian genome 
encodes for proteins that will be synthesized by ER membrane-bound ribosomes and 
translocated into the ER for further processing [4]. Therefore, the ER represents the entry 
point of the secretory pathway which is highly conserved in the eukaryotic kingdom. The 
secretory pathway is composed of different membrane-bound compartments notably the ER 
and Golgi that control the export of mature proteins from the lumen or the membrane of the 
ER to the Golgi apparatus and subsequently to either the plasma membrane, the extracellular 
medium or other organelles. 
 
The ER in fact provides a specialized environment for folding, assembly and maturation of 
newly synthesized proteins. Protein folding and assembly are discussed in more detail in this 
introduction (Part II-1) as their regulation is essential for maintaining cellular homeostasis. 
Once synthesized, proteins undergo a process of maturation including signal sequence 
? ???
cleavage, glycosylation, isomerization of proline or lipid conjugation and formation, 
isomerization or reduction of disulfide bonds catalyzed by protein disulfide isomerases 
(PDIs). All these modifications ultimately allow proteins to achieve a properly folded 
conformation for ternary or quaternary structures [5,6]. After maturation, proteins can then be 
exported from the ER in coat protein complex II (COP II)-coated transport vesicles in 
specialized region of the ER: the ER exit sites (ERES). The COP II machinery mediates the 
budding event to initiate vesicle formation and traffic for subsequent steps of the secretory 
pathway [7], the ER-Golgi intermediate compartment (ERGIC) and the Golgi complex to 
finalize their maturation and traffic to their final destination [8,9]. And, it is important to 
precise that the organization and functionality of ERES are regulated by the activity of the 
small GTPase Sar1, which controls the assembly of COPII complexes on ER membranes. 
Indeed, we will discuss their importance for Brucella in the Chapter 3. This secretory 
pathway is represented in the Figure 1- (extracted from [10]), and Figure 2-, with other 
important ER steps as folding or protein degradation, essential for ER homeostasis and further 
described later in this chapter [11].??
? ???
?
Figure 1- Schematic representation of the secretory pathway, highlighting some of the 
components discussed during the conference newly synthesized proteins enter the pathway at the ER and are 
subejcted to repeated sorting and transport between membrane organelles until they arrive at their designated 
destination. Figures and legends extracted from [10]. 
 
 Indeed, correct folding and maturation of proteins to prevent aggregation and transport of 
dysfunctional proteins to the rest of the cell makes the ER a central point for protein quality 
control, a process termed ER quality control (ERQC). 
? ???
 
Figure 2- Protein Secretion Through the Secretory Pathway is Regulated by the Activity of ER Protein 
Folding, Trafficking and Degradation Pathways. Proteins co-translationally entering into the ER in non-
native conformations engage ER- localized chaperones (e.g., BiP, GRP94, CNX, CRT) and folding factors (e.g., 
PDIs, PPIases) that facilitate their folding into their proper three-dimensional conformation (green box). These 
proteins are then packaged into vesicles for trafficking to downstream secretory environments such as the 
extracellular space (blue box). However, proteins unable to fold in the ER are directed towards degradation 
pathways such as ER-associated degradation where they are retrotranslocated from the ER to the cytosol and 
degraded by the ubiquitin- proteasome pathway (purple box). This partitioning of proteins between ER protein 
folding/ trafficking or degradation pathways is referred to as ER quality control and functions to limit secretion 
of non-native protein conformations to downstream secretory environments. The primary impact of activating 
each UPR signaling arm on ER quality control is also depicted. PERK-dependent translation attenuation 
decreases the import of newly-synthesized proteins entering the ER, reducing ER protein folding load (top). 
Alternatively, IRE1/XBP1s and ATF6 activation induces transcriptional remodeling of ER proteostasis pathways 
involved in protein import, folding, degradation and trafficking. Figures and legends extracted from [11].  
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II-) Endoplasmic Reticulum Stress and Endoplasmic Reticulum Quality Control 
 
Any conditions that disrupt ER homeostasis create a state commonly referred to as 
“ER stress” [12]. A few examples of these conditions provoking ER stress are loss of calcium 
homeostasis, point mutations in secreted proteins that stabilize intermediate folding forms or 
cause aggregation, nutrient deprivation, hypoxia and microbial infections [13]. In order to 
overcome ER stress the cell activates multiple adaptive mechanisms. However, when the 
stress is too high to be counteracted it can also lead to programmed cell-death, also known as 
apoptosis. The specific response elicited to restore homeostasis is dependent on the perturbing 
agent (bacteria, virus), conditions (drugs as tunicamycin) and the intensity or duration of the 
stress (chronic or transient). Eukaryotic cells have many regulatory checkpoints to manage 
and to control this stress which can be divided in 4 major mechanisms: (i) increase or 
acceleration of adequate protein folding, (ii) induction of protein clearance via ER-associated 
degradation (ERAD), (iii) activation of the unfolded protein response (UPR), (iv) or a specific 
autophagy also called ER-phagy [14]. It is important to keep in mind that all these pathways 
are intimately connected inside the cell. For example, the same ER resident protein chaperone 
can participate in different mechanisms. Moreover, these different regulatory mechanisms can 
occur simultaneously if necessary.  
For the sake of clarity, I have decided to split the description of these processes in four 
different parts even if they are intimately connected.  
 
1-) Chaperons and Protein Folding Process 
 
The accumulation of misfolded proteins is one of the main causes of ER stress. 
Although protein misfolding takes place continually, it can be enhanced because of intrinsic 
and/or extrinsic perturbations. This is why the ER requires a robust system for protein folding. 
Indeed, the simultaneous presence in the ER of misfolded proteins, nascent proteins, and 
proteins at intermediate stages of folding may expose hydrophobic patches, making them 
available and vulnerable to aggregation with other misfolded or nascent proteins [15]. 
Fortunately, this exposure of hydrophobic patches to the environment is also recognized by 
protein chaperones in the ER which will ensure that exposed hydrophobic patches on such 
proteins are concealed, inhibiting protein aggregation. ER chaperones and their co-factors are 
therefore essential actors for ensuring ERQC. 
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The most common and abundant type of molecular chaperones are the heat-shock 
proteins (Hsps) which were firstly identified in Drosophila melanogaster [16]. These 
chaperones have been classified into families according to their molecular weights, including 
Hsp40, Hsp60, Hsp70, Hsp90. As interest in these proteins grew, it was discovered that Hsps 
play a role in elicitation of proper protein folding, assembly, secretion and degradation and, as 
we will see later in this chapter, also in the UPR. There are two major chaperone families in 
the ER the Hsp70s and the lectin-chaperones such as the type I membrane protein calnexin 
that resides in the ER membrane and its soluble homolog calreticulin that resides in the ER 
lumen. 
The Hsp70 family can interact with both glycosylated and non-glycosylated proteins 
in contrast to lectin-chaperones which generally recognize incompletely folded glycosylated 
proteins. More recently, the Hsp40 proteins also called Endoplasmic Reticulum DNA J 
domain containing proteins (ERdjs)1-7 have been implicated in the ERQC. Indeed, several 
studies have since highlighted their connection with the Hsp70 family and their implication in 
several ER-related functions including protein folding (discussed just below, section II-1-b) 
but also in ERAD (section II-2). 
 
a-) BiP 
 
Of the Hsp70 family members the most famous chaperon is BiP (also called Grp78). 
Nascent polypeptide chains, both in the cytosol and in the ER, bind primarily to the Hsp70 
family proteins and especially BiP [17,18]. BiP has structural features that are common to all 
proteins of the Hsp70 family, such as a highly conserved N-terminal nucleotide-binding 
domain (NBD) that interacts with various nucleotide exchange factors (NEFs) and a C-
terminal substrate-binding domain (SBD) composed of eight β-strands with a helical lid. 
There is also a linker between these 2 domains that controls their allosteric interaction [18] 
While hydrolysis of ATP to ADP allows stable interactions between BiP and its 
substrates, exchange of ADP to ATP causes substrate dissociation by inducing conformational 
changes in the substrate-binding domain of BiP. At the structural level, when BiP is in its 
ATP-bound form, the SBD maintains its lid open and is docked on the NBD. ATP hydrolysis 
causes a conformational change that results in undocking of the two domains and the closing 
of the lid over the SBD providing a high-affinity state. Nucleotide-exchange factors then 
release ADP allowing ATP to rebind and the new protein to be released and folded or targeted 
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for degradation. This process is illustrated in the Figure 3- extracted from the study of Pobre 
et al[4]. 
 
 
Figure 3- BiP ATPase cycle. Step 1, in the ATP-bound form, the nucleotide-binding domain (NBD) (blue) and 
the substrate-binding domain (SBD) (orange), with its lid open, are docked to each other resulting to a form with 
high-substrate binding and release kinetics and low-substrate affinity. Step 2, upon ATP hydrolysis, the NBD 
and SBD become undocked, and the lid of the SBD closes providing a form that has high-substrate affinity but 
slow binding and release rates. This cycle is regulated by ER-localized DnaJ cofactors (ERdjs) that interact with 
unfolded proteins and transfer them to the ATP-bound form of BiP, while simultaneously triggering ATP 
hydrolysis. Step 3, substrate is released with the help of nucleotide-exchange factors (NEFs) that stimulate the 
release of ADP. Step 4, binding of ATP causes a conformational change in the SBD resulting in a more tightly 
compacted conformation that is thought to “squeeze” the substrate out. Step 5, interaction with ERdjs reorders 
the polypeptide-binding pocket of the BiP–ATP2 SBD, readying it to interact with another substrate. Step 6, BiP 
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is post-translationally modified through AMPylation, and this causes the protein to be inactive. AMPylated BiP 
adopts a “domain-docked” structure similar to that of the ATP-bound state even in the apo- or ADP-bound state 
and is unable to interact productively with ERdjs. Ribbon representations of the structures (insets): ATP-bound 
BiP with the polypeptide-binding pocket open (BiP-ATP). Figures and legends extracted from [4]?
b-) ERdj proteins 
 
The ERdj family is composed of seven ERdj1-7 proteins that contribute to diverse cellular 
functions. ERdj3-6 can directly interact with proteins which need to be folded. This family is 
divided in 3 different types [19,20]: 
-? Type I (DNAJA) with an N-Terminal J domain, followed by a Gly/Phe-rich region 
which can serve as a flexible linker. This linker is necessary for the substrate binding 
domain which often includes a cysteine-rich zinc-binding motif and which terminates 
with a dimerization domain. This structural conformation is similar to BiP structure. 
This subgroup only has ERdj3. 
-? Type II (DNAJB) proteins possess all the same domains and in the same order as type 
I proteins, except that the cysteine-rich domain is missing. As the type I we only find 
one protein, Erdj4, in this subtype. However, it is important to note that both type I 
and II DnaJ family members can bind directly substrates for folding processes.  
-? Type III (DNAJC) proteins is the largest group of ERdjs with ERdj1,2,5,6,7. This 
subgroup only contains the J domain in their sequences, anywhere in the protein. 
Some of the type III DnaJ proteins bind unfolded proteins directly, whereas others do 
not seem to be able to. 
 
The domains of all ERdjs are presented in the Figure 4- 
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Figure 4- Domain structure of ERdj family members. A, domain arrangements of primary sequences of 
each of the known ERdj proteins. Abbreviations used are as follows: SS, signal sequence; J, J domain; TM, 
transmembrane region; CR, charged amino acid region; SANT, SANT domain; Sec63/Brl, Sec63/Brl 
domain; G/F, glycine/phenylalanine-rich flexible linker region; IA and IB, bifurcated substrate-binding 
domain; II, cysteine-rich domain; III, dimerization domain; SBD, substrate-binding domain; Trx, thioredoxin 
domains; Trx-L, thioredoxin-like, enzymatically inactive domain; TPR, tetratricopeptide repeat domain 
(each con- taining three subdomains). Figures and legends extracted from [4] 
 
ERdjs are well described for having a role in folding, in particular they are involved in the 
BiP-dependent folding processes. In some cases, ERdjs can interact directly with unfolded 
proteins in the ER and transfer them to the ATP-bound form of BiP, while simultaneously 
triggering ATP hydrolysis and closing the lid on the substrate [21,22]. All ERdjs can also 
directly interact with Hsp70 proteins or via a ribosome-associated complex in order to 
increase folding of nascent proteins. Taken together, the available data suggests a role of 
ERdjs in substrate recruitment and modulation of BiP function [23,24]. A recent example 
nicely illustrating the importance of these interactions is ERdj1, a transmembrane protein with 
a cytosolic domain that associates with ribosomes on the ER membrane while its luminal 
domain associates with BiP. It was demonstrated that this ERDj protein, in the absence of 
BiP, inhibits nascent polypeptide translocation into the ER, thus ensuring BiP association to 
nascent proteins [24].  
 
ERdj3 directly interacts with the substrate via highly conserved hydrophobic residues in 
the substrate-binding domain[23]. As these substrates fold rapidly in cells, the binding 
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appears to be very transient and terminated by transfer of the substrate to BiP, which depends 
on the interaction of the conserved QPD motif located in its J domain. 
ERdj5, considered in the field as the lonely ERdj, has the property of also belonging to 
the PDI family of enzymes that form, isomerize or reduce disulfide bonds, processes that are 
also critical for assigning a protein its final structure [25]. Not surprisingly, ERdj5 is shown to 
bind peptides lacking cysteines in vivo [26]. One example of the role of ERdj5 is its 
implication in the maturation of the low-density lipoprotein receptor, which requires the 
reduction of non-native disulfide bonds that are part of its normal folding trajectory [27]. 
Finally, ERdj6 was shown to selectively bind misfolded vesicular stomatitis virus G 
proteins. After the folding process, ERdj6 is released. Furthermore, it was demonstrated that 
the function of ERdj6 depends of its interaction with BiP. Indeed, in some studies it was 
indicated that overexpression of the ER form of ERdj6 enhanced the proper maturation of 
some substrates, arguing for a possible role as a pro-folding co-chaperone [23]. Evidence that 
ERdj directly participates in folding process is still lacking, but it is clear that ERdj6 is a 
cofactor that helps BiP activity. 
 
Recent advances have provided a better understanding of the regulation of BiP and 
more generally of folding processes with the characterization of the ERdj protein family. 
Nonetheless, it is clear that more studies are needed to understand whether ERdjs that bind 
unfolded proteins play dedicated roles in folding versus Endoplasmic-Reticulum Associated 
Degradation (ERAD, process that is described just below) or whether this outcome is protein-
specific. It is also unclear whether the substrate binding ERdjs have distinct specificities. The 
finding that some proteins can associate with multiple ERdjs raises the questions of how 
common this is, whether there is an order to these interactions, and how transfer from one 
type of ERdj protein to another is carried out.  
In the next section we will learn about another system which allows reduction of the 
amount of misfolded proteins if the normal folding process is not sufficient: ERAD. 
 
2-) ERAD 
?
Despite the presence of a sophisticated system for protein folding with the 
involvement of several chaperones to help regulate the process, some misfolded proteins can 
persist in the ER [28]. Fortunately, these misfolded or unfolded proteins are quickly identified 
by the ER, retrotranslocated to the cytosol to be ubiquitinated, and then degraded via the 26S 
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subunit of the proteasome [29]. This succession of events is called ERAD and is an important 
part of ERQC. The ERAD was first investigated in the model organism Saccharomyces 
cerevisiae where several studies identified 3 main different ERAD pathways depending on the 
localization of the misfolded protein or more precisely the localization of the misfolded 
domain.  
a-) Overview of different ERADs 
?
ERAD substrates have molecular degradation signals which are called degrons [28] 
and whi[30,31]. Thus, ERAD-C is associated with membrane proteins that have their 
misfolded domains or degrons in the cytosol. On the contrary, ERAD-M substrates have their 
degrons in the membrane. ERAD-L is associated with substrates which have their misfolded 
domains located in the ER lumen. Then they are retrotranslocated into the cytosol to be 
uquitinated and degraded. However, there is one exception described for soluble ERAD-C 
substrates which do not require retrotranslocation for proteasome-mediated degradation [31].  
In addition to the canonical ERAD-L, -C, and -M pathways, recent studies have 
provided evidence of more specialized ERAD pathways mediating protein quality control at 
the ER. One of these newly characterized pathways involves the degradation of ribosome-
associated polypeptide chains at the ER membrane, which has been called ERAD of 
ribosome-associated proteins (ERAD-RA). In budding yeast, ER-targeted polypeptides within 
stalled ribosome complexes are marked for proteasomal degradation by the E3 ligase Ltn1 
[32]. Ltn1 interacts with ribosomes and has a general role in mediating ribosome-associated 
protein quality control [33]. The ERAD-RA pathway seems to be conserved in higher 
eukaryotes as the Ltn1 mammalian ortholog called Listerin also appears to mediate ERAD-
RA [34]. 
The second pathway recently described is ERAD-T for translocon-associated proteins. 
This ERAD pathway mediates the degradation of Sec proteins associated with the 
translocation complex (also called translocon), induced by aberrant interactions or 
abnormalities in the translocation process [35].  
ERAD-RA and ERAD-T are two examples of newly identified ERAD pathways 
where the molecular mechanisms remain poorly characterized. Therefore, for the rest of the 
discussion I decided to focus only on ERAD-L, -M and -C summarized in the Figure 5-. 
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Figure 5- The scheme shows the ubiquitin-ligase complexes involved in the ERAD-L, -M, and -C pathways. 
Components in orange and green belong to the Hrd1p core and Cdc48p ATPase complexes, respectively. Stars 
show the location of the misfolded domain of a substrate. Ub is ubiquitin. Figures and legends extracted from 
[36]. 
b-) Recognition and retrotranslocation of misfolded proteins 
?
As mentioned above, ERAD begins with the recognition of misfolded protein 
domains. This step is primordial and needs to be tightly controlled because inefficient 
detection of misfolded proteins will lead to their accumulation [31]. On the other hand, 
overactive ERAD would come at a very expensive energy cost for the cell, with the 
degradation of folding intermediates. In ERAD the main recognition actors are the E3 ligase 
complexes. E3 ligase complexes are best characterized in yeast where Doa10 (mammalian 
TEB4/MARCH) and Hrd1 (mammalian HRD1/Gp78) complexes were shown to assemble in 
the ER. These complexes are responsible for specific classes of ERAD substrates. Indeed, 
depending on the nature of the ERAD substrate a specific E3 ligase complex takes charge of 
the protein for degradation. ERAD-L and -M substrates are taken by the Hrd1 complex while 
ERAD-C substrates by the Doa10 complex [28]. For a summary of the equivalence between 
identified proteins in yeast and in mammals please see Table 1. 
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Table 1 
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?
The Hrd1 complex will process all of ERAD-L and -M substrates with the help of 
several other important proteins: Hrd3, Kar 2, Der1 and Yos9 as represented in Figure 5-. 
Briefly, Hrd1 is the main component of the complex with its ligase activity involved in the 
retrotranslocation of the substrates. Hrd3 also plays an important role because it is involved in 
the recognition of a large panel of ERAD-L substrates helped by lectin chaperons specialized 
in recognition of glycoproteins, as for example Yos9 in yeast and OS9 in mammals [37,38]. 
However, certain ERAD-M substrates appear to be recognized directly by the E3 ligase Hrd1 
without the help of Hrd3 or other chaperons [39]. In yeast, the membrane protein Der1 is also 
involved in the recognition of the substrates and allows membrane insertion of the misfolded 
protein in the Hrd1 complex [40]. Finally, Kar2, the last component of this complex, has a 
chaperone activity besides its ability to transfer and insert substrates in the membrane channel 
formed by the Hrd1 ligase [36]. It is the synergy of all these actors that ensures the high 
efficiency of the Hrd1 complex in the recognition process which is an essential first step of 
ERAD. 
  One particular exception worth mentioning is the case of misfolded glycoproteins and 
ERAD-L. This process is well described in Saccharomyces cerevisiae, nicely illustrating how 
ERAD can coexist with the protein folding process in the same compartment, often with the 
involvement of the same protein complexes. For this reason, I have decided to present this 
process in more detail. 
When glycoproteins enter the ER lumen, they are often modified at asparagine (N) 
residues with a fixed glycan chain moiety composed of three glucose, nine mannose, and two 
N-acetylglucosamine residues, Glc3–Man9–GlcNAc2 [41]. The N-linked glycan or N-
glycoprotein is then trimmed by several enzymes which will determine their fate in the 
secretory pathway. Indeed, early glycan-processing enzymes such as glucosidases lead to the 
binding of lectin chaperons that facilitate the folding of the newly synthesized N-
glycoproteins [42]. In contrast, late acting enzymes, such as the mannosidase Htm1, trigger 
the binding of a different lectin that engages the protein in ERAD [43]. This difference in the 
kinetics of the glycan-trimming enzymes provides an opportunity for newly synthesized 
proteins to acquire the native conformation and traffic beyond the secretory pathway. When 
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these glycoproteins stay too long in the ER, the N-linked glycan is truncated to generate a 
terminal α-1,6-linked mannose residue with the mannosidase Htm1. This protein extremity 
can then be recognized by the lectin Yos9 which in turn is bound to the luminal domain of 
Hrd3 of the Hrd1 complex directing the target towards degradation [40,44]. Both the yeast 
Htm1 and its mammalian counterpart EDEM are in complex with oxidoreductases (Pdi1 in 
yeast and Erdj5 in mammals), required for the stability of Htm1 and also for reducing 
disulfide bonds in misfolded proteins, which impacts specific ERAD steps [45]. However, the 
binding of Yos9 to the α1,6-linked mannose is not sufficient to trigger the degradation of the 
misfolded protein, which must be unstructured to bind Hrd3, with the help of the luminal 
chaperone Kar2 (BiP) [44]. The dual recognition of a specific N-linked glycan by Yos9 and 
an unstructured segment by Hrd3 likely enhances the specificity of ERAD substrate 
recognition and clearly facilitates its insertion in Hrd1 hub [46]. 
The recognition mechanism of misfolded luminal N-linked glycoproteins is very 
similar in mammalian cells because the yeast components are largely conserved in 
eukaryotes, but with an added level of complexity. OS-9 and XTP3-B, the mammalian 
homologues of Yos9, interact with glycans in the misfolded protein but also with Sel1, the 
mammalian version of Hrd3, which is itself a glycoprotein. In either case, using the same 
domain to interact with a component and a substrate offers OS-9/XTP3-B an additional 
mechanism to regulate recognition of N-glycosylated ERAD substrates [47]. 
Finally, additional work in yeast suggests that a different type of glycosylation, O-
mannosylation, is important for removal of certain luminal proteins from unsuccessful folding 
cycles to favour their degradation by ERAD. The enzymes involved in O-mannosylation 
directly interact with the ERAD machinery. However, how ERAD components capture O-
mannosylated proteins is still unknown. Interestingly, N-glycan trimming and O-
mannosylating enzymes both appear to mediate relatively slow processes, in which substrates 
have to be retained for prolonged periods in the ER. In contrast, newly synthesized proteins 
seem to be protected from degradation for an initial period of time, even when conditions are 
suitable for inducing misfolding [48]  
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The main component of the Doa10 complex is Doa10, a large E3 ubiquitin ligase with 
14 transmembrane segments and an N-terminal RING domain [49]. The Doa10 complex is 
? ???
also conserved in eukaryotes and the human Doa10 ortholog TEB4/MARCH6 appears to 
contain a similar membrane topology and localization. Initially it was thought Doa10 
primarily targets ERAD-C substrates with degrons exposed to the cytoplasm or nucleoplasm. 
However, it was recently demonstrated Doa10 can also recognize specific ERAD-M 
substrates [50,51]. The first evidence suggesting Doa10 could target intramembrane degrons 
came from studies showing that the Doa10 cofactor Ubc6 is a short-lived protein and that its 
C-terminal membrane anchor is likely to be part of the relevant degron [52,53]. The 
identification of Doa10 substrates containing ERAD-M degrons suggests Doa10 can 
recognize a broader spectrum of substrates than previously thought. While cytosolic and 
membrane degrons are placed into separate categories, it is possible these degrons share 
certain features that remain to be identified.  
Although shared characteristics of Doa10-dependent degrons have been described, it 
remains unclear if Doa10 directly interacts with substrates. It is possible that Doa10 interacts 
with substrates through its transmembrane segments, forming an internal channel [49], similar 
to what has been suggested for the E3 ligase Hrd1 [54]. The conserved regions of Doa10 that 
might have a role in substrate recognition include the TEB4-Doa10 domain, which includes 
three transmembrane segments, and the highly conserved 16-residue C-terminal element [55]. 
Another possibility is that Doa10 substrate recognition is mediated through adaptor proteins, 
such as molecular chaperones as for Hrd1 recognition process. Indeed, it has been shown that 
degradation of several Doa10 substrates requires Hsp40 and Hsp70 molecular chaperones 
[56,57], highlighting the interconnexion between folding and ERAD.  
To conclude it appears that these E3 ligases Hrd1 or Doa10 are quite specific for each 
ERAD branch even if some downstream actors are common. In mammalian cells the best 
studied E3 ligases are the homonymous Hrd1 and Gp78. These 2 mammalian ligases are 
homologous to yeast Hrd1 E3 ligase. Nevertheless, they have differential affinities according 
to the substrate class. The molecular mechanisms of ERAD in mammalian cells still require 
further elucidating as new E3 ligases participating in ERAD are still being identified but 
whose functions remains mostly unknown. It remains to be determined for example whether 
there is a substrate affinity difference between these E3 ligases. 
All these studies described in this section of the introduction, highlight how 
challenging it is to clearly separate ERAD pathways due to such high level of cross-
interactions of E3 ligases and their protein complexes. 
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Finally, it is important to keep in mind that recognition of misfolded proteins can be 
divided in 2 processes one slow and one faster. Not surprisingly it is the slowest recognition 
process which is associated to ERAD more likely to allow for extra time for folding 
intermediates to be taken by folding chaperons. The molecular mechanisms that allow a cell 
to co-regulate folding kinetics and ERAD in the same compartment remain to be elucidated. 
c-) Retrotranslocation and Ubiquitylation 
?
Nascent protein translocation involves the insertion of integral membrane proteins into 
the ER membrane or the transport of luminal and secretory proteins to the ER lumen [58]. 
Consequently, translocation does not concern all the proteins. Nevertheless, this step is 
essential in the protein biogenesis process. At the molecular level, translocation occurs 
through a protein-conducting channel that is formed by a heterotrimeric membrane protein 
complex, the Sec61 or SecY complex. In the previous section relating to ERAD we 
mentioned retrotranslocation as means for elimination of membrane or luminal proteins 
[58,59]. At cellular level, retrotranslocation consists of transport of the substrate across the 
ER lipid bilayer back into the cytoplasm.  
Once at the cytosolic side of the ER membrane, the substrate is ubiquitylated [36]. 
Briefly, ubiquitin is a small protein of 8.5 kDa that can be attached to substrates in a variety of 
ways. It is the attached ubiquitin which is recognized by the proteasome for degradation. The 
general process of ubiquitination is represented in Figure 6-. E1, E2 and E3 are ligases that 
will pass the ubiquitin group between them to finally bind to the substrate. Attachment of a 
single ubiquitin (mono-ubiquitination) to a protein is not usually sufficient for recognition by 
the proteasome and is typically involved in other regulatory processes as it can inhibit 
interaction of the ubiquitinated protein with other partners [60] ; however, ubiquitination at 
multiple sites within a protein can target it for proteasomal degradation. More commonly, 
ubiquitin is attached to proteins in the form of ubiquitin chains, which are formed when the C-
terminus of a donor ubiquitin (G76) is attached to one of the seven lysine side chains or the α-
amino group of the first methionine of an acceptor ubiquitin. Poly-ubiquitin chains can be 
homotypic or heterotypic: the former is composed of a single linkage type while the latter 
contains multiple types of linkage and is characterized by a branched topology [61]. 
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Figure 6- The ubiquitin proteasome system. The process of ubiquitination is catalyzed by an organized milieu 
of E1, E2, and E3 enzymes, which promote the ligation of a ubiquitin molecule to the lysine residues in the 
protein substrates. Lysine-48-linked polyubiquitination chain attached proteins are targeted to the 26S 
proteasome for protein degradation. DUB enzymes are involved in reversing ubiquitin conjugation and in the 
recycling of ubiquitin molecules through the ubiquitin proteasome pathway. Figures and legends extracted from 
[62]. 
Ubiquitination is an ATP-dependent mechanism. It is the RING domain of E3 ligases 
that is responsible for the ligase activity in the cytoplasm [63]. We have mentioned E3 ligases 
Doa10 and Hrd1, previously, but E2 ligases are also well characterized: Ubc6 and Ubc7. 
Ubc6 is specific for the Doa10 complex whereas Ubc7 is associated with all 3 previously 
described ERAD and thus the Hrd1 complex.  They both have mammalian orthologs Ubc6 
and Ube2G1/Ube2G2 [31].   
It is difficult to dissociate retrotranslocation from ubiquitination because these 2 
processes are closely connected. After the recognition of ERAD substrates, these are inserted 
in Hrd1 or Doa complexes. The precise mechanism still remains unclear because to date it is 
not yet known how the misfolded proteins enter in the Hrd1 channel with even the possibility 
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that the entry would occur via the lipid phase. 
Once the substrate is in the cytoplasmic side, the next step is its ubiquitination by 
Ubc6 and 7 proteins. Ubc7 cooperates with Cue1, which serves as a membrane anchor and 
activator [64,65]. Its CUE domain promotes K48 ubiquitin chain formation which is required 
for the degradation of ERAD substrates [66]. In human cells, the Ubc7 ortholog, UBE2G2, 
associates with TEB4 to promote K48 (Lysine 48) chain formation in vitro. 
Until recently, Doa10 and Hrd1 were thought to be the only ER resident E3 ligases 
participating in ERAD in yeast; however, recent studies have identified the transmembrane 
Asi complex as part of a previously uncharacterized ERAD pathway operating exclusively at 
the inner membrane of the nuclear envelope which is a subdomain of the ER [67]. This 
specialized complex highlights again the high complexity of ERAD even in a simple 
organism as the yeast. Asi complex is composed of 3 proteins Asi1-3 and is specialized in the 
degradation of misfolded proteins from the inner nuclear membrane. This spatial segregation 
of different ERADs strongly suggests the importance of this process for ERQC [67]. I 
mention this particular ERAD because the E2 ligase Ubc6 is also involved. Ubc6, is an 
integral component of the Doa10 pathway and in Asi pathway Ubc6 was shown to take part at 
this process. Ubc6 and Ubc7 are both required for efficient degradation of most Doa10 
substrates. This raises the question of why these ERAD pathways should require multiple E2 
ligases while Hrd1 complex in yeast only has Ubc7. The answer could be that Ubc6 and Ubc7 
ligases have distinct catalytic properties which would explain their specificity [67] but this 
remains to be investigated.  
Before reaching the proteasome for degradation there is the involvement of the 
cytosolic Cdc48 ATPase complex (p97 or Valosin-containing protein VCP in mammals) that 
separates polypeptides from protein complexes or from membranes, in our case Doa 10 or 
Hrd1 complexes [68]. Cdc48 is recruited to the membrane by an interaction between the 
polyubiquitin chain with the cofactors Ufd1/Npl4/Ubx2 and is thus involved in the late stages 
of the retrotranslocation process but also in ubiquitination [69]. The ATPase activity of Cdc48 
is used to drive the unfolding of the substrate, [70]. Then the factor Ufd2 intervenes, possibly 
following substrate release from Cdc48 to increase substrate affinity for the proteasome or the 
proteasome shuttle factors Rad23 and Dsk2 [71]. Once the substrate is fully removed from the 
ER, Cdc48 probably dissociates from the Ubx2 anchor, diffusing away from the membrane 
with its associated substrate. The substrate is then released from Cdc48 in a process that 
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requires trimming of the polyubiquitin chain by a deubiquitinase. Finally, the substrate is 
passed on to the proteasome for degradation. 
Another recent Cdc48 cofactor was identified in yeast, the deubiquitylating enzyme 
Otu1, is required for substrate release following substrate unfolding and initial polypeptide 
transfer through the Cdc48 pore [72]. This illustrates that much remains to be discovered, 
constantly increasing the complexity of ERAD-associated pathways, especially in mammals. 
Even if Saccharomyces is a model organism that allowed researchers to establish the basics of 
our knowledge of ERAD, it is now crucial to increase the number of studies using mammalian 
models. It seems clear that mammalian system is more sophisticated than yeast because there 
is a higher diversity of molecular actors as shown by the increasing number of identified E3 
ligases. In addition, although I tried to separate the different kinds of ERAD-L-M and –C, 
even in yeast there are exceptions or cross-interactions so only future studies will lead to a 
better and total comprehension of ERAD processes in humans. Moreover, the identification of 
orthologs does not mean that proteins have exactly the same functions. This is why this 
research area is still very exciting and, in addition, dysregulations of this pathway can lead to 
severe diseases. Understanding the molecular mechanisms implicated could pave the way for 
developing new therapeutic approaches to counter these dysfunctions and help restore ER 
homeostasis in a disease context. 
In the next section we will focus on the molecular mechanisms of the proteasome 
which ends the ERAD process and how this macromolecular machine is tightly regulated. 
d-) Proteasomal degradation 
?
The 26S proteasome is the principal macromolecular machinery responsible for 
protein degradation in eukaryotes. It is composed of a 20S subunit which is the proteasome 
capped core particle and a second 19S subunit which is the regulatory particle (Figure 7-). It 
degrades proteins to peptides by a multistep process and is essential for ensuring protein 
recycling in the cell [73]. 
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Figure 7- Structure of the proteasome. Figures extracted from [74] 
Regulation of gate opening in the 20S proteasome is essential for proteasome function. The 
cell has evolved many different proteasomal regulators that control 20S gate opening with the 
19S subunit [75]. The 26S proteasome is a structurally dynamic complex. Indeed, many 
conformational changes take place around the central axis during the ATP-dependent 
processing of substrates. These conformational changes are necessary for substrate protein 
unfolding and injection into the 20S core particle [76]. Ubiquitin-dependent proteasomal 
degradation requires several steps: (i) substrate binding, (ii) 20S gate opening, (iii) substrate 
unfolding and translocation, and (iv) deubiquitination.  
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First, the 19S regulatory particle has three integral subunits that serve as substrate 
receptors: Rpn1, Rpn10, and Rpn13. These substrate receptors reversibly associate with 
ubiquitin and have only low affinity for mono-ubiquitin this is why substrates destined for 
? ???
degradation require poly-ubiquitination [77]. The multiplicity of ubiquitin receptors coupled 
with a variety of shuttling factors, such as proteins that have a ubiquitin-like (UBL) domain 
and a ubiquitin-associating domain (UBA), allows the 26S proteasome to recognize and 
degrade many types of ubiquitin conjugates [78]. Substrate binding to the ubiquitin receptors 
induces a conformational change aligning the 19S ATPase translocation channel directly over 
the 20S gate [79], induces gate opening, and stimulates ATP hydrolysis [80]. 
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Substrate insertion requires a poorly folded region of the protein and particularly an 
unstructured initiation site. Substrate is then inserted into the ATPase ring in an ATP-
dependent manner [81]; the six ATPase subunits (Rpt1–6) form a ring at the bottom of the 
19S complex with their C termini inserting into the 20S inter-subunit pockets, likely inducing 
a conformational change in the subunits, opening the gate [82]. 
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Tyrosine pore loops inside the ATPases tightly associate with the substrate enabling 
substrate unfolding and translocation into the 20S core [78]. The six ATPase subunits ensure 
processive unfolding and translocation of substrates into the 20S core coupled with ATP 
hydrolysis [29]. 
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Rpn11 is a proteasome-associated deubiquitinase enzyme of the 19S complex that is 
positioned directly above the translocation channel. When the substrate is committed for 
degradation, Rpn11 removes the entire ubiquitin chain as the protein is translocated. Two 
other deubiquitinases are transiently associated with proteasomes (Usp14 and Uch37) and can 
trim substrate ubiquitin chains prior to the commitment step, rescuing the substrate from 
degradation which constitutes an important regulatory checkpoint [77]. 
In addition to the general process of proteasomal degradation described above, other 
proteasome gate activator families exist, 11S and PA200/Blm10, neither of which contains 
unfoldase activity or require ATP. These other proteasome activators are specific of some 
other cellular processes [74]. Indeed, the proteasome gate PA200 was demonstrated to play a 
crucial role in spermatogenesis [83] to thus form the spermatoproteasome crucial for sperm 
maturation and viability [84]. The existence of interchangeable proteasome subunits allowing 
? ???
for different proteasome “combinations” highlights the flexible cell repertoire of proteasome 
complexes tailored for specific cellular roles. 
Proteasome is the last component in the ERAD. Because of its dominant role in the 
degradation of proteins, any inhibition would lead to an accumulation of misfolded proteins.  
The ERAD is initiated when the folding process does not succeed to properly fold proteins as 
it is presented in the Figure 8-. If the protein is properly folded after the involvement of 
different chaperones the protein will be exported (pathway c.). Otherwise it is the ERAD 
pathway that will be activated, and the protein will go from the step b. to d. Consequently, if 
both folding and ERAD are not enough to fulfill ERQC by drastically reducing the load of 
misfolded proteins, the cell will enter in a stress state which will activate a particular pathway 
known as the UPR as it is summarized in the figure 9-. 
 
Figure 8- The ER Quality Control (ERQC) Machinery. Two main chaperone systems, the lectins 
CNX/CRT (a) and the Hsp70 chaperone BiP (b), aid the folding proteins for secretion (c) or if folding fails, 
target them for ERAD (d). (a) The oligosaccharyl transfer (OST) complex attaches a core oligosaccharide from a 
dolichol donor to the Asn of the Asn-X-Ser/Thr motif on nascent proteins during their translocation into the ER. 
GlcI and II remove the outer two glucose residues of the oligosaccharide, allowing the remaining glucose to be 
recognized by CNX/CRT. CNX/CRT assists protein folding in concert with further co-chaperones such as the 
protein-disulfide isomerase ERp57. Proteins exit the CNX/CRT cycle once the last glucose residue is removed 
by GlcII. If folded properly, the protein is released from the lectin chaperone cycle and is transported further 
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along the secretory pathway. Incompletely folded intermediates can re-enter the CNX/CRT cycle if a single 
glucose is re-attached by the folding sensor UGT. If folding ultimately fails, proteins are further trimmed by 
ERManI and/or an EDEM resulting in removal of 4 mannose residues and recognition by OS-9 and XTP3-B, 
which then transfer the trimmed glycoprotein to the ERAD machinery for disposal. (b) The Hsp70 chaperone. 
BiP binds hydrophobic patches exposed on nascent or incompletely folded proteins that are often non-
glycosylated. BiP possesses low substrate binding affinity in the ATP-bound state and high affinity upon 
hydrolysis of ATP to ADP. Grp170 and Sil1 facilitate substrate release from BiP by stimulating the release of 
ADP and allowing ATP to rebind and open the lid on the substrate binding domain. Seven ERdj co-factors have 
been identified that interact with BiP via their J-domain and assist BiP in its functions during protein 
translocation (ERdj2), protein folding (ERdj3 and 6) and ERAD (ERdj4 and 5). The functions of ERdj1 and 
ERdj7 are not well understood, nor is the role of the large Hsp70, Grp170, that also binds to some incompletely 
folded BiP client proteins. (c) Once the threshold of folding set by the ERQC is met, proteins exit the ER in 
COPII-coated vesicles, a process that is initiated by Sec12 and driven by a GTPase, Sar1, and four major coat 
proteins, Sec23, Sec24, Sec13 and Sec31. (d) Once proteins that are clients of either chaperone system are 
delivered to the ERAD machinery, their retrotranslocation into the cytosol is facilitated by a complex of several 
transmembrane proteins including Sel1, Derlins, VIMP, Herp and Hrd1, which connect the machinery in the ER 
lumen to the protein ubiquitination machinery in the cytosol, allowing the ERAD client to be recognized by the 
p97 hexameric ATPase in the cytosol that provides the energy for extracting a protein from the ER for 
degradation by the 26S proteasome. Figures and legends extracted from [24]. 
 
Figure 9- The general ERAD pathway for degradation of misfolded ER proteins. ERAD is 
initiated on the recognition of non-native proteins as aberrant molecules by quality control receptors. These 
terminally misfolded or unassembled proteins are then sorted to an ER-membrane-associated 
dislocation/ubiquitination complex containing adaptor proteins that recognize the quality control receptor and/or 
the ERAD substrate directly. A translocon then acts as a conduit for the retrotranslocation of the protein to the 
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cytosol, and this process is often coupled with ubiquitination by an ER-associated E3 ubiquitin ligase. Cytosolic 
components are also recruited to the retrotranslocation complexes to aid in the extraction of the ERAD substrate 
from the ER and prepare the substrate for proteasomal degradation. Figures and legends extracted from [85] 
3-) Unfolded Protein Response 
 
As mentioned above, the ER tries to ensure efficient quality control of protein 
biogenesis coordinating the action of its several chaperones and the ubiquitin-proteasome 
system in order to properly fold proteins or to degrade misfolded proteins. In order to restore 
homeostasis and to fight against “protein-toxic” stress or more generally ER stress, cells can 
activate a signaling pathway called UPR that results in the reprogramming of a series of 
events that can be either pro-survival or pro-death, depending on the extent of the damage or 
the length of the stress [13,86].  
 
In yeast, ER stress results in the upregulation of a large cluster of genes involved in 
protein folding, quality control, and secretion. While in mammals, the UPR has evolved a 
complex network of interconnected signaling pathways initiated by the stimulation of three 
signal transducers located in the ER known as Inositol-REquiring protein 1 (IRE1) (α and β), 
activating transcription factor- 6 (ATF6) (α and β) and protein kinase RNA (PKR)-like ER 
kinase (PERK) [87]. Activation of the UPR will play on two temporally distinct cellular 
events to fight against protein misfolding: an initial reaction to reduce protein synthesis and 
enhance degradation of misfolded proteins and a second wave of transcriptional upregulation 
of hundreds of target genes involved in ERQC, including those implicated in protein folding 
and ERAD. The ER chaperone BiP/Grp78 previously introduced in the folding process is also 
fundamental for the activation of the three main sensors. Upon ER stress, BiP binds to 
misfolded proteins through its substrate binding domain, operating as an allosteric regulator to 
release the sensors IRE1, ATF6 and PERK [88]. Under basal conditions, BiP associates with 
the ER luminal domain of PERK and IRE1α via its ATPase domain, maintaining them in an 
inactive monomeric state [88]. When stress is induced, the ER relies on its three distinct UPR 
branches to first attempt to overcome this stress and restore homeostasis. However, when the 
stress conditions are too intense and cannot be controlled, the UPR activates a cell death 
pathway, generally via intrinsic apoptosis involving the mitochondria [89,90]. In fact, ER 
stress is primarily a pro-survival adaptive response against different types of cellular troubles. 
 
? ???
a-) UPR for homeostasis: the adaptive UPR 
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IRE1 was the first pathway characterized genetically in S. cerevisiae, leading to the 
identification of a signaling pathway between the ER and the nucleus in cells witnessing the 
stress of unfolded protein accumulation [91]. This pathway is involved in ERAD 
enhancement, regulation of lipid synthesis and protein secretion. 
IRE1 is the most conserved UPR signaling branch. It is a transmembrane protein with 
an N-terminal ER luminal sensing domain and a cytosolic C-terminal domain containing a 
serine/threonine kinase and an endoribonuclease (RNase) [92,93]. There are two IRE 
isoforms, IRE1α and IRE1β; the first one is expressed ubiquitously on ER membranes, while 
the second one is found only on epithelial cells of the gastrointestinal tract [90]. In the context 
of this introduction we will focus only on IRE1α. 
In response to unfolded protein accumulation in the ER, IRE1 dissociates from BiP, its 
luminal domain self-associates, causing its own dimerization and trans-autophosphorylation. 
This in turn induces a conformational change that activates its RNase domain to catalyze 
excision of a 26-nucleotide intron within the X-Box Protein 1 (XBP1) gene [92,93].  The 
spliced form of XBP1 controls the expression of genes encoding factors that modulate protein 
folding, secretion, ERAD, protein translocation into the ER and lipid synthesis [94]. 
The efficiency of XBP1 mRNA splicing is regulated at different levels. For example, 
the delivery of its mRNA to the ER membrane is mediated by the transient expression of the 
unspliced form of XBP1 (XBP1u). Although XBP1u is very unstable and rapidly degraded by 
the 26S proteasome, during its translation, the nascent chain docks the ribosome to the ER 
membrane allowing the efficient processing of XBP1 mRNA in the cytosol [95,96]. In 
addition, the selective targeting of the XBP1u mRNA to the ER membrane is mediated by a 
direct interaction of IRE1α with the Sec61 translocon [97]. Interestingly, the XBP1u mRNA 
is delivered to the IRE1/Sec61 complex by docking of its nascent protein to the classical 
signal-recognition particle pathway through the hydrophobic domain. After cleavage of XBP1 
mRNA, the tRNA ligase RtcB completes the cytosolic splicing event, leading to the 
expression of XBP1s [98], a hallmark of activation of the IRE1 UPR pathway. 
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As IRE1, PERK is also transmembrane protein kinase associated with BiP in its 
inactive form that gets activated after BiP dissociation. The role of this UPR pathway is to 
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inhibit general protein translation through the phosphorylation of eukaryotic translation 
initiator factor-2 (eIF2α) [12]. which blocks the recycling of eIF2α in its active GTP-bound 
state, needed for starting polypeptide chain synthesis. This event thus reduces the overload of 
ER translocating proteins in a stressed cell but also allows the selective translation of the 
mRNA encoding the transcription factor ATF4, contributing to reinforcement of an 
antioxidant response, enhancement of the folding capacity of the ER, upregulation the 
transcription of growth arrest and upregulation of autophagy [99-101] 
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ATF6α is also an ER transmembrane protein that contains a bZIP transcription factor 
on its cytosolic domain, a member of the leucine zipper family. As IRE 1, ATF6 also has 2 
isoformes ATF6 α and β.  
Following UPR activation, ATF6 translocates to the Golgi apparatus, where it is 
cleaved by the proteases S1P and S2P in a cytosolic fragment cleaved ATF6 α [102]. In this 
active form, it translocates to the nucleus and acts as a transcription factor. It will cause 
upregulation of a select set of UPR genes presenting ATF/cAMP response elements or ER 
stress response elements (ERSE) within their promoter. Upregulated genes include those that 
enhance the ERAD pathway such as BiP, and protein disulfide isomerase [103]. Unlike 
ATF6α, ATF6β is not crucial in responding to UPR or regulating ER chaperones. Moreover, 
ATF6β has been shown to inhibit ATF6α-mediated activity during UPR [104]. 
ATF6α was also shown to regulate the transcription of ERAD components. Levels of 
ERAD components, including EDEM, HRD1 and Herp. Herp is also a very important player 
in ERQC and will be further described below. All these critical regulators were found to be 
lower in ER stress-induced ATF6α−/− mouse embryonic fibroblasts (MEFs) compared to 
ATF6α+/+ MEFs (Hirsch 2013 Apoptosis). 
Finally, it has also been shown that ATF6 can associate with XBP1s by forming 
heterodimers, which may drive specific gene expression programs [105]. This final example 
perfectly illustrates the interconnexion between the different UPR pathways (Figure 10-). 
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Figure 10- Unfolded protein response activation during Endoplasmic Reticulum (ER) 
stress conditions. Accumulation of misfolded proteins in endoplasmic reticulum induces the activation of 
three ER stress sensors. Figures and legends extracted from [106]. 
 
b-) UPR for cell death: the terminal UPR 
?
If the adaptive responses fail to restore protein-folding homeostasis, UPR signaling 
continues to persist and can progress into a signaling program called the “terminal UPR” that 
promotes apoptosis (see Figure 11-) [107]. Strong evidence supports that the two UPR 
kinases, PERK and IRE1α, engage a distinct set of pro-apoptotic genes that contribute to cell 
degeneration and death if ER stress cannot be resolved. For example, while a temporary pause 
in protein translation due to eIF2α phosphorylation can be beneficial by reducing secretory 
load, a prolonged block in translation from sustained PERK signaling is incompatible with 
survival [108]. 
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Figure 11- ER Stress-Induced Apoptosis Pathways. When exposed to chronically high levels of ER 
stress, PERK and IRE1 both drive multiple signaling outputs that lead to cell dysfunction, activation of the in- 
flammasome, and apoptosis. A key step in the regulation of apoptosis is the crosstalk between the ER and 
mitochondria through transcriptional and post- translational modifications of members of the BCL-2 family of 
proteins. In addition, calcium release from the ER and exacerbated protein synthesis and ROS production may 
influence the induction of apoptosis. Figures and legends extracted from [13] 
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As described above, IRE1 RNase is involved in the splicing of XBP1. But its RNase 
activity also regulates the stability of multiple RNAs through a direct endonucleolytic 
cleavage reaction in a process known as regulated IRE1-dependent decay (RIDD). When 
hyperactivated by chronic ER stress, phosphorylated IRE1α assembles into high-order 
oligomers. These associations allow the RNase domain to acquire affinity for RIDD 
substrates, causing massive endonucleolytic decay of hundreds of these ER-localized 
mRNAs. Consequently, it will lead to degradation of ER and protein-folding components that 
will further worsen ER stress [109]. RNA substrates include mRNAs, ribosomal RNA and 
microRNAs which have important biological functions in the control of glucose metabolism, 
inflammation and apoptosis [110]. 
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IRE1α oligomerization under irremediably high levels of ER stress also induces 
activation or upregulation of a number of pro-inflammatory and pro-apoptotic proteins. For 
example, when hyperactivated, IRE1 RNase reduces the levels of select microRNAs that 
normally repress pro-apoptotic targets, such as thioredoxin-interacting protein (TXNIP), 
leading to their rapid upregulation. Increased TXNIP protein levels then activate the NLRP3 
inflammasome and its caspase-1-dependent pro-death pathway, leading to sterile 
inflammation and pyroptotic cell death [111]. 
Sustained IRE1α activity may serve as an activation platform. It can associate with 
many different proteins, in which the nature of the associated proteins will engage different 
cellular responses. For instance, association with apoptosis signal-regulating kinase 1 (ASK1) 
and its downstream target c-Jun NH2-terminal kinase (JNK) may regulate apoptosis under 
chronic stress [112,113]. Another example, ABL kinase family members hyperactivate IRE1α 
RNase at the ER membrane to promote apoptosis. While other interactions with the adaptor 
proteins Nck engages nuclear factor κB (NF-κB) [114,115].  
Fortunately for the cell, the kinetics and amplitude of IRE1α signaling are also 
controlled by the binding of positive and negative regulators including several proteins 
previously linked to apoptosis, including members of the BCL-2 family or BH3-only proteins 
[116,117]. The BCL-2 family (Bak, Bax, Bim, Puma, and Noxa) is a large class of both pro- 
and anti-death proteins whereas BH3-only proteins are another class of exclusive pro-
apoptotic proteins with Bim and Puma. These 2 proteins were shown to selectively enhance 
the sustained signaling of IRE1α [118].  
In contrast, the ER-located protein BAX inhibitor-1 (BI-1) interacts with the cytosolic 
domain of IRE1α accelerating its attenuation after prolonged ER stress [119]. Other proteins, 
such as Fortilin, were recently shown to inhibit IRE1α signaling through a direct interaction, 
increasing cell death resistance under ER stress [120]. In addition, another study suggested 
that IRE1α levels are also controlled by the ERAD pathway, a process that unexpectedly 
depends again on BiP. It was proposed that, under ER stress, BiP is released and IRE1α is 
stabilized [121]. Thus, multiple checkpoints regulate IRE1 signaling through distinct protein-
protein interactions, defining the precise threshold of stress necessary for its activation. 
β?????????????????
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PERK under chronic ER stress and sustained ATF4 expression contribute to induction 
of apoptosis with the activation of downstream genes such as CHOP and HERP [122,123]. 
This latter protein will be discussed in the next part. 
Upregulation of the CHOP transcription factor inhibits the expression of the gene 
encoding anti-apoptotic BCL-2 to hasten cell death. CHOP represents a crucial player in ER 
stress-mediated cell death and all three branches of UPR can affect CHOP expression [124]. 
Nevertheless, PERK and ATF6 are the most involved branches that can sustain CHOP 
upregulation. During persisting ER stress, ATF4 and CHOP promote cell death by activating 
genes involved in protein synthesis, such as GADD34 and endoplasmic reticulum 
oxireductin1α (ERO1α) [125]. GADD34 induces the dephosphorylation of eIF2α and thus 
restores protein synthesis. If the protein synthesis is over-regulated, it saturates the system 
with accumulation of high amount of proteins that worsen the ER stress. ERO1α, which is 
involved in the oxidation of PDI, leads to a condition of hyper-oxidation in ER which is 
deleterious for cell [126]. Moreover, by augmenting ERO1α expression, CHOP also promotes 
Ca2+ release via channel inositol 1,4,5-triphosphate receptor (IP3R) from ER to the cytoplasm. 
The increase of Ca2+ in the cytoplasm activates the calcium/calmodulin-dependent protein 
kinase II (CaMKII), which acts as an upstream molecule regulating apoptosis (Ozcan 2010 
Cell Cycle). 
CHOP can also directly induce apoptosis by inducing both extrinsic and intrinsic apoptotic 
pathways. CHOP up-regulates death receptor 5 together with caspase-8, which in turn 
generates the truncated form of Bid (tBid) and transports it into the mitochondria [127], 
activating the intrinsic apoptotic pathway. On the other hand, CHOP can also trigger the 
intrinsic pathway by decreasing the expression of anti–apoptotic Bcl-2 and Bcl-xL proteins, 
while increasing the expression of pro-apoptotic proteins such as Bak, Bax, Puma, and Noxa 
[128]. Finally, it can also enhance the expression of pro-apoptotic BCL-2 members such as 
Bim, as well as improving protein synthesis and oxidative stress [108]. 
c-) General conclusions on UPR  
?
In mammals, the activation of ER stress sensors involves the chaperone BiP, in 
addition to the binding of misfolded proteins to engage an optimal UPR response. It is 
important to keep in mind that other ER chaperones were also implicated in modulation of the 
UPR. For example, the disulfide isomerase PDIA6 binds and controls the attenuation of 
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IRE1α and PERK signaling, but not ATF6 [129]. In contrast, another disulfide isomerase 
(PDIA5) selectively regulates ATF6 activation [130] with the fact that luminal disulfide 
bonds in ATF6 modulate its translocation to the Golgi apparatus. 
The control of the temporal behavior of UPR signaling is fundamental in determining 
the fate of a cell under ER stress, although the mechanisms explaining the transition from 
adaptive to a terminal pro-apoptotic UPR are not completely established yet [13,131]. Under 
conditions of mild ER stress, activation of XBP1 mRNA splicing is transient, leading to its 
attenuation after prolonged stimulation, which may sensitize cells to undergo apoptosis [132]. 
In contrast, the activity of RIDD under increased IRE1α oligomerization is sustained over 
longer periods of time [133].  
Initially, studies viewed UPR signaling as a direct and linear transduction of ER stress 
levels. However, recent findings have indicated that the three major UPR sensors are tightly 
regulated through post-translational modifications and the binding of cofactors. A new 
concept has recently been described: the UPRosome. This term was mainly associated to 
IRE1, considered as a scaffold where many components assemble dynamically to regulate 
different signaling outputs. The UPRosome may also serve as a platform to enable the 
crosstalk between UPR and other signaling pathways [13]. Indeed, the nature of the 
components which associate to IRE1 will engage different cellular responses. Although less 
explored, PERK and ATF6 are important for ER even if PERK is more associated to terminal 
UPR. There are also subject to complex regulation that is not totally characterized and 
understood [13,134]. Overall, these selected findings illustrate the dynamic and complex 
nature of UPR signaling, where several checkpoints are established to determine downstream 
signaling responses.  
d-) UPR and immunity  
Recently, UPR was shown to be interconnected at different levels with innate immune 
response pathways. Briefly, in the innate immune response, pathogen-associated molecular 
patterns (PAMPs), for example, lipopolysaccharides or nucleic acids such as CpG DNA or 
dsRNA, are recognized by pattern recognition receptors (PRRs), such as Toll-like receptors 
(TLRs), nucleotide-binding oligomerization domain (NOD)-like receptors or retinoic acid-
inducible gene I (RIG-I) receptors. PRRs activate signaling pathways leading to the 
expression of genes involved in inflammation, immune cell regulation, survival and 
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proliferation. TLRs are amongst the most characterized PRRs [135,136]. UPR signaling was 
shown to be connected to TLR2 and TLR4. These 2 TLRs specifically activate the IRE1-
XBP1 branch of the UPR, promoting the production of inflammatory mediators (i.e., IL-6) 
[137]. Interestingly, this activation occurs in the absence of a full ER stress response, 
demonstrating that a specific arm of the UPR can be activated independently of the others. 
Recently, researchers of Tsolis lab demonstrated that NOD1 and NOD2, two members of the 
NOD-like receptor family of PRRs, which are traditionally considered as sensors of bacterial 
peptidoglycan, have a major role in inducing inflammation during ER stress [138]. This study 
is further discussed in the Chapter 3 on Brucella (section IV3-)). 
The activation of NF-κB, a key regulator for immune and inflammatory responses, has 
being also linked to UPR [139]. NF-κB activation may be dependent on the intensity of UPR. 
These new data are very exciting because they changed our perception that UPR is only 
activated for ER stress with a negative connotation. In the case of NF-κB, preconditioning 
with low dose of ER stress inducers was shown to attenuate NF-κB activation in endothelial 
cells. However, additional studies have shown that ER stress can influence NF-κB activity 
positively or negatively making it difficult to make a general statement regarding the outcome 
of UPR activation on NF-κB activation. It has been proposed that NF-κB activation by ER 
stress occurs in the early adaptive phase, whereas its inhibition occurs in the terminal phase; 
the inhibition of signaling mediated by NF-κB was shown to be dependent on induction of 
CHOP by UPR [140]. 
Finally, the UPR has been implicated in additional cellular functions not described in 
this introduction as for example in the production of reactive oxygen species (ROS) that have 
an anti-microbial role [135], consistent with an overall critical impact of UPR pathways on 
cellular responses. 
4-) ER-phagy 
 
Before describing ER-phagy, I have to briefly introduce the general concept of 
autophagy. This a cellular process which allows degradation and recycling of cellular 
components. There are three major types of autophagy: macro, micro and chaperone 
mediated-autophagy (all represented Figure 12-) [141]. Macro-autophagy more commonly 
referred to as autophagy is the best-studied type, a catabolic process that gathers all 
degradation pathways. The component to be degraded, called cargo, is engulfed by a double-
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membrane organelle termed phagophore, which eventually closes to form a vesicle called the 
autophagosome. The cargo is then delivered for degradation in the lysosome (vacuole in 
yeast), a major recycling cellular compartment [142]. However, autophagy can also 
selectively target distinct organelles and cellular structures that are damaged and/or need to be 
turned over [143].  
The 2 other types of autophagy, micro-autophagy and chaperone-mediated autophagy 
do not require autophagosome formation. During micro-autophagy invagination of the 
lysosome/vacuole membrane directly engulfs small cytosolic components [144]. In contrast, 
in chaperone-mediated autophagy, cytosolic proteins containing a KFERQ motif are 
recognized by the chaperone protein Hsp70 and directly translocate across the lysosomal 
membrane [145].  
Typical substrates and receptors of selective autophagy have LC3-interacting regions 
(LIRs) that bind to autophagosomal protein light chain 3 LC3 and γ-aminobutyric acid 
receptor-associated protein (GABARAP) family proteins. Selective substrates are directly or 
indirectly recognized by Atg8 or its homologs present on autophagic membranes [143,146]. 
Alternatively, autophagy adaptors or receptors that have LC3-interacting regions (LIRs) or 
GABARAP interaction motifs (GIMs) mediate recognition of selective substrates, often in a 
ubiquitination-dependent manner [147,148]. 
? ???
 
Figure12- Different Types of Autophagy. Macroautophagy: A portion of cytoplasm, including 
organelles, is enclosed by an isolation membrane (also called phagophore) to form an autophagosome. The outer 
membrane of the autophagosome fuses with the lysosome, and the internal material is degraded in the 
autolysosome. Microautophagy: Small pieces of the cytoplasm are directly engulfed by inward invagination of 
the lysosomal or late endosomal membrane. Chaperone-mediated autophagy: Substrate proteins containing a 
KFERQ-like pentapeptide sequence are first recognized by cytosolic Hsc70 and cochaperones. Then they are 
translocated into the lysosomal lumen after binding with lysosomal Lamp-2A.  
After all three types of autophagy, the resultant degradation products can be used for different purposes, such as 
new protein synthesis, energy production, and gluconeogenesis. Figures and legends extracted from [149] 
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a-) ER-Phagy in yeast 
 
The first studies on ER-phagy were performed in yeast. The ER provides membranes 
for autophagosomes and is itself a target of autophagy. In yeast, selective substrates are 
recognized by autophagy receptors (for example Atg19 and Atg34) containing the Atg8-
interacting motif (AIM) and are delivered to the vacuole. The term ER-phagy was used for the 
first time by Peter Walter’s group in describing how, during UPR, ER becomes selectively 
degraded by the vacuole [150]. During UPR conditions, the ER significantly enlarges its 
volume and membrane content. However, soon after, cells start to recover the initial ER 
homeostasis by eliminating superfluous membrane via vacuolar degradation [151]. Yeast ER-
phagy can also function as a detoxification system in which aggregated or unwanted proteins 
are restricted to specific ER compartments and subsequently eliminated by vacuolar 
degradation [152]. Yeasts have two ER-phagy receptors, Atg39 and Atg40, which are AIM-
containing ER membrane proteins that play key roles in sequestering ER fragments into 
autophagosomes [153]. 
 
b-) ER-Phagy in mammals 
 
In mammalian cells, degradation of ER components by autophagy, initially termed 
reticulophagy, was discovered as a back-up system for the inefficient proteosomal 
degradation of ER proteins via the ERAD pathway [154-156]. In a process equivalent to what 
has been described in yeast, ER-phagy includes the re-shaping after ER expansion upon 
stress, as well as the lysosomal degradation of protein aggregates within the ER lumen. In 
mammals, the Atg8 homologs are classified into two subfamilies: LC3 and GABARAP. The 
specialized ER-phagy receptor RETREG1 (also known as FAM134B) was the first one to be 
described and characterized [148]. Indeed, ablation of RETREG1 or inactivation of its LIR 
domain have been shown to block ER fragmentation and subsequent lysosomal degradation 
[157]. Initially, RETREG1 was described as a Golgi protein but was more recently classified 
as an intra-membrane ER-resident protein, mainly located at the edges of the ER sheets, that 
is characterized by the presence of a reticulon homology domain. RETREG1 has the intrinsic 
property to fold double layer ER membranes to form phagophore [148,157]. 
At least 3 other ER-resident proteins that bind to mammalian Atg8 have revealed that 
the selective elimination of ER involves different receptors that are specific for different ER 
subdomains or ER stresses. These include reticulon 3 (RTN) which is a protein that is able to 
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remodel the ER network and ensure the basal membrane turnover and Sec62 and Ccpg1 that 
are transmembrane ER receptors were shown to function in response to ER stress signals 
[158]. 
Previously, autophagy was thought to be a nonselective bulk degradation pathway; 
however, it is now clear that some proteins and damaged organelles are selectively recognized 
and degraded by autophagy [147,149]. Ccpg1 is closely connected to UPR because of its 
upregulation in response of UPR induction. In vivo, Ccpg1-mediated ER-phagy protects 
pancreatic acinar cells against the aggregation of ER luminal proteins. Therefore, Ccpg1 may 
act as a bridge between UPR signaling and ER-phagy in a physiological context [159].  
However, in contrast to what is seen in yeast, mammalian cells do not appear to use 
micro-autophagy to re-establish ER shape and homeostasis. This is ensured by the translocon 
component Sec62, that can mediate ER-phagy through a LIR motif in its C-terminal cytosolic 
domain [160]. 
As a summary RETREG1 RTN3, CCPG1 and Sec62 functions may be 
spatiotemporally different [158,161]. RETREG1 and RTN3L are important for starvation-
induced degradation of ER sheets and tubules, respectively [158]. CCPG1 is induced during 
ER stress and activates autophagic degradation of peripheral ER [159]. 
ER-phagy is still an emerging pathway, this is why there are few studies about the 
topic. In 2019 Chino et al. [162] identified a new receptor for autophagic degradation, the 
protein Tex264. TEX264 interacts with LC3 and GABARAP family proteins more efficiently 
and is expressed more ubiquitously than previously known ER-phagy receptors. 
Finally, another recent study also identified ATL3 as an ER-Phagy Receptor for 
GABARAP-mediated autophagy [163]. This is interesting because ATL3 belongs to atlastins 
family. Atlastins (ATL1, ATL2, and ATL3), in mammals, are a class of membrane-bound, 
dynamin-like GTPases that function in ER fusion. Authors show ATL3 specifically binds to 
GABARAP, but not LC3 via 2 GIMs. The specificity of binding to GABARAP motif may 
lead to a specific ER-phagy process but much remains to be discovered. All these data of ER-
phagy are summarized in Figure 13-. 
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Figure 13- ER-phagy is mediated by ER-phagy receptors localized to distinct 
subdomains of the ER. FAM134B is restricted to the curved edges of ER sheets. RTN3 is found 
exclusively on ER tubules. Sec62 is localized to ER sheets following ER-stress. CCPG1 is found in areas of the 
ER with high content of insoluble proteins. The currently known receptors do not interact or functionally 
cooperate with each other. All of them contain LIR domains that are able to bind to LC3/GABARAP-decorated 
autophagic membranes. The process of ER-phagy can be summarized in four steps: 1) cargo sequestration via 
interaction between LIR and LC3/GABARAP; 2) closure of the autophagic membrane (aka isolation membrane) 
around the cargo; 3) fusion of the resulting autophagosome with the lysosome; 4) degradation of the enclosed 
ER fragments by lysosomal hydrolases and acidic pH. Figures and legends extracted from [164] 
  
III-) Herp is a central regulator in the ERQC 
Homocysteine-inducible ER stress protein (Herp) is an ER membrane–integrated 
chaperone-like protein which is a crucial actor of many cellular processes in the ER, very 
important for ERAD in the retrotranslocation and degradation processes [65]. Due to its 
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importance for my PhD project, I decided to dedicate one section of this introduction for this 
protein. 
Indeed, Herp (Usa1 in yeast) is demonstrated to be strongly upregulated by ER stress 
and plays an essential role in ERAD through the interaction with Hrd1, the translocon 
component Derlin1, the ATPase p97, and the proteasome [165-167]. Herp participates in the 
retrotranslocation process of ubiquitylated proteins from the ER to proteasomes for 
degradation thanks to its two important domains: UBA et UBL [165,168,169]. Moreover, 
highlighting its importance for the cell, Herp depletion accelerates ER stress-induced 
apoptosis and suppresses ER stress-induced inflammatory reactions [165,170]. Although 
primarily associated with the ER membrane, Herp can also accumulate in the trans-Golgi 
network [171].  
Even though Herp expression is strongly enhanced by UPR, after ER stress induction, 
Herp is also rapidly degraded by Ube2g2–gp78-mediated ubiquitylation and proteasomal 
degradation[165]. At the molecular level, the polyubiquitylation of Herp in vitro depends on 
its physical interaction with the CUE domain of gp78. And the UBL domain of Herp, is 
essential for Herp degradation in vivo during ER stress recovery. Although Herp promotes 
cell survival under ER stress conditions, sustained high levels of Herp expression can 
ultimately reduce cell viability under oxidative stress conditions, suggesting that Herp plays a 
dual role in adaptation to cellular stress [172].  
Consequently, a major question that remains unanswered is how Herp expression is 
regulated according to different levels of ER stress and how Herp switches its pro-survival to 
pro-death activity. Many studies have investigated the consequences of Herp depletion or 
overexpression. Knockdown or knockout of Herp were shown to stabilize several ERAD 
substrates [173,174]. Overexpression of Herp can protect cells from ER stress-induced 
apoptosis, mainly by interaction with different ERAD components as p97, Derlin1, Os9 and 
Hrd1 which stimulates degradation of aberrant ER proteins [165,169,175,176]. Gp78 appears 
to be an Herp regulator because it can ubiquitinate Herp in vitro which leads to its degradation 
in cells [177]. Gp78-mediated Herp turnover represents another way of controlling the Herp 
protein level in addition to transcriptional upregulation by ER stress inducers [123,165]. 
At the cellular level, during ER stress, Herp assists Hrd1 in mediating ubiquitination 
of aberrant ER proteins. After substrates are eliminated, the UBL domain in Herp functions as 
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a ubiquitin moiety and is recognized by the CUE domain of gp78. As described previously, 
Gp78 cooperates with Hrd1 in ubiquitin chain assembly. As a result, HERP is ubiquitylated 
and degraded, thus initiating the ER stress recovery process [178] 
Herp was first shown to be highly upregulated by the PERK branch (Ma 2004 Journal 
of Biological Chemistry) but it now appears that all the UPR pathways directly or indirectly 
overregulated Herp [13].  
Herp is therefore highly unstable and quickly degraded by proteasomes. Any situation 
that compromises proteasomal activity will increase the levels of Herp and lead to ERAD 
complex recruitment and compartmentalization. As Herp has the ability to assemble a 
complex containing the ERAD components Hrd1, Sel1, OS-9, Derlin-1 [169,179], 
proteasomes and the ubiquitinated substrate [173] it has been proposed that Herp is a master 
organizer of the ERAD machinery. 
IV-) ER stress, UPR and bacterial pathogens 
 
As mentioned before, the UPR is induced in response to a wide variety of cellular 
perturbations. Microbial infections have long been known to cause stress on the ER and to 
induce the UPR, especially viral infections probably due to their strict dependency on host 
protein synthesis. Indeed, several viruses modulate the UPR to ensure viral protein 
production, replication and cell survival [180]. Furthermore, to gain entrance to the cytosol 
where they exert their destructive capabilities several viruses were shown to hijack the ER 
quality control machinery [181]. Not surprisingly, many bacterial pathogens also interfere 
with UPR and ERQC. Many of these changes are also induced by intracellular bacterial 
pathogens, which subvert the host immune response and cellular processes to establish a 
compartment that allows their survival and replication. However, this is still an emerging field 
with only a few studies available. We will see in the next sessions that according to the 
pathogens the UPR can be activated or inhibited. This is mainly dependent on the necessity of 
the bacteria to keep host cell alive or not. Nonetheless, there are still exceptions as we will see 
with Brucella that in specific cells types, induction of ER stress generates inflammation, cell 
death and dissemination in the environment [138]. 
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1-) Bacteria that induces ER stress 
?
This section does not aim to make an exhaustive list of pathogens that induces UPR. I 
decided to select 4 pathogens that induces UPR in order to kill cells and 4 others that instead 
benefit from UPR induction by maintaining cells alive and further controlling the 
consequences of UPR activation. The specific case of Brucella will be discussed in a 
dedicated Chapter 3. 
 
a-) Mycobacterium tuberculosis 
 
Mycobacterium tuberculosis is a strict aerobic mycobacterium that is responsible of 
tuberculosis [182](Fogel 2015 Tuberculosis). It represents a major public health issue 
nowadays because of the increase of multi-drug resistant strains [183], with 8.7 million of 
new cases and 1.4 million deaths recently reported [184]. Overall, infection leads to the 
induction of an apoptotic response. The early secreted mycobacterial antigen ESAT-6 of 
Mycobacterium has been identified as an apoptosis inducer in human macrophages and 
epithelial cells. In the study of Choi et al. [185], they demonstrated that the stimulation of 
human epithelial A549 cells by ESAT-6 also induces the ER stress response with an increase 
of intracellular Ca2+ concentration. This calcium perturbation results in reactive oxygen 
species (ROS) accumulation, and therefore induces the molecular hallmarks of ER stress-
induced apoptosis [185]. Few years later, another study showed XBP-1 splicing was increased 
by the same mycobacterial secreted protein ESAT-6. An increase of BiP and CHOP mRNA 
expressions and protein levels after ESAT-6 treatment in A549 cells was also observed. They 
also visualized an increase of eIF2α phosphorylation and ATF4 expression which are both 
associated to the PERK branch of UPR. They also showed that ESAT-6 induced CHOP 
expression, consistent with pro-apoptotic phenotype during infection, was dependent on the 
ASK1/JNK signal cascade which is connected to IRE1 pathway. Indeed, ESAT-6 association 
with IRE1α/ASK-1/JNK causes apoptosis following ER stress induction. More precisely at 
the molecular level it has been shown that IRE1α binds to TRAF2, and the resultant 
IRE1α/TRAF2 complex leads to ASK1-JNK activation [112,113]. Once the complex 
IRE1/ASK-1/JNK is associated, it leads to significant caspase activation which further 
regulates CHOP expression during the mycobacterial infection of macrophages. This explains 
why XBP1 splicing is also increased. ESAT-6 acts at two different levels of the UPR, playing 
an important role in Mycobacterium pathogenesis. 
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These studies on Mycobacterium have also shown that the ER stress-mediated 
apoptosis plays an important role in bacterial pathogenesis [185-187]. Recent evidence 
suggests that HBHA, another protein secreted from mycobacteria, also induces ER stress 
responses via intracellular Ca2+ release [186], resulting in ER stress-mediated apoptosis in 
macrophages.  
 
b-) Listeria monocytogenes 
 
Listeria monocytogenes is a Gram-positive facultative intracellular bacterium that is 
mainly transmitted by the ingestion of contaminated food [188]. The bacteria were shown to 
induce ER expansion as well as UPR prior to entry into host cells. Listeria is an inducer of all 
three ER stress sensors and the main bacterial virulence factor identified is the famous toxin 
listeriolysin (LLO) because a mutant strain of Listeria that does not produce LLO lacked the 
UPR response. As Mycobacterium, sustained Listeria infection with host eukaryotic cells 
resulted in apoptosis. LLO is a “swiss knife” for Listeria because it is also involved in 
membrane permeabilization during infection and can interfere with many cellular processes 
(eg SUMOylation, Ubiquitination, etc) which gives LLO a very broad spectrum of action but 
also raises the question of the specificity of its actions. Extracellular delivered LLO induces 
UPR [189]. Nevertheless, previous studies have revealed that once intracellular, LLO is 
targeted for host-mediated degradation [190]. LLO is a member of the family of cholesterol-
dependent cytolysins (CDCs) known to form large pores in target membranes that leads to the 
depletion of intracellular Ca2+ stores and it is known that rupture in calcium homeostasis 
provokes ER stress [167]. Splicing of xbp1 mRNA in effector CD8+ T cells has also recently 
been demonstrated in mice following infection with Listeria and authors suggest that it 
contributes to the differentiation of effector CD8+ T cells during acute infection [191].  
 
c-) Helicobacter pylori 
 
Helicobacter pylori is a Gram-negative bacterium that is naturally present in the 
stomach of a part of the population. But in case of acute inflammation it can lead to peptitc 
ulcer disease or the most severe form that is a stomach cancer [192]. In the case of H. pylori, 
it is autophagy that has been shown to be modulated following ER stress induction during 
infection. The secreted protein HP0175, a peptidyl prolyl cis-trans isomerase of H. pylori was 
identified to promote autophagy in gastric epithelial cells. H. pylori was shown to enhance the 
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expression of PERK and also activate the phosphorylation of PERK in an HP0175-dependent 
manner [193].?This was also accompanied by phosphorylation of eIF-2α and transcriptional 
activation of ATF4 and CHOP. Furthermore, silencing of PERK inhibited the conversion of 
LC3 to LC3II during infection. These findings suggested that the UPR is linked to H. pylori-
mediated autophagy [194].  
Conversely to Mycobacterium and Listeria, Helicobacter invokes UPR that can trigger 
apoptosis induction but rather for disturbing downstream pathways as autophagy also 
activated by UPR.  
 
d-) Orientia tsutsugamushi 
 
O. tsutsugamushi is an obligate intracellular bacterium that is the etiological agent of 
nonmalarial febrile illness [195]. This bacterium replicates in the cytosol but the host cellular 
pathways subverted by this pathogen are poorly defined [196,197].  A recent a study showed 
that the bacterium induces UPR in the first 48 h of infection in vitro and benefits from ER 
stress. Indeed, in the same period to profit of amino acid nutrients, O. tsutsugamushi also 
impedes ERAD to accumulate misfolded proteins. Interestingly after 72h pi, Orientia reverses 
this process because ER stress is then attenuated and ERAD proceeds unhindered. These data 
are very interesting because they highlight the adaptation of the bacterial strategy according to 
the infection kinetics which is not the same at the early and late stages of infection. The 
authors demonstrated that a prolonged inhibition of ERAD using RNA interference results in 
an O. tsutsugamushi growth defect at 72 h. Thus, O. tsutsugamushi temporally blocks ERAD 
while ERAD-derived amino acids are needed to support its growth but afterwards it can 
switch mechanisms by controlling both UPR and ERAD. Moreover, they identified the 
effector Ank4 linked to this phenomenon. Indeed, they show that ectopic expression of Ank4 
blocks ERAD, a phenotype that was confirmed during O. tsutsugamushi infection. Besides 
they demonstrated Ank4 interacts with Bat3, a eukaryotic chaperone that is essential for 
ERAD and especially in retrotranslocation and degradation processes. This is the first study 
which presents how a bacterial pathogen interferes with ERQC processes and ERAD to 
satisfy its nutritional virulence requirements [197]. 
 
At molecular level they have shown that Bat3 knockdown did not abolish O. 
tsutsugamushi growth what is not surprising given the redundancy of eukaryotic actors in 
ERAD process. Moreover, O. tsutsugamushi as Helicobacter can also induce autophagy 
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without being cleared [193,198]. It is reasonable to think that autophagy may help ERAD to 
degrade proteins that are accumulated during infection. Amino acids resulting from autophagy 
have been shown to be beneficial for intracellular growth of Anaplasma phagocytophilum, 
Helicobacter pylori and Ehrlichia chaffeensis [199,200], which are also obligate intracellular 
bacteria that belong of the order Rickettsiales with O. tsutsugamushi. As a final hypothesis 
authors suggest Orientia alternates autophagy and ERAD to always have nutrients at different 
steps of infection. 
This elegant study highlighted a novel strategy used by an obligate intracellular 
bacterium to finely modulate cellular ERQC processes to facilitate its replication. This may be 
a common strategy employed by diverse intracellular pathogens. Finally, this type of study 
identified the UPR and ERAD pathways that bacterial pathogens modulate as possible 
pharmacologic targets for treating infectious diseases. 
 
2-) Bacteria that inhibit ER stress 
 
Because UPR is connected to apoptosis and immunity processes, several pathogens 
subvert the UPR to ensure their survival inside their hosts and to avoid activation of immune 
mechanisms of the host. Moreover, because some intracellular bacteria need to establish a 
safe niche, often in very close association with the ER, they use an arsenal of weapons to 
interfere at different levels of UPR.  
 
a-) Chlamydia order 
α????? ?????????????????
 
Simkania negevensis is a Gram-negative, obligate intracellular bacterium that belongs to the 
order of Chlamydiales. Simkania-containing vacuoles in infected eukaryotic cells were shown 
to be associated with the ER and close to mitochondria [201]. Simkania can be maintained in 
eukaryotic cells for more than 10 days as it strongly inhibits host apoptosis. Simkania 
negevensis was also shown to interfere with UPR by blocking translocation of the 
transcription factor CHOP into the nucleus. Therefore, authors speculated that S. negevensis 
knockdown of CHOP inhibits ER-stress induced apoptosis [201]. However, the infection 
cycle is more complex as at early stages of the infection Simkania induces an ER-stress 
response, which is later downregulated. Indeed, authors showed that induction of ER-stress 
with chemical drugs as thapsigargin or tunicamycin was strongly inhibited in cells infected 
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with Simkania. Similarly, Simkania interfered with chemically induced ER-stress 
cycloheximide (that indirectly induces ER stress by inhibiting host protein synthesis) in 
infected cells indicating that the pathogen actively inhibits the cellular ER-stress machinery. 
Simkania blocked BiP upregulation at the protein level which is a rather late event in ER 
stress. In contrast, translocation of transcription factor CHOP is blocked at early time points 
and CHOP appears to be retained within the Simkania-containing vacuoles. The association 
between bacteria, mitochondria and ER also places Simkania in a perfect position to establish 
an anti-apoptotic response based on ER-stress inhibition mechanisms.  
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Chlamydia pneumoniae causes acute infections of the upper and lower respiratory 
tracts. Species of the genus share a unique biphasic developmental cycle [202] with a 
persistent latent form and a more infectious productive phase. These 2 states are very 
important and have distinct impacts on UPR processes. Furthermore, persistent Chlamydia 
infection was associated with the pathogenesis of chronic lung diseases such as chronic 
obstructive pulmonary disease and asthma [203]. In productive infection, Chlamydia 
trachomatis inclusions directly interact with the ER and the Golgi apparatus to acquire 
nutrients from host cells [204]. Direct interactions of Chlamydia pneumoniae with the ER are 
essential for intracellular productive infection. Besides, the ER resident chaperone BiP was 
also identified as an important player Chlamydia pneumoniae infections [205]. In this study, 
authors observed BiP induction at the very early stage of infection and during the persistent 
phase along with reduced phosphorylation of eIF2α. However, in the late phase of IFN-γ-
induced productive infection BiP expression is downregulated accompanied by 
phosphorylation of eIF2. This is consistent with an active on/off control of BiP expression to 
ensure that at the end of infection cycle loss of BiP function results in host cell apoptosis 
important for Chlamydia dissemination [206,207]. 
To conclude BiP plays a key role to restore cells from stress conditions at the early 
stage of infection in order to establish a persistent form of the bacteria. But it can also be 
downregulated further to allow bacteria to finish its infection. 
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b-) Legionella pneumophila 
 
Legionella pneumophila is a Gram-negative facultative intracellular bacterium 
responsible for a pneumonia also-called Legionnaire’s disease [208]. It has been shown in 
several studies that this pathogen also interferes with UPR [209-212]. The used mechanisms 
of this pathogen provide a good example of how sophisticated can be the bacterial strategy to 
interfere with UPR. Furthermore, it also illustrates that scientific community has to be very 
careful on the interpretation of some results when studying UPR modulation by pathogenic 
bacteria. 
Indeed, L. pneumophila was demonstrated to induce a global repression of protein 
translation in the infected host [210,212]. Furthermore, it was also shown that Legionella 
infection impacts mTOR activity which is associated to translational process and confirms 
this first set of data. Afterwards, it was shown that this inhibition relies of five T4SS L. 
pneumophila effectors Legionella glucosyl transferases1,2 and 3 (Lgt1, Lgt2, Lgt3, SidI and 
SidL). Indeed, These effectors modified a serine residue in eIF2α translation factor which was 
also shown to result in an inhibition of protein synthesis during L.pneumophila infection 
because the deletion of all these effectors in a mutant strain results in a defect in blocking 
translation without affecting the growth of the bacteria in both amoeba or human 
macrophages [213]. The connection between Legionella infection and hijacking of UPR 
process is correlated with 2 other studies where it has been shown that CHOP, XBP1s and 
BiP are repressed at protein levels even after use of the chemical stress inducer 
thapsigargin[209,211]. Treacy et al. [209] first demonstrated the involvement of the T4SS 
effectors as mutant strain for the secretion system does not impair host translation. Hempstead 
et al. [211] then later identified the effectors Lgt1 and Lgt2 implicated in the repression of 
XBP1s at translational level. Nevertheless, the effectors involved in CHOP and BiP 
repression remained to be found. This study of Legionella was also important as it highlights 
the precautions that we have to take in studying UPR. Indeed, for XBP1s, it was shown in the 
first time an increase of the mRNA spliced form of XBP1 but not at protein level which in 
fine indicates an UPR inhibition. 
 In parallel it has been shown that PERK pathway is largely unaffected contrary to 
IRE1 and ATF6 pathways. It might be to avoid a derived ER-stress induced apoptosis. 
regarding the 2 other pathways, even if the effectors that may repress these pathways have not 
yet been found, Legionella recruits BiP on its vacuole probably after its dissociation from the 
sensors to inhibit its function. Thus, Hempstead et al. [211] suggest this translational 
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inhibition may be a common strategy used by pathogens to limit the innate immune response 
associated with UPR by preventing enhanced proinflammatory response [211].  
 
c-) Francisella tularensis 
 
F. tularensis inhibits ER stress by controlling BiP expression and glycosylation by 
modulating expression of numerous glycosidase and glycosyltransferase genes. As it was 
previously described, glycosylation is a very important process in protein maturation for the 
secretory pathway. This is why a subversion of this process can lead to ER disorders and 
extensive ER stress. Francisella especially affects N- and O-glycosylation in infected 
macrophages. More precisely, Francisella was shown to trigger an increased expression and 
glycosylation of BiP [214]. Indeed, authors have visualized a reduced activation of PERK by 
decreased phosphorylation following by a decreased expression of CHOP. Although they 
found a weak activation of ATF6, increased phosphorylation of IRE1 was observed that 
resulted in a higher activation of IRE1 [214]. As Francisella needs to replicate inside infected 
cells, it is its interest to protect cell from death, probably explaining the differential activation 
of PERK and ATF6 in contrast to IRE1. In fact, the IRE1 pathway was shown to be important 
for Francisella replication [215]. To my knowledge, this is the only study presenting an 
example of subversion of the host glycosylation process by a bacterial pathogen, a topic that 
merits further investigation. Glycosylation is also an important process in the control of 
ERAD and the folding process. It would be interesting to know how differential glycosylation 
affects BiP and the consequences on the protein maturation process.   
 
V-) General conclusions 
 
To conclude on this section only few studies are currently published on the subversion 
of UPR by bacterial pathogens. Moreover, they all focused on the activation or inactivation of 
the main sensors of UPR pathway, but it is likely that many other molecular actors remain to 
be found. Consequently, further and deeper studies are required to have a better understanding 
of how bacteria pathogens inhibit ER stress at the molecular level. Nevertheless, a common 
strategy emerges for all of the described pathogens to modulate BiP functions because of its 
association to the three UPR sensors. In addition, PERK and ATF6 are often down-regulated 
because of its close connection to apoptosis. 
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Interestingly, invasion alone is sufficient to induce UPR, but bacteria can rapidly regulate 
different pathways to counteract this activation. Bacteria clearly have many strategies and 
tools (as secreted effectors) to finely regulate or manipulate UPR as we can see with 
Legionella, which is able to repress XBP1s at translational level using 5 different effectors.  
 
In this chapter I tried to provide a global overview of the importance of the ER for the 
eukaryotic cell. I mainly focused on protein-associated ER processes because this a subject 
that is the most documented in the literature and because it is for me a very fascinating topic. 
It is important to keep in mind that the ER is also associated with many other processes 
related to other biomolecules or metabolites with a crucial involvement in lipid synthesis and 
calcium regulation for example. The ERQC is fundamental for maintaining a healthy cellular 
lifestyle and to avoid its self-destruction. It is also crucial for some innate immune processes.  
The 4 processes described in this chapter, folding, ERAD, UPR and ER-phagy are intimately 
connected and also take part in many cellular processes. Although the UPR is now well 
described, research must be continued for ERAD and ER-phagy where the molecular 
mechanisms remain to be found. UPR, ERAD and autophagy processes were historically 
studied in yeast. These first studies provided strong and solid pedestal of knowledge. 
Nevertheless, the complexity of these processes in the human system is much higher and 
requires further development of additional models and techniques to study these pathways in 
mammals.  In addition, the intermingling between ERQC processes significantly complexifies 
the studies, making it very hard to dissect individual pathways.  The study of host-pathogen 
interactions may provide a wonderful cell biology tool to investigate deeper ER processes. 
Indeed, the action of effectors that can be directed against one pathway without affecting 
other pathways may provide a powerful tool. 
The study of how bacteria interfere with ERQC is in its early days; overall the molecular 
mechanisms remain to be determined that will help dissect the consequences for the host and 
also the benefit for the pathogens, perhaps providing novel therapeutic approaches. 
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Chapter 2 Mitochondria 
 
I-) Global overview of mitochondria 
 
Mitochondria were for a long time considered simply as the energy central of the cell 
and their sole purpose was to provide energy by oxidative phosphorylation (after the Krebs 
cycle). But today mitochondria are known to be associated to a huge variety of processes as 
apoptosis, innate immunity, autophagy (called mitophagy), redox signaling and calcium 
metabolism (Figure 14-. Moreover, it is well established they communicate with other 
organelles, although these interactions are still poorly characterized at the molecular level 
[216]. 
 
Figure 14- Overview of mitochondrial functions. Figures extracted from [217] 
 
1-) Structure and energy production 
 
? ???
 
Figure 15- Mitochondria and bacteria are both adapted for intracellular life. (a,b) 
Transmission electron microscopy (TEM) images depict (a) a dividing bacterial cell and (b) a heterogeneous 
mitochondrial population, also schematized in panels c and d. (c) Bacterial division and conjugation (transfer of 
plasmids between bacterial cells) are juxtaposed with (d ) mitochondrial fusion and fission processes. (e,f ) The 
architecture of (e) a bacterial cell and ( f ) a mitochondrion.. Figures and legends extracted from [218]. 
 
The mitochondrion is a membraned organelle that originated from the clade α-
proteobacteria, considered as a bacteria-like entity that succeeded to establish a symbiotic 
relationship with the eukaryotic cell (Figure 15-a-b) [219]. Thus, not surprising, it has an 
outer and an inner mitochondrial membrane (OMM and IMM, respectively) separated by a 
periplasm just as bacteria (Figure 14-d). Mitochondria have their own DNA called 
mitochondrial DNA (mtDNA) and specific mitochondrial proteins. The OMM is involved in 
metabolic processes between IMM and the cytosol of the cell and the release of ROS and 
mtDNA. For the IMM it is composed of 3 distinct regions: the membrane boundary, the 
cristae junctions, and the cristae [220] (Figure 15-f). The cristae are the invaginations of the 
inner membrane that allows a significant increase of the surface area. This is also the 
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localization of the different protein complexes that compose the respiratory chain which allow 
the electron transport chain to provide energy for the cell in a process called oxidative 
phosphorylation (OXPHOS); explaining why it is important that cristae to occupy the highest 
surface area as possible [221]. Before the OXPHOS there is the Krebs cycle that takes place 
in the mitochondria (see Figure 16-). OXPHOS will use NADH and FAD into the respiratory 
complex I and II, respectively to produce electrons. These electrons will move along the 
respiratory complexes of the mitochondrial respiratory chain while protons are transported 
from the matrix into the intermembrane space, it will create a proton gradient across the inner 
membrane, called the electromotive force, very much like a battery that stores energy. This 
energy will be used by the final complex of the respiratory chain the ATP synthase (also 
called complex V) which will convert ADP to ATP by adding a phosphate. A small part of the 
produced ATP is s utilized by mitochondria for its own functions and the rest is released into 
the cytoplasm as a form of chemical energy that will be used for several cellular processes 
[216]. 
 
Figure 16- The mitochondria are the powerhouses of the cell. Left: A cartoon of a 
mitochondrion showing its outer and inner membranes, the cristae, and the matrix. Fat and sugar enter the 
mitochondria through channels of the outer membrane. Right: The Krebs, or citric acid, cycle feeds the chain of 
respiratory complexes I through IV which create an electrical and proton (H+) gradient, the electromotive force 
across the inner membrane. ATP synthase utilizes the electromotive force to generate ATP from ADP and 
inorganic phosphate (Pi). Figures and legends extracted from [222] 
 
2-) Mitochondrial dynamics 
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Mitochondria can modulate their structure to create a tubular network coordinated by 
fission and fusion processes [218] making them a highly dynamic interacting organelles. The 
regulation between fusion and fission events impacts mitochondrial number size, shape and 
positioning.  Fission is the division of 1 mitochondrion into 2 daughter mitochondria whereas 
fusion is the association of 2 mitochondria in 1 mitochondrion. A deregulation of these 2 
mitochondrial processes severely impacts the mitochondrial network. At the mitochondrial 
level, an excess of fission results in fragmentation of the mitochondrial network giving rise to 
round-shape mitochondria; in contrast, an excess of fusion processes results in a hyperfused 
network with elongated and highly connected mitochondria [223]. Cycles of fusion and 
fission are required to ensure mitochondrial function but also to adapt to cellular needs for 
example to respond to nutrient availability and to the metabolic state of the cell [216,224]. 
Moreover, different morphological states are associated with multiple physiological and 
pathophysiological conditions [225]. For example, it has been found that some mutations in 
fusion and fission proteins are linked to Charcot-Maire-Tooth neurodegenerative disease 
[226,227]. 
 
a-) Fusion and fission 
 
As mentioned above, mitochondrial clusters are capable of fusion which will lead to 
the formation of an interconnected tubular network which can occupy the totality of the 
volume of the cell. At cellular level this process involves the fusion of both OMM and IMM 
of 2 separate mitochondria. Interestingly, the mtDNA of each mitochondrion becomes 
completely mixed upon fusion [228]. At the molecular level, the fusion process involves 3 
GTPases: Mitofusin 1 and 2 for OMM fusion (Mfn1 and Mfn2 respectively) and optic atrophy 
1 (OPA1) for IMM [218,229]. Astonishingly, it is the OPA1 fusion process that was shown to 
be dependent of OXPHOS while this not the case for mitofusin mediated fusion [230]. Fusion 
processes are important for maintaining mitochondrial homeostasis in case of cellular stress 
[231]. At cellular level Friedman et al. [232] demonstrated that mitochondrial fission occurs 
at positions where ER tubules contact and constrict mitochondria. These constrictions would 
facilitate the recruitment of Dynamin-related/-like protein 1 (DRP1). Mitochondrial fission 
also requires the protein Dynamin2 (Dnm2) and is carried out in collaboration with elements 
of the actin cytoskeleton [218,233,234]. The importance of the cytoskeleton is highlighted by 
the fact that Drp1 is recruited by microtubules but requires actin microfilaments for targeting 
of mitochondrial constriction sites. Interestingly, different receptors for Drp1 have been 
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identified in OMMs. Recently, syntaxin 17 has been found to be involved in mitochondria 
fission. This protein is found at the ER-mitochondria contact sites where it interacts with 
Drp1 and modulates the mitochondria fission by regulating Drp1 activity and localization 
[235]. Fission is necessary for the distribution of mitochondria during cell division and 
embryonic growth [236]. However, if fission is not controlled and balanced by fusion, the 
network becomes too fragmented which leads to metabolic and mitochondrial disorders, 
inducing mitochondrial inner membrane potential decline or the downregulation of ATP 
production [237]. 
If mitochondria fusion is reduced or impaired it will lead to mitochondrial 
fragmentation. Conversely, if this is the fission process that is targeted mitochondrial network 
become more elongated and excessively interconnected which often over-activates 
mitochondrial processes [222]. Therefore, tight regulation of these processes needs to be 
ensured to guarantee cellular homeostasis. Not surprisingly, fusion and fission processes are 
cross-regulated by sharing several molecular actors and regulators. Indeed, the interaction of 2 
heptad-repeat motifs of Mfn2 blocks fusion while their association to Drp1 enhances the 
fusion process [238]. Another example is the size if OPA1, where the full-length protein 
mediates fusion contrary to its enzymatic truncated form that promotes mitochondria fission 
[239]. Moreover, another study reported that the 2 processes may form a continuous 
fusion/fission cycle to enable mitochondrial renewal and dynamics. 
b-) Fragmentation and Hyperfusion  
 
As described above, fragmentation can occur when there is a too much fission or 
following induction by intrinsic or extrinsic stress, as for example due to an increase of 
calcium concentration. Very often, mitochondrial fragmentation is linked to mitochondrial 
dysfunction due to a defect in fusion process or an overregulation of fission process, as this 
morphological state predominates during elevated stress levels or cell death [217]. 
Furthermore, a fragmented network is also more sensitive to an induced apoptosis [240]. 
However, fragmentation is not necessarily connected to induction of cell death; for example, 
it still occurs under the influence of drug as carbonyl cyanide m-chlorophenyl hydrazone 
(CCCP) that does not induce apoptosis [241]. Nonetheless, a fragmented network is often 
associated to metabolism disorders [242]. 
Mitochondrial fragmentation is also observed in “positive” contexts, for example 
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during the G2/M phase of the cell cycle where there is a need for enhanced mitochondrial 
motility, quality control and mtDNA inheritance [241,243]. A second example of “positively” 
induced fragmentation can be found following accumulation of truncated forms of Opa1, 
indicative of a role for short Opa1 in cell division. Thus, it is important to keep in mind the 
notion that a fragmented mitochondrial network is not always associated with increased 
apoptosis but on the contrary can also protect cells from apoptotic death [223]. Mitochondrial 
fragmentation also has an important impact on metabolic processes at is was shown that it can 
enhance glycolysis [244]. 
The mitochondrial network can also become hyperfused to counteract stress disorders. 
Indeed, when the mitochondrial network is hyperfused, an improved matrix component 
distribution is achieved, and it also modifies metabolic processes by stimulating OXPHOS 
activity [245]. Interestingly Dynamin2-depleted cells or Drp-1depleted cells both were shown 
to present a hyperfused mitochondrial network, despite the different nature of the depletion. 
Interestingly, mitochondria hyperfusion was observed during macroautophagy induction by 
different stress conditions.  Mitochondria hyperfuse to escape autophagosome engulfment in 
order to avoid their degradation and instead to induce cell survival mechanisms [246]. In 
addition, mitochondria present a hyperfused network during the G1/S transition of the cell 
cycle [247]. Even if hyperfusion is mainly seen as an adaptive mechanism to counteract some 
intrinsic and extrinsic disorders, a very recent report showed how this mitochondrial process 
leads to a neuropathy in Drosophila [248]. This discovery opens new ways of research to 
better understand neuropathologic diseases. To conclude with this first part, depending on the 
stress type and severity, mitochondria can adapt their form, either by inducing a fragmented 
or a fused network which can have important functional consequences. 
 
II-) Mitochondrial-Associated Membranes: at the ER mitochondria interface 
 
Mitochondria-associated membranes were the first described inter-organelle contact 
sites [249], referring to the association between ER and mitochondria. These sites act as hubs 
that take part in several processes as lipid and calcium metabolism [250,251]. Moreover, as 
ER was shown to take part in mitochondrial fission it is not surprising to discover that MAMs 
are also crucial for regulation mitochondrial morphology [232]. Furthermore, MAMs were 
also shown to be involved in reactive oxygen species (ROS)-induced cell stress (mtROS) 
[250], autophagy [251] and apoptosis. The study of the function of MAMS is a very exciting 
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field that is in expansion with the recent characterization of specific markers necessary to 
better study these structures. To date, the enzyme fatty acid CoA ligase 4 (FACL4), which is 
involved in triacylglycerol synthesis, is currently considered one of the most reliable MAM 
marker proteins [252]. To conclude, many studies have focused on the identification of 
specific proteins and their characterization in relation to mitochondrial and ER related 
processes. There is indeed a growing list of MAM markers however, the global 
comprehension of all the coordinated processes dependent on MAMs is still at the very early 
stages and will require many more years to identify all the molecular actors and to fully 
understand how they are regulated and inter-connected. 
A few of the key functions assigned to MAMs are described in more detailed below. 
1-) Calcium metabolism 
?
Calcium is a metabolite that strongly binds ER and mitochondria, with continuous 
exchanges taking place. MAMs act as the hub that regulates Ca2+ transfe? from the ER to 
mitochondria in order to sustain cellular bioenergetic metabolic processes of mitochondria, 
mitochondrial dynamics but also the induction of cellular processes as apoptosis [253,254]. 
Ca2+ is involved in mitochondria metabolism because ATP production is regulated by Ca2+ 
transfer from the ER to mitochondria and several mitochondrial dehydrogenases of the Krebs 
cycle require calcium as cofactor during NADH production [255,256]. In the case of Ca2+ 
transfer, it is the inositol-1,4,5-trisphosphate (InsP3) receptor (InsP3R see Figure 17-) that 
interacts with the OMM protein voltage-dependent anion channel isoform 1 (VDAC1) 
through the molecular chaperone GRP75. MAMs generate microdomains of localized calcium 
spikes released from the ER through InsP3Rs, thus stimulating calcium uptake by 
mitochondria [256,257]. Therefore, it has been proposed that GRP75 acts as a bridge between 
the 2 organelles and indeed, downregulation of GRP75 abrogates the functional interaction 
between IP3R and the mitochondria. This alteration impairs the normal transfer of Ca2+ to the 
mitochondria while overexpression of VDAC1 has been shown to promote Ca2+ uptake into 
mitochondria [258]. Furthermore, some MAM proteins, such as Mitofusin2 and phosphofurin 
acidic cluster sorting protein-2 (PACS-2) have been implicated in calcium dependent 
processes [259-261]. The control of Ca2+ exchange between ER and mitochondria is essential 
also for ER functions. Indeed, Ca2+ enables the correct activity of several ER enzymes and 
chaperones shown previously to be crucial for ERQC like calnexin and calreticulin [262]. 
This is also the case of another specific MAM marker, the ER protein sigma-1 receptor (Sig-
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1R) [263]. Sig-1R is a Ca2+ sensitive chaperone complex that binds BiP and prolongs Ca2+ 
signaling from the ER to the mitochondria by stabilizing IP3R subunit 3 at MAMs [263]. 
In addition to the InsP3R- GRP75-VDAC1 complex, other MAM proteins were 
proposed to physically connect the ER to the mitochondria at supramolecular level. Indeed, a 
new kind of structure was found in yeast, called ER-mitochondria encounter structure 
(ERMES) complex. This complex is composed of ER and mitochondrial proteins, such as the 
ER protein mitochondrial morphology protein 1 (Mmm1), the mitochondrial distribution and 
morphology protein 10 (Mdm10) and GTPase EF-hand protein of mitochondria 1 (Gem1) 
[264]. This complex is also involved in lipid transfer and mitochondrial fission [265]. 
However, ERMES machinery has not been identified in mammalian cells yet. 
 
Figure 17- IRE1α expressed at MAMs docks the InsP3Rs at the mitochondrial–ER 
contact sites possibly through a physical interaction,which may enhance InsP3R channel activity. The 
presence of IRE1α at MAMs favours calcium transfer into the mitochondria and bursts in ATP production. 
Figures and legends extracted from [266]. 
 
2-) Autophagy 
?
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  MAMs were also demonstrated to be central for the biogenesis of autophagosomes, as 
they determine the position of mitochondrial fission and impact the dynamic and the number 
or mitochondria. Indeed, with fission process it will provide resting membranes for 
phagophore formation.  Given the link of ER and autophagy as described in Chapter 1 
section II-4-b-), as well as between mitochondria and autophagy it is not surprising that 
MAMs are at the center of this process. For mitochondria associated autophagy (considered as 
a form of macroautophagy) we actually found the term of mitophagy shown to be a recycling 
process that can occur after recognition of mitochondria damages [267]. Briefly at molecular 
level, there is still the formation of a phagophore that will enclose mitochondria to be deliver 
to lysosomes. A study led by the group of Ohsumi [268] reported that MAMs are involved in 
phagophore assembly. Indeed, upon autophagy induction, ATG14L involved in initiation 
autophagy complex with LC3 and double FYVE domain-containing protein 1 (DFCP1), 
known to migrate to omegasomes (Insp3 enriched ER subdomains) during autophagy 
relocalize to the MAMs to initiate autophagosome formation. Moreover, autophagosome 
formation marker autophagy-related 5 (ATG5), also shifts to the MAMs after starvation 
[251](Hamasaki 2013 Nature). Interestingly, syntaxin 17 that participates in mitochondrial 
fission is also implicated in the autophagosome formation through its interaction with 
ATG14L promoting the recruitment of phosphatidylinositol 3-phosphate (PI3P) complex 
[235]. In contrast, the disruption of ER-mitochondria contacts sites reduced the number of 
autophagosomes. Taken together, all these studies highlight the importance of MAMs in the 
biogenesis of autophagosome through the recruitment of ATG proteins to the ER-
mitochondria contact sites. Further studies are required to better understand the role of 
molecular components of mitophagy, as it starts to be done for ER-phagy process. 
3-) UPR 
?
During early phases of ER stress, in the perinuclear region an enrichment of MAMs 
was observed. In this cellular context, it highly suggests that connections between ER and 
mitochondria participate in the regulation of ER stress [269,270]. Indeed, it has been shown 
that the UPR sensor PERK is enriched at the MAMs, and furthermore, it was demonstrated 
that PERK is crucial to regulate ROS-induced cell death induced by UPR [250,269]. 
Moreover, PERK deficiency was associated with a decrease of mitochondrial Ca2+ uptake, 
which results in an ER stress-mediated apoptosis inhibition by the reduction of the release of 
downstream apoptosis actors as caspases or cytochrome c [250]. A recent study by the group 
of Zorzano[271] reported that the mitochondrial protein MFN2 physically interacts with 
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PERK at MAM sites and this binding is required for the regulation of cellular homeostasis 
upon ER stress. Thus, perturbations of ER-mitochondria contact sites induce ER stress [271]. 
Indeed, very interesting studies also highlighted the involvement of another major 
UPR sensor IRE1 in MAM-related functions. The authors demonstrated that IRE1α 
expression was required to increase metabolism in response to ER stress with the induction of 
a transient burst in ATP production during the early response to ER stress [270]. Added to 
that it was visualized that a fraction of IRE1α was also found to be located at MAMs. A 
separate study showed stabilization of IRE1α by Sig-1R that may enhance its signaling 
[263,272]. An additional very elegant study deeply associates IRE1α to MAMs integrity and 
functions. They have established that IRE1α is important for MAMs by regulating 
mitochondrial calcium uptake [266]. In addition, IRE1α deficiency resulted in marked 
alterations in mitochondrial physiology and energy metabolism under basal conditions 
without ER stress. At the molecular level, IRE1α determined the distribution and availability 
of InsP3Rs at MAMs by operating as a calcium scaffold to modulate OXPHOS and, 
consequently, ATP production (see Figure 17-) [266]. But it is important to note that this IRE 
1 activity is independent from its enzymatic domain. Furthermore, it is clear that IRE1α 
regulates mitochondrial activities because there is an important decrease in ATP in IRE1α-
deficient cells and the absence of this sensor induces fragmentation of the mitochondrial 
network[266].  
Interestingly Carreras-Sureda et al. observed in a second time an increase of AMP-
activated protein kinase (AMPK) phosphorylation IRE1α-deficient cells without any ER 
stress [266]. However, AMPK is a sensor that detects a decrease of ATP availability. To 
fulfill this energetic decrease it phosphorylates several targets, in order to increase in ATP 
generation and/or a reduction in ATP consumption [273]. Moreover, AMPK level is reversely 
correlated to calcium level. Indeed, it is proven that reduced calcium uptake into mitochondria 
is also associated with AMPK activation [254], connecting this sensor to IRE1 and supporting 
the importance of IRE1 on Ca2+ regulation.   
 
III-) Mitochondria, MAMs and apoptosis 
?
Apoptosis is a programmed death that is orchestrated by the cell [274](Biala 2014 
Trends in cardiovascular medicine). Apoptosis is composed of 2 different pathways: the 
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extrinsic pathway and the intrinsic pathway (Figure 18-) that can be induced by the first one. 
However, depending on the nature of the stimuli apoptosis can also start directly with the 
intrinsic pathway as it is shown in the case of terminal UPR. As a reminder many of the pro-
death signals from the UPR sensors ultimately converge on the intrinsic mitochondria 
apoptotic pathway to finally lead to activation of terminal apoptosis actors: the caspases (e.g., 
caspase-3) [13].  
 
Figure 18- Interplay of cell death signaling pathways. Apoptosis and necrosis are mediated by the death 
receptor (extrinsic) and mitochondria (intrinsic). In death receptor pathway, TNF-α stimulates formation of 
complex I comprising TRADD, TRAF2, TRAF5, RIP1, and cIAPs. Complex I activates NF-κB signaling and 
promotes cell survival. Dissociation of complex I from TNF-α receptor, results in the deubiquitination of RIP1, 
which together with FADD-RIP3 forms complex II. Active caspase-8 can either trigger downstream death 
effector caspases-3,-6 and -7 or inactivate RIP1/RIP3 complex through RIP1 cleavage. This releases caspase-8 
from complex II triggering activation of the intrinsic mitochondrial apoptosis pathway. Apoptotic signaling in 
response to caspase-8 activation promotes proteolytic cleavage of Bid to t-Bid and recruitment of Bax/Bak 
proteins to mitochondrial outer membrane (OMM). Oligomerization of Bax/Bak provokes OMM 
permeabilization, resulting in the release of cytochrome c and other apoptotic proteins from mitochondria, 
resulting in further caspase activation and apoptosis. Inhibition of caspase-8 results in the formation of complex 
III, which contains phosphorylated RIP1 and RIP3 and adapter proteins for programmed necrosis. 
Mitochondrial-associated RIP1/RIP3 promotes glycolysis and glutaminolysis, ROS production, mitochondrial 
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Ca2+ overload, loss of the inner mitochondrial membrane (IMM) integrity, permeability transition pore opening 
(mPTP), and necrosis. Mst-1 provides a molecular switch for apoptosis or autophagy through phosphorylation of 
Beclin-1. During cellular stress, phosphorylation of Beclin-1 by Mst-1 increases Beclin-1-Bcl-2 complexes 
displacing Bax from Bcl-2 resulting in apoptosis; alternatively, phosphorylation of Beclin-1 diminishes Beclin- 
1-Vps34-Atg14L complexes and inhibits autophagy. Figures and legends extracted from [274].  
Briefly the extrinsic pathway is initiated in response to stimulation of death receptor 
proteins at the cell surface by the binding of death factors such as Fas ligand (FasL or 
CD95L) or more generally Tumor Necrosis Factors (=TNF) which induce the formation of 
the Death-Inducing Signaling Complex (=DISC). This DISC complex (also called complex 1 
in the Figure 18-) contains the initiator pro-caspase-8, Fas-Associated Death Domain 
(FADD) and TNF1R-Associated Death Domain (TRADD) [275,276]. Then the caspase 8 is 
activated by an auto-catalytic process and will proteolytically activate other downstream 
effector caspases such as caspases-3, -6 and -7. The proteolysis of the BH3-only (BCL2 
homology 3) protein BH3 interacting death domain agonist (BID) can also occur at the same 
time. Its truncated form t-BID is translocated to the mitochondria and activates the intrinsic 
pathway of apoptosis [276]. Stress stimuli independent of the extrinsic pathway such as 
cytokine deprivation or DNA damage can also result in cleavage of BID or other BH3-only 
proteins (BAD, BIK, HRK, BIM, NOXA and PUMA) and directly activate the intrinsic 
pathway.  
Mitochondria are the major players of this arm of apoptosis which is characterized by 
one key event: mitochondrial outer membrane permeabilization. This is mediated by two 
proteins of Bcl-2 family BAX and BAK that oligomerize to form the pores in the OMM. 
After this process cytochrome c and other factors are released in the cell cytosol, such as 
second mitochondria-derived activators of caspases (SMAC and DIABLO). This process is 
followed by the recruitment of caspase-9 and apoptotic protease-activating factor 1 (APAF1), 
resulting in formation of a supramolecular complex known as apoptosome [274-276]. This 
complex activates caspase-9 which will in turn activate effector caspases and lead to 
apoptosis. The intrinsic pathway can also lead to caspase-independent cell-death 
demonstrating the complexity of these signaling cascades. Caspase-2 has also been shown to 
directly induce mitochondrial outer membrane permeabilization and intrinsic apoptosis but its 
mechanism remains poorly characterized [274,275]. 
At molecular level, it is a well-known fact that MAMs are the carrefour in apoptosis 
induction. Indeed, cytochrome c binds to InsP3R channels during apoptosis induction what 
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blocks the Ca2+-dependent inhibition of InsP3 function and promotes apoptotic Ca2+ release 
[253,277]. Indeed, the phosphatase and tensin homolog (PTEN) has also been reported to be 
located at the MAMs and enhances Ca2+ signaling to the mitochondria in situations of 
increased ER stress and pro-apoptotic signaling. Moreover, during apoptosis, mitochondrial 
network was often shown to be fragmented and increases due to the recruitment of the fission 
protein DRP1 to the OMM. Then DRP1 was shown to stimulate pro-apoptotic proteins BAX 
and BAK and after it undergoes their oligomerization. Interestingly, the importance of PACS-
2 for MAMs was still demonstrated as its depletion also induced apoptosis [260] and an 
induction of unfolded protein response (UPR). 
IV-) Mitochondria and Immunometabolism focus on the Warburg Effect 
1-) Warburg effect and cancer cells 
 
The Warburg effect is a metabolic process that was first discovered in proliferating 
cancer cells [278]. This particular metabolic state is characterized by a modification of both 
catabolic and anabolic processes especially in the context of glycolysis and Krebs cycle 
intermediates that are mainly used for biosynthesis pathways. The classical metabolism starts 
with glycolysis that is followed by the Krebs cycle. Then the metabolic process ends with 
mitochondrial respiration with OXPHOS that allows the cell to produce 36 molecules of ATP 
for 1 consumed molecule of glucose (left panel of Figure 19, oxidative phosphorylation) 
[279]. Upon a Warburg shift, the fermentation pathway is favoured instead of the Krebs cycle, 
a process commonly referred to as aerobic glycolysis (right panel, Figure 19) [280]. As a 
consequence of this shift, the final glycolysis intermediate pyruvate cannot reach the Krebs 
cycle to be transformed in acetyl-coA but instead accumulates and gets converted into lactate 
giving rise to only 4 ATP for each consumed Glucose (see Figure 19-).
 
? ???
Figure 19- Comparison of glycolytic metabolism between non tumoral cells and tumoral 
cells. Figures and legends extracted from The Paradox of Cancer’s Warburg Effect by Docteur Jason Fung 
Consequently, one of the questions that intrigued researchers was to determine the role 
of mitochondria in cancer cells because their catabolic process dependent of the Krebs cycle 
associated to OXPHOS was not used anymore. Interestingly, it was found that mitochondria 
participate in several other metabolic processes including nucleotide, amino acid and lipid 
biosynthesis. Thus, in the context of a Warburg shift, the mitochondrial anabolism functions 
are stimulated instead of catabolic degradation of pyruvate glycolysis intermediates.  
To conclude, the hallmarks of a metabolic shift that is associate to Warburg metabolism are: 
- a huge increase of available glucose that is associated to an exacerbated glycolysis to 
maintain ATP production. There is also an accumulation of glycolytic intermediates as 
pyruvate that are used in biosynthetic pathways or for fermentation thus associated to an 
increase of lactate. 
- a differential use of citrate and other Krebs cycle intermediates and acetyl-coenzyme A that 
are transported from mitochondria to the cytosol and used in lipid and other biosynthesis. 
- an accumulation of NADH and NADPH in the cytosol through glycolysis and the pentose 
? ???
phosphate pathway (PPP), respectively, to be also used for anabolic processes [280,281]. 
  
2-) Warburg effect and immune cells 
?
The interplay between immunological and metabolic processes is an exciting emerging 
field known as immunometabolism. Interestingly, the Warburg process is also observed 
during immune processes. The current model proposes that innate or non-activated immune 
cells mainly rely in an OXPHOS metabolism that is shifted to Warburg metabolism upon 
immune activation [279,282]. For instance, some T-cells were shown to switch to Warburg 
metabolism upon activation by APCs including TH1 and TH17 helper cells [283,284]. But with 
several other studies it has been demonstrated that a switch to Warburg metabolism can be 
observed in a large panel of other immune cells, such as macrophages, DCs, neutrophils, B-
cells and natural killer cells [279,285-288]. A few examples where Warburg metabolic shift 
was observed upon immune activation include macrophages via their PRRs [285,286], T-cells 
via their cytokines receptors [289] or also B-cells activated by antigen receptors [287]. 
Interestingly, it has been also shown that Warburg metabolic shift can be associated with 
precise immune functions as phagocytosis and IL-1β production by macrophages [290], 
acquisition of costimulatory capacity by DCs [286], TH17 polarization by activated T-cells 
[291] and formation of nets by neutrophils [292]. 
3-) Warburg effect and infected cells 
?
It has also been recently reported that mammalian cells infected with intracellular 
bacteria have an altered metabolism that resembles the Warburg effect seen in cancer cells 
[293-295]. In the Chapter 3 I will further detail the Warburg shift in context of Brucella 
infection. Often for bacterial pathogens, this metabolic shift it associated with an increase of 
glucose availability that can be used by pathogens as Legionella, Salmonella or Brucella 
[294,296,297] for their own replication.  
V-) Mitochondria and pathogens 
 
In the context of my work, it is important to highlight a few examples of pathogens that target 
mitochondria.  
 
? ???
1-) Listeria monocytogenes 
?
As Listeria monocytogenes was shown to induce ER stress (Chapter 1), it has been 
observed by microscopy that this bacterial pathogen fragments the mitochondrial network, in 
contrast to the nonpathogenic Listeria innocua. Again, LLO was identified as responsible of 
the mitochondrial fragmentation. LLO was sufficient to induce a mitochondrial membrane 
potential decrease and a drop in ATP level [298]. Interestingly authors conclude in their study 
that this LLO fragmentation cannot be associated with an apoptosis induction because they do 
not observe a release of cytochrome c either in infection or following treatment with LLO. 
Moreover, mitochondrial dynamics were shown to be important for Listeria infection. Indeed, 
after siRNA treatment that inhibited either fusion or fission processes, a decrease in the rate of 
infection was observed [298]. However, LLO did not seem to affect mitochondrial dynamics 
directly.  
In another study by Zhang et al. [299] it was elegantly demonstrated that Listeria 
monocytogenes interferes with mitochondria associated autophagy (or mitophagy) to avoid 
being killed. Indeed, it is known that host autophagy can take part in bacterial pathogen 
clearance. They demonstrated that mitophagy is triggered in macrophages and in weak 
manner in HeLa cells and that this phenotype was associated to LLO [299]. Authors went on 
to identify NLRX1 as the target of LLO, the only Nod-like receptor (NLR) family member 
with a mitochondrial targeting sequence that also contains an LC3-interacting region (LIR). 
This domain allows a direct association with LC3 after being oligomerized by the LLO that 
favors the binding of the LIR motif. Thus, Listeria promotes mitophagy induction to promote 
its survival.  
2-) Coxiella burnetii 
?
Coxiella burnetii is the etiological agent of human Q fever, a zoonotic infection with a 
worldwide distribution. Because this pathogen represents a threat even at low infectious dose 
and given its ability to disseminate and to survive Coxiella is classified as a category B 
pathogen by WHO [300,301]. As Legionella, Coxiella has a T4SS that secretes effectors and 
during these last year more over 130 Coxiella effector proteins have been identified. Among 
all these effectors some of them have been shown to be fully required for efficient 
intracellular replication and CCV biogenesis [302](Larson 2015 Infection and Immunity). A 
subset of Coxiella effectors show mitochondrial localization when they are ectopically 
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expressed in human cell lines. CBUA0020, CBU1825, CBU1425 and AnkJ all were shown to 
colocalize with mitochondrial markers [303-305]. 
For 2 of the mitochondrial located effectors CaeB (CBU1532) and AnkG (CBU0781) it was 
demonstrated that they have an anti-apoptotic effect by associating with mitochondria 
[303,306,307]. AnkG acts as a sensor of apoptotic stress at mitochondria, and consequently 
activate processes to counteract induced apoptosis by interacting with p32 [304,308]. 
Nevertheless, for CaeB molecular mechanisms it remains to be further investigated in order to 
find how apoptosis is impaired. Another recent study by Fielden et al. further characterized 
[309](Fielden 2017 Infection and immunity) the effector mitochondrial Coxiella effector 
protein A (MceA), which was previously found to co-localize with lysosomal markers during 
ectopic expression in HeLa cells [303]. This effector was also shown to localize to the OMM 
where it interacts with itself to form a multimeric complex. Interestingly it was shown that 
this effector is farnesylated via a CAAX motif (C for cysteine, A for aliphatic and X for any 
amino acid) present on the C-terminus, which contributes to the stabilization of the effector at 
the mitochondrial membrane. Nevertheless, the action of MceA at OMM needs to be further 
investigated. 
3-) Helicobacter pylori 
?
We have previously seen that Helicobacter pylori modulates UPR with the the 
secreted protein HP0175. However, contrary to the pathogens L. pneumophila or Coxiella 
burnetii which can deliver over 100 effectors, Helicobacter seems to have a more restricted 
repertoire of T4SS effectors. Among these, the best characterized is cytotoxin-associated gene 
A (CagA) which is responsible for severe damage of host cells by targeting multiple 
pathways. In contrast the pore-forming toxin VacA induces apoptosis and localizes to 
mitochondria [192]. Several studies showed that CagA promotes cell survival with an anti-
apoptotic effect to counteract VacA-induced apoptosis. VacA mitochondrial localization 
results in a change of permeabilization of mitochondrial membranes as observed for LLO. 
This finding is important in the context of long-term infection, which can lead to cancer 
development after stomach colonization. The pathogen inhibits the cytotoxin VacA using two 
complementary mechanisms both involving CagA. It is important to highlight that the choice 
of either mechanism is dependent of the state of phosphorylation of CagA by host kinases. 
Indeed, when CagA is in a phosphorylated form, it inhibits the entry of the VacA into the cell 
by preventing its pinocytosis. In contrast, the second mechanism depends on the 
? ???
unphosphorylated form of CagA to prevent VacA localization at the mitochondrial level, 
inhibiting the permeabilization of the mitochondrial outer membrane and release of the 
cytochrome c [310]. In addition, CagA also leads to an increase of Bcl2 anti-apoptotic factors 
(Bcl-2, Bcl-XL, Mcl-1) that contribute to blocking apoptosis. This coupled action of two 
effectors VacA/CagA demonstrates a pernicious strategy of the pathogen towards its host. 
Indeed, firstly VacA is used by Helicobacter to colonize and then it is CagA that ensures it 
can colonize the host durably. 
4-) Ehrlichia chaffeensis 
?
Ehrlichia chaffeensis is a Gram negative, obligate intracellular bacteria etiologically 
responsible for human monocytotropic ehrlichiosis considered as an emerging zoonosis [311]. 
This bacterium also has a T4SS [312] and in 2012 authors identified the effector ECH0825 
that is translocated and found to have a mitochondrial localization during infection. 
Ectopically expressed, ECH0825 was still targeted to mitochondria and resulted in inhibition 
of apoptosis, associated with a high increase of mitochondrial manganese superoxide 
dismutase (MnSOD). In infection, this component was indeed increased over 9-fold and the 
amount of reactive oxygen species (ROS) significantly reduced compared to uninfected cells. 
This study shows that by up-regulating MnSOD, Ehrlichia prevents ROS-induced apoptosis 
to allow its intracellular infection [313]. 
5-) Shigella Flexneri 
 
Shigella flexneri is a Gram-negative pathogenic bacterium belonging to the 
Enterobacteriaceae family. It is the responsible agent of dysentery in humans that causes 
diarrhea and severe inflammation in the gut. Upon entry into the cytoplasm of infected cells, a 
sub-population of the bacteria hijacks the actin cytoskeleton and stimulates its polymerization 
on the bacterial surface, forming so-called actin comet tails because of their resemblance of 
their space homologs [314,315].  
I decided to talk about this pathogen because of a very interesting study that 
demonstrated that the application of mechanical forces lead to mitochondrial fission [316]. 
The originality of the project is authors used 3 different kind of mechanical forces: infection 
by Shigella flexneri, pressure by an atomic force microscope or via cell migration. For all 
three processes they observed mitochondrial fission with the recruitment of involved proteins 
as Drp1. To more develop the aspect by Shigella infection, authors observed by time-lapse 
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microscopy experiments that there are collisions between motile bacteria and the 
mitochondria. Therefore, these collisions resulted in 60 % of cases in a fission process 
between 1 to 5 min after collisions. Furthermore, they also observed in rare cases that 
collisions lead to a loss of fluorescence which indicates a constriction of the mitochondria 
matrix [316]. Afterwards, they wanted to determine DRP1 involvement in DRP1-depleted 
cells either with siRNA or shRNA transfection and also after CRISPR-associated protein 9 
(CRISPR-Cas9) method. With the 3 different methods of DRP1 down regulation or knock out 
they observed that Shigella could no longer induce mitochondrial fission. This is consistent 
with another result of the study where they have shown that sites of collisions are associated 
to DRP1 foci. Nevertheless, it appears that DRP1-depleted cell mitochondria resist less to 
bacterial collision. Thus, mitochondria undergo fission in the case of Shigella infection to 
counteract mechanic stresses induced by bacterial motility.  
6-) Legionella pneumophila 
?
As Brucella or Coxiella, Legionella is found in a vacuole called Legionella-containing 
vacuole (LCV). Mitochondria have been shown to be recruited around the LCV 
independently of the T4SS of Legionella [294]. Added to that authors have visualized that 
LCVs transiently interact with mitochondria. As early as 6 h post-infection mitochondria 
surround the LCV, interact and then move away. The nature of the contacts requires deeper 
investigation, nevertheless still in the same study they have found approximately 25% of 
mitochondrial proteins in the proteome of purified LCVs suggesting membrane exchanges are 
occurring [294]. Consequently, Legionella pneumophila has developed strategies to control 
mitochondrial functions. Some T4SS effectors have been implicated in modulation of 
mitochondrial functions. In this part I decided to focus on LpSPL and Mitochondria 
fragmentation factor (MitF) [294,317].  
LpSPL (also known as LegS2) is a T4SS secreted effector that has structural similarity 
to eukaryotic sphingosine-1-phosphate lyase (SPL). Consequently, it also has the enzymatic 
activity that catalyzes the irreversible cleavage of sphingosine-1-phosphate. Thus, this 
effector can finely regulate sphingolipid levels that are involved in autophagosome formation.  
It is a way to inhibit autophagy known to have a role in bacterial clearance as previously seen 
with Helicobacter pylori in the Chapter 1-[278]. 
Interestingly LpSPL was shown to have different localizations: in the ER [318] and to 
? ???
mitochondria [319]. Today with the evolution of our knowledge regarding MAMs, it seems 
reasonable to think that this effector may localize to the MAMs. Moreover, consistent with 
this hypothesis it has been shown that the substrate of LpSPL sphingosine-1-phosphate is 
involved in several MAMs processes as calcium transfer [320], lipid metabolism [321], 
apoptosis [322] and autophagosome formation [251]. Finally, LpSPL was also shown to 
interfere with mitochondrial functions that can be associated to MAMs as the fission process 
[323], lipid biosynthesis [318] and autophagosome formations [318].  
In 2017 Escoll et al. [294] identified a new T4SS effector MitF that induces 
mitochondrial fragmentation through fission DRP1 protein and Ran binding protein 2 
(RanBP2) because silencing of these proteins results in a reduced mitochondrial 
fragmentation. As Listeria it is important to note that DRP1 silencing affects the bacterial 
replication with a decrease of CFU. Authors showed that this mitochondrial fragmentation 
consequently affects mitochondrial metabolism by inhibiting OXPHOS even if a glycolysis 
activation was in parallel observed with a drastic reduction of consumed oxygen. Thus, it is 
an anaerobic glycolysis that is stimulated, and this is why authors characterized this shift as a 
Warburg-like effect. This metabolic shift induced by Legionella was demonstrated to favor its 
own replication. Nevertheless, it is important to note that at early stages of the infection (ie up 
to 1h pi) mitochondrial respiration was upregulated independently of the T4SS. 
As mitochondrial fragmentation is often associated to apoptosis, they measured the 
release of cytochrome c between 6h to 12h pi. Surprisingly cytochrome c was found to stain 
in the mitochondria which indicates that apoptosis is not induced by the fragmentation. We 
will see in the Chapter 4- that our Brucella effector has a similar phenotype.  
In summary, with the study of this MitF, authors highlighted again the importance of 
dynamic mitochondrial processes in host metabolism, as the induction of fragmentation and 
the impairment of metabolism both are induced by MitF. Finally, in this study DRP1 was 
found to be a crucial factor for the bacteria to be hijacked in order to manipulate associated-
mitochondrial functions. 
V-) General conclusions 
?
 Emergence of MAMs studies provide new challenges for the scientific community to 
better understand the relationship between ER and mitochondria. It demonstrated the 
involvement of both organelles in same processes as illustrated in the section on the calcium 
? ???
metabolism. Otherwise for bacterial pathogens, mitochondria constitute an attractive target to 
manipulate given its link to energetic and biosynthetic metabolism but also for the control of 
the programmed cell death. Indeed, this latter process is crucial to be controlled if the 
pathogen wants to establish a safe niche in the cell and have the time to replicate.  
Future studies should carefully follow the advancement of MAMs characterization to help 
study the function of bacterial effectors that are probably associated to MAMs especially if 
both ER and mitochondria localizations were found during infection. On the other hand, 
bacterial effectors can also provide original tools to help decipher the functions and molecular 
components of MAMs as they often have very specific functions with “smoother” effects in 
contrast to chemical drugs or RNA interference treatments that can lead to some undesirable 
side-effects. 
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Chapter 3 Brucella 
 
I-) Global overview of a fascinating pathogen 
1-) Brucella epidemiology 
 
The Brucella genus belongs to the ?2-subdivision of the proteobacteria (represented 
Figure 20- which includes several animal pathogens such as Bartonella henselae, Rickettsia 
ricketsii and the phytopathogen Agrobacterium tumefasciens [324]. Bacteria from the 
Brucella genus are the aetiological agents of brucellosis, also called Malta or Mediterranean 
fever. It is still considered by the World Health Organization (WHO) as an important 
neglected zoonosis re-emerging in poverty associated regions with 500 000 referenced human 
cases by year and because of its impact on agriculture given the ability of Brucella to infect a 
large spectrum of hosts [325-327].  
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Figure 20- Phylogenetic Tree of the α-Proteobacteria. The protein sequences of select conserved 
genes were concatenated and aligned, and a phylogenetic tree was inferred of all sequenced α-Proteobacteria. 
The Anaplasmataceae (purple) and the Rickettsiaceae (yellow) are highlighted. Figures and legends extracted 
from [324] 
 
Brucellosis is still endemic and a threat in the Mediterranean region, Asia (except 
Japan and Corea), sub-Saharan Africa and some countries in Latin America [326,328]. In the 
developing world, it is often associated with absence of competent veterinary services and 
political structure. Moreover, these regions practice an intensive pastoral agriculture that 
increases the risk of animal brucellosis and complicates the diagnostics of the cattle because 
of the high number of animals. Overall, we are still facing major challenges to contain or 
eradicate brucellosis outbreaks worldwide [328]. To add to this problem, Brucella spp. are 
also prevalent in marine and terrestrial wild-life (e.g. dolphins, seals, bison, elk, wild-boar) 
which hampers eradication. The recent identification of a growing number of atypical strains, 
such as those isolated from amphibians and voles point towards a common ancestor in the soil 
and suggest that new Brucella environmental niches are yet to be discovered.   
 
2-) History, vaccines  
a-) History and discovery 
?
Brucellosis was first reported in 1859 (and the strain was first isolated in 1887 by the 
English officer David Bruce. Almost a century later the first animal vaccine against caprine 
brucellosis was developed: Rev1[329]. Since then, several vaccines are used in the field to 
control animal brucellosis. It is important to note that no vaccine is yet available for humans. 
Among animal vaccines 2 are mainly used today: S19 and RB51.  
 
b-) Brucella vaccines: a balance between risk and benefit 
 
Firstly, S19 is a live attenuated vaccine good to immunize calves. But the major 
problem of this vaccine is the antibody production, which cannot be distinguished from an 
antibody response induced by an infection. Consequently, the main restriction of this vaccine 
is the age of the vaccination, which has to be injected at the youngest age of the cheptel to be 
sure that antibody detection is not the result of an infection. S19 for agriculture is an 
interesting vaccine because it does not induce abortion nor sterility and still gives a good 
vaccine cover contrary to other vaccines[330]. 
? ???
 The second vaccine, RB51, is also considered a good vaccine and does not have this 
age restriction problem. It is also a live strain derived from Brucella abortus but with a rough 
morphology, due to absence of the O-polysaccharide, the most external component of the 
lipopolysaccharide (LPS). However, vaccination with RB51 of pregnant animals can cause 
abortion. For male animals it can lead to infertility, which not surprisingly represents a major 
inconvenient in agriculture. Another issue with RB51 is that this vaccine needs to be applied 
several times. Nevertheless, the main advantage of this vaccination is that the antibody 
response, which is different, compared with classical Brucella infection. Indeed, we can make 
the difference between infected animals compared with vaccinated animal. Thus, with RB51 
we can be monitor immunization with standard serology tests [331]. 
Regarding humans, it is important to notice that these vaccines are dangerous because 
they both can cause infections in humans. Consequently, their use requires safety training 
which adds a high cost difficult to support for developing countries. 
Despite of all the negative points discussed above, S19 and RB51 are the officially 
approved vaccine strains. Vaccinology research has to continue in order to find a better 
vaccine with less inconveniences that can be used for livestock, without associated abortion or 
infertility and inducing an immune response different from Brucella infection. Finally, it 
would be desirable that the future vaccine is also efficient for humans to protect farmers and 
veterinary personal[331].  
   
Consequently, nowadays the control of animal brucellosis and indirectly of human 
brucellosis is dependent on strict food hygiene, animal management measures and milk 
pasteurization. In North America, Australia, and some northern European countries, control of 
Brucella in the zoonotic reservoir species by massive vaccination programs and killing of 
infected animals has strongly reduced the incidence of human brucellosis. However, in 
several countries brucellosis is still prevalent and far from being controlled. This is the case 
for example of Africa bovine brucellosis with more than 250 outbreaks/year reported since 
2003  and also in China/Mongolia regions [332]. It is clear that a global coordinated effort has 
to be set in place to encourage official veterinary services and public health officers to collect 
and share epidemiological data for designing improved control and eradication plans in these 
regions against this bacterial agent. 
 
c-) Symptoms and dissemination 
 
? ???
The clinical symptoms of brucellosis are very different between humans, and animals 
and depend of the stage of infection. Indeed “farm animals” can be colonized for life without 
any major symptoms and bacteria mainly affects reproductive organs and establishes its 
replicative niche inside the placenta and foetus, which results in abortion at middle or late 
stages of the pregnancy. It can also lead to sterility of male animals or arthritis11 as it was 
reported in pigs after B. suis infection [333]. However, in some cases, animals can present a 
fever, inflammation of the mammary gland in the breast (mastitis) and hygromas which are 
pockets of inflammation containing synovial liquid associated to joints [333,334]. And if the 
pregnant female can succeed to deliver its offspring it often results in very weak progeny. 
For the marine mammals and especially cetaceans, 2 species are the main etiological 
agents: B. ceti and B. pinnipedialis. Abortion cases have also been reported in infected 
dolphins [335]. They are often associated with skin and cutaneous lesions. The pathology can 
evolve in more severe forms with spinal discopondylitis, meningoencephalitis and some other 
neurologic disorders [336]. 
 In humans, we can distinguish two different phases for brucellosis. At the beginning, 
the acute phase is characterized by a febrile illness, which resembles flu with undulant fever. 
In absence of therapeutics, brucellosis can evolve into a more severe and debilitating illness 
with cardiac and neurological complications and the formation of infectious foci in bone 
joints [325,326]. There are no major differences according to the gender [337]. The disease is 
accompanied with significant increase of the size of the spleen and liver, not surprisingly 
because of their involvement in immunity. In clinics, list of symptoms used for diagnostic of 
Brucella infection in addition to fever are hepatomegaly, splenomegaly, hepatosplenomegaly 
and arthritis. Prompt diagnosis is vital to rapidly treat the disease and to avoid the further 
complications. These can include endocarditis, which requires surgery and a heavy treatment 
to clear the bacteria but can also be mortal [338]. Neurological complications have also been 
reported, with the entry of the bacteria in the central nervous system. This invasion leads to 
meningitis or meningoencephalitis and demyelination disorders [333]. Degradation of the 
optic nerve has also been reported during neurobrucellosis [339]. Thus, brucellosis remains an 
infectious disease that requires careful diagnosis and surveillance even if few human cases are 
reported in the year the disease can become extremely debilitating, associated with significant 
morbidity worldwide.  
 
We have seen that symptoms are different between marine and aquatic animals and 
humans. Unfortunately, there does not seem to be a species barrier that could block a 
? ???
transmission between “natural” animal hosts. This transmission can be horizontal with these 
above described actions as: 
- Inhalation of bacterial aerosol from an abortion for example  
- Contact with body fluids from infected animals 
- Genital contact during the mating [340] 
 
Thankfully for humans the most effective route for infection is the inhalation of 
contaminated aerosols that might occur in laboratory or animal slaughterhouses. Indeed, the 
majority of human brucellosis cases are caused by ingestion of unpasteurized milk and dairy 
products. In addition, the last important part of human brucellosis comes from exposure in a 
professional context for people in contact with infected animals: farmers, veterinarians and 
butchers [325]. There is currently no evidence of transmission between humans except in 
pregnancy, where Brucella can pass to the unborn fetus and cause abortion in the first 
trimester of pregnancy.  
 
d-) Brucella tropism and infected tissues 
?
In animals Brucella has a preferential tropism for the genital tract. Indeed, the 
infections of mammary gland and placenta allow the bacteria perfect setting for effective 
dissemination because Brucella can use these organs as a way to spread in the environment 
through the milk, the genital secretions and aborted foetus. The genital tract is a free highway 
for Brucella dissemination because this conduct in mammals has developed immunology 
particularities to tolerate foreign antigens such as those generated by spermatozoid and the 
foetus [341].  
In humans, only few studies characterized in vivo the nature of infected cells as most 
of the experiments are carried out in mice.  However, given the nature of the symptoms that 
are previously mentioned, Brucella can infect immune cells as it is a safe niche to replicate 
without being detected. Following inoculation, infection can progress undetected for many 
months. And given the cardiac and the neurological complications it may suggest that 
Brucella can infect a large variety of cells. This is confirmed in in vitro experiments where 
Brucella was shown to infect a huge spectrum of human cell types with a high capacity to 
infect and to replicate within immune cells as macrophages, dendritic cells (DCs), but also 
osteoblasts and fibroblasts as well as epithelial cells and trophoblasts [342-347]. Indeed, 
cultured epithelial cell lines are considered as a routine model for laboratories because they 
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are easy to manipulate and adequate for microscopy experiments. 
A little focus on the trophoblast which appears to be an important cellular target for Brucella 
pathogenesis in both animals and humans. Indeed, it is important to note that Brucella was 
demonstrated for the first time to establish its replicative niche in the ER in infected goat and 
bovine placenta indicating a tropism for trophoblast cells [348]. Furthermore, in infected 
placenta, it has been shown by microscopy Brucella localizes to trophoblasts and replicates in 
placental trophoblasts [348]. More recently it has been shown that late in gestation Brucella 
localizes both in trophoblasts and extracellular which explains its spread after infection  [341]. 
Nonetheless, recent investigations of Brucella spp. infection of human trophoblasts revealed 
interesting differences in intracellular trafficking that will be discussed latter in this chapter.  
II-) Brucella and host immunity, a game of hide-and-seek 
 
We have seen that Brucella has different species that can infect many animals and 
humans. An important topic occupying researcher is how do these bacteria succeed to persist 
in infected hosts without being killed by the immune system. The immune response to 
Brucella infection has been characterized most extensively in the mouse model. Many studies 
show that Brucella spp. evolved different strategies using both passive and active mechanisms 
to avoid immune detection by its host by maintaining low the immune surveillance. Yet, it 
manages at critical times and in specific tissues to induce important inflammatory responses 
that contribute to pathology of the disease. In this section a global overview of different 
mechanisms will be discussed. 
 
1-) Brucella and its structural modification 
 
As a passive mechanism to avoid innate immunity it has been shown that Brucella 
evades detection by complement, TLRs and most NLRs through a stealthy design of its cell 
envelope. First of all, it has been shown that Brucella does not express any pili, fimbriae or 
capsule which are considered as PAMPs and can be recognized by the immune system [349]. 
As several other bacteria, Brucella has a flagellum on its surface, but the pathogen has 
modified the flagellin protein constituting the flagellum in order to activate less TLR5 
contrary to a normal flagellum [350,351].  
Another component of the bacterial cell envelope is the lipopolysaccharide (LPS) 
complex which is composed of 3 components: the O antigen, an oligosaccharide core and a 
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lipid A. These 3 components are highly variable in their composition and in the case of 
Brucella the modification of its own LPS allows avoidance of immune activation. Indeed, it 
has been shown that Brucella spp. passively evade detection by TLR4 via modification of the 
lipid A moiety of LPS. Indeed, the difference of the lipid A results in a reduction of phosphate 
groups and the presence of the long acyl chains found also in plant bacteria as Rhizobium 
which belong to the same clade (See Figure 20-) [352]. Besides, a second anti-inflammatory 
feature of Brucella LPS is its resistance to deposition of complement component C3 which 
avoids bacterial lysis or opsonization [353]. Finally, as a last modification of the LPS it has 
also been shown that the O chain antigen of the LPS associates with major histocompatibility 
complexes (MHC) class II. This association inhibits the ability of macrophages to present 
Brucella antigen in order to further activate CD4+ T lymphocytes [354]. 
 
2-) Brucella and its type IV secretion system  
 
Bacterial secretion systems are huge macromolecular machines that allow bacteria to secrete 
proteins from their cytoplasm to their environment or in a target cell.  They are involved in 
many processes in the lifestyle of bacteria that have some secretion systems as bacterial 
killing with the type VI secretion system or conjugation for the type IV secretion system 
(T4SS). This research area is too broad to summarize here, and this is why I will focus on the 
VirB T4SS of Brucella which is a major virulence factor. However, it is important to mention 
that, there are other identified secretion systems as type I and V that are present in Brucella 
genome. The T1SS is involved in the export of proteins from the cytoplasm to the 
extracellular environment in a single step without involving periplasmic intermediate. As 
secreted proteins of this kind of system we can usually find toxins, proteases, cell surface 
proteins and lipases. Moreover, this system can also transport non-proteic substrates as the 
cyclic β-glucans and polysaccharides [355]. In the case of Brucella there are no toxins and 
over two third of the T1SS are ABC transporters. 
The T5SS is associated with the Sec/Tat pathways which are used to cross the 
cytoplasmic membrane into the periplasm. The protein is then secreted in the extracellular 
medium thanks to the T5SS [356]. To date three different of T5SS were referenced: Va, Vb 
and Vc. In the case of Brucella, it is the T5SSVc that is identified with the identification of 
YadA protein. For the bacteria it allows the adhesion as it was demonstrated to secrete 
adhesins and might also contribute to the virulence process [356]. 
? ???
  The T4SS secretion system was firstly identified in the phytopathogen Agrobacterium 
tumefasciens where it is genetically encoded by the Vir operon. This system has been 
referenced in both Gram negative and positive bacteria. T4SS can be divided in 2 groups 
given the nature of the involved operon and protein subunits: type A with VirB operon which 
was mentioned above and the type B more closely resembling the Dot/Icm operon [357,358]. 
Brucella encodes for a T4SSA, composed of VirB1-11 and an additional VirB12. 
Interestingly, Brucella lacks the gene encoding for VirD4. In addition, VirB1, VirB7 and 
VirB12 do not seem to be essential for persistence in the mouse model [356]. Electronic 
microscopy revealed that T4SS form a protuberance called pilus, whose function is still not 
entirely elucidated. It may be involved possibly in the transport of secreted molecules and/or a 
device for attachment to the target bacterial cell. The T4SS pili (which should not be confused 
with the type IV pilus associated with type 2 secretion) is composed of the VirB2 and VirB5 
subunits. All other VirB proteins are the structural core of the system forming a large complex 
inserted in inner and outer bacterial membranes. This secretion system is ancestrally 
associated to conjugation systems and are involved in horizontal gene transfer and virulence. 
This bacterial process mediates transfer of plasmids and other mobile, extra-chromosomic 
genetic elements. These DNA transfer processes are very well studied because transferred 
plasmids containing arrays of antibiotics-resistance genes can be propagated through bacterial 
populations thanks to this contributing to the spread of antibiotic resistance which is a major 
public health issue. 
A number of bacterial pathogens use T4SS for pathogenicity such as Legionella spp., 
Bartonella spp., Brucella spp., Coxiella spp. and Helicobaceter pylori. In the context of 
bacterial pathogenicity, the T4SS allows them to inject proteins often called effectors in plant 
or animal cell targets. These effectors will first cross the bacterial membranes, a secretion 
process requiring ATP. Then effectors are translocated into eukaryotic cells, where they can 
modulate cellular functions. Bacterial effectors can be considered as potent “weapons” or « 
tools » that ensure bacterial multiplication. Most of the effectors have a eukaryotic-like 
domain suggesting an interaction with proteins in the infected host cell [359].  
 The Brucella T4SS has an essential role in intracellular survival and replication[360-
364]. Indeed, it has been highlighted the inability of virB mutant bacteria to replicate inside 
host cells. The absence of the T4SS prevents the translocation of effectors essential for 
controlling several host functions and mediate fusion with the ER which is the replicative 
compartment of Brucella [360,363,365-367]. But as we will see in a later part Brucella also 
has to avoid phago-lysomal degradation in early stage of infection.  
? ???
 
It has been reported that Brucella requires a functional T4SS to elicit innate immune 
responses in mice [368]. Indeed, early during infection of mice, it has been shown that the 
host response is a T helper 1 (TH1) response, with gamma interferon (IFN-γ) production by T 
cells and natural killer (NK) cells. T4SS is critical for inducing production of IFN-γ and other 
proinflammatory chemokines. virB mutants failed to elicit any inflammatory response. In 
addition to an early TH1 response, B. abortus also induces the anti-inflammatory cytokine 
interleukin-10 (IL-10 produced by CD4 cells B cells and macrophages) [369,370]. IL-10 can 
inhibit the microbicidal activity of macrophages against Brucella as well as antagonizing the 
activity of IFN-γ [371]. Therefore, the T4SS plays a complex role contributing to induction of 
inflammation but also as an active mechanism to counteract the host innate immune system. 
As it was mentioned in this study of Christelle Roux et al. [368] in 2007 “it is possible that 
the VirB T4SS of Brucella elicits inflammation by translocating either conserved bacterial 
ligands or T4SS effectors that trigger proinflammatory signaling via cytosolic innate immune 
receptors”. Indeed, Brucella secretes at least 1 effector VceC that elicits immune response and 
2 TIR domain-containing effectors BtpA (also known as TcpB) and BtpB that allow it to 
actively manipulate the immune system and reduce inflammation in the infected host. It is not 
clear yet how these opposing effects are regulated but it may be related to specific cellular 
targets and steps of the infection. It is possible that VceC shown to induce inflammation and 
associated abortion is acting mainly on macrophages and trophoblasts in the context of 
placental colonization whereas BtpA and BtpB would be involved in down-modulation in 
specific types of migratory macrophages and DCs, important in dissemination, lymph node 
colonization and granuloma formation. It is also likely that these sets of effectors intervene at 
different chronological stages of the infection cycle, for example to contribute towards 
reducing an immune response induced by the T4SS in order to ensure long term persistence in 
the host. These effectors and their molecular modes of action are discussed in greater detail in 
the section IV-4-).  
 
3-) Granuloma formation 
?
The generation of a mild inflammatory response has important consequences for persistence 
of Brucella spp. in tissue. Indeed, Brucella does not exert a total inhibition of immune 
processes. Another point that is important to mention is Brucella infection induces 
granulomatous “bodies” that can be observed in histology biopsy samples from both mice and 
? ???
humans.  These analyses reveal small granulomas in liver, spleen, bone marrow, and more 
generally all targeted tissues by bacteria [372]. Those granulomas are developed by the host 
in attempt to wall off the bacteria that cannot be eliminated by macrophages. These 
granulomas contain epithelioid macrophages (macrophages with an increased amount of 
cytoplasm) and are a site of bacterial persistence during Brucella infection [372]. This type of 
granulomas is better studied in context of Mycobacterium tuberculosis infection. Indeed, it 
has been shown with  Mycobacterium tuberculosis that granulomas serve as a niche of 
persistent mycobacterial infection, in which bacteria may multiply and eventually spread to 
other sites in the host[373]. This latent strategy perfectly highlights how the bacteria optimize 
all the processes of its host to establish chronic infection.  
As a conclusion for this part, we have seen how Brucella benefits from important 
modifications of its own surface components to adapt to its host in order to avoid extensive 
immune recognition that would lead to its destruction. Moreover, with its T4SS, the bacteria 
actively manipulate host immune processes to counteract the establishment of an adaptive 
immunity by avoiding the activation of the key factor NF-κB at molecular level or the antigen 
presentation at cellular level. Additional mechanisms have been implicated in modulation of 
host immunity during Brucella infection but are beyond the scope of this thesis. These include 
for example, the protein L-Omp19 that inhibits MHC-II expression and studies showing 
Brucella also acts on MHC-I expression by retaining the immune complex in the Golgi 
apparatus [374], interfering with adaptative immune response and activation of CD8+T 
lymphocytes.  
 
III-) Brucella intracellular lifestyle: from trafficking to replication and bacterial 
release 
1-) Entry of the bacteria 
?
The success of Brucella infection is associated to its ability to invade or be taken up by 
host cells. Therefore, the pathway of entry is determinant for bacterial fate. The integrity of 
the smooth LPS has been shown to be key for this process. Indeed, interaction between the O 
antigen of Brucella smooth LPS and the class A scavenger receptors located in the lipid rafts 
of host cell membrane is essential for the intracellular survival [375,376]. Therefore, rough 
mutants for LPS do not enter through lipid rafts and are quickly degraded by lysosomes [377]. 
Moreover, as mentioned above, Brucella can infect phagocytic and non-phagocytic 
? ???
cells [378]. The nature of the infected cell line obviously impacts the mechanisms of 
internalization. Little is known on the mechanisms of entry into non-phagocytic cells. The 
entry of bacteria has mostly been characterized in immune cells where 2 different pathways 
were described for the Brucella uptake and the difference resides in the opsonized state of the 
bacteria. In the case of non-opsonized Brucella, internalization requires a lipid raft-mediated 
entry [375]whereas opsonized bacterial entry is independent of lipid rafts and involves Fc 
receptors for IgG [379]. After the recognition by the receptors Brucella is taken up by 
phagocytosis or macropinocytosis. Another example has been described for dendritic cells 
where it has been shown that opsonized Brucella fail to persist in murine bone marrow-
derived DCs [343] and its entry partially requires lipid rafts [380]. These examples show that 
Brucella can present multiple “sophisticated” mechanisms to enter host eukaryotic cells.  
2-) From endosomal compartments to ER: the endosomal Brucella-containing vacuole  
?
Once inside cells, the early stages of infection start to be well characterized. In this 
section, we will summarize the current knowledge on the trafficking of the bacteria through 
the endosomal compartments until the establishment of the replicative niche in the host 
eukaryotic ER.  
After the uptake within professional or non-professional phagocytes, Brucella is found 
inside a membrane compartment called Brucella-Containing Vacuole (BCV). This vacuole is 
a phagosome that is modified by the bacterium with acquisition of early endosome marker at 
the beginning of infection: early endosomal antigen1 (EEA1), the transferrin receptor TfR and 
the small GTPase Rab5. The acquisition of these proteins on the surface of the BCVs will 
allow bacteria to benefit from interactions with the host endosomal pathway.  Given the 
nature of acquired EEA1 and Rab5, this first stage of vacuole trafficking has the name of 
endosomal BCV (eBCV) [360].   
Afterwards, Brucella will acquire late endosomal and lysosomal components in order 
to partially acquire phagolysosomal properties [381]. The transient acquisition of the late 
endosomal membrane proteins 1 and 2 (LAMP1 and LAMP2), the multi-vesicular body 
marker CD63 and the small GTPase Rab7 is followed by an acidification (pH around 4.5), 
necessary for the induction of the T4SS [382,383]. Added to that it is important to note that 
Brucella was initially thought to avoid lysosome fusion without acquiring specific proteins of 
the lysosome. Nevertheless, Starr et al. (2008 Traffic) alerts that it can be due to the 
preparation of the microscopy samples as it has been shown previously on Salmonella study 
[384]). The authors have shown that there was a loss of antigen markers because of fixation 
? ???
and permeabilization steps. In Starr et al they consequently used the fluorescent markers in 
live cells to assess if eBCVs acquire lysosomal markers. They found an acquisition of 
lysosomal markers and even a proteolytic activity which a hallmark of lysosome. 
It is important to note that even Brucella strategy seems perfectly established to avoid 
degradation by the endocytic pathway, almost 90% of bacteria do not succeed to reach the ER 
and are killed by macrophages as it was reported in different studies [360,381]. Consequently, 
it asks the question of why Brucella uses this dangerous pathway to reach the ER. The answer 
is simple as eBCV stage represents only a transitional but also necessary step towards rBCV 
biogenesis and allows the acidification of the BCV to induce T4SS which is crucial for 
downstream processes. Furthermore, it has been established that Brucella modulates its cell 
cycle during the eBCV stage. Indeed, it has been shown that Brucella cell cycle is blocked in 
the G1 phase until 6 h pi. And surprisingly the bacterium resumes its cell cycle and 
chromosomal replication whilst still in the eBCV stage [385]. 
 
3-) Replicative Brucella containing vacuole strongly requires secretory pathway 
 
Between 8 and 12h pi eBCVs will reach a sub-compartment of the ER the 
Endoplasmic Reticulum Exit Sites (ERES). BCV interactions with ERES allow subsequent 
fusion with the ER cisternae, transforming the eBCVs into an ER-derived organelle. Thus, the 
bacteria will progressively loose endosomal and lysosomal markers, which are replaced by 
specific markers of the ER (calnexin, calreticulin, sec61β) [345,360,381]. These new markers 
are characteristic of the replicative vacuole of Brucella. 
 Thus, the bacteria will start to replicate in this new vacuole [345,360,381] known as 
replicative BCVs (rBCVs). Added to that, in a recent study where they performed 3D electron 
microscopy, we can visualize in detail the fusion process of BCV and ER. With this 
resolution authors clearly show that BCVs are ER-derived compartments that are continuous 
to ER cisternae which gives all the sense to the name of ER-derived vacuole [386]. Interaction 
with ERES is an essential first step for onset of rBCVs. These ER compartments are 
specialized in the formation of COPII cargo vesicles, essential components of the secretory 
pathway. The importance of the secretory pathway for Brucella is highlighted by the use of 
Brefeldin A, that blocks a major regulator of the secretory pathway the small GTPase ARF1 
[387]. The consequence of inhibited ARF1 was Brucella failed to acquire ER membranes 
required for rBCV biogenesis. Afterwards, several GTPases were identified to be important 
for Brucella pathogenesis, as Rab1 and Rab2 that control anterograde and retrograde vesicular 
? ???
traffic between the ER and Golgi apparatus [388,389] and the small GTPase Sar1, which 
controls COPII coat assembly, ERES formation and function. They were all shown to be 
important for Brucella abortus [387,390,391]. For example, in the case of a deficient Sar1, an 
impairment in rBCV biogenesis and bacterial replication was observed consistent with the 
specific interactions of BCVs with COPII components [387,392]. A few years later the 
importance of Sar1 and COPII components was once again highlighted with Taguchi et al. 
who showed that Brucella infection upregulates production of Sar1 but also Sec23 and 
Sec24D which are COPII components [392]. Conjointly these studies have highlighted the 
importance of controlling vesicle trafficking to promote rBCV biogenesis.  
Thus, rBCVs are the replicative vacuole of Brucella, and it is in this vacuole that the 
longest stage of the Brucella infection cycle takes place to allow extensive intracellular 
multiplication (until 48h pi). We have seen in this section the complex and crucial role of 
vesicular trafficking and secretory pathway for eBCV conversion and then the establishment 
of Brucella replicative niche. Moreover, we have seen the intermingling between different 
processes of the secretory pathway. We are going to discuss now a second level of complexity 
associated with Brucella multiplication, its link to the UPR. The best study that highlights this 
increasing complexity was made by Taguchi et al. [392] They identified a new eukaryotic 
protein Yip1A that is associated to ER secretion processes and also ER stress.  
 
4-) Brucella, ER stress and UPR 
??
As mentioned in the Chapter 1, pathogenic bacteria are more and more known to 
interfere with UPR. Given the localization of the rBCV for bacterial proliferation, it is not 
surprising to learn that Brucella also induces ER stress and interferes with the UPR. There are 
several studies that demonstrated UPR induction by Brucella is found in different cell lines as 
HeLa cells, macrophages and trophoblasts. To date UPR induction by Brucella was reported 
to be mainly dependent of IRE1 pathway [138,161,361,392] even if the study of Smith et al is 
the only one that observed an induction of the three branches of UPR with Brucella melitensis 
[161]. Interestingly with Brucella it has been demonstrated in 2 studies that UPR is also 
necessary for Brucella replication. Indeed, in a first example authors infected IRE1 knock-out 
mice and a drastic reduction of bacterial replication was observed [215]. In the second case in 
Smith et al. used a chemical inhibitor of ER stress TUDCA and they also observed an 
impairment of Brucella replication. Another point which is important to be highlighted is 
Brucella seems to be inducing ER stress early in infection as phosphorylated activation of 
? ???
IRE1 was detected at 4h pi [161,392]. It seems counter intuitive that a pathogen would induce 
UPR given its link to innate immunity processes [137]. More recently, important studies have 
begun to shed light on the consequences of ER stress.  In the context of placental 
colonization, Brucella relies on ER stress for strong induction of inflammation and 
subsequently causing abortion. This phenotype is dependent on a specific effector called 
VceC discussed in the next section of this chapter. 
Indeed, it is clear that UPR induction is not a side effect due to bacterial replication as 
we will see later that several effectors specifically trigger ER stress. Taguchi et al. [392] were 
the first to find a good reason for the bacteria to induce UPR, by showing a connexion with 
ERES and rBCV biogenesis with Yip1A.  
First of all, they identified that IRE1α activation is dependent of the ERES-localized 
protein Yip1A. Indeed, they have demonstrated that Yip1A is involved in the phosphorylation 
step required for IRE1 dimerization because knock-down of Yip1A by RNA interference does 
not show any increased level of phosphorylated IRE1. Furthermore, this eukaryotic factor was 
reported to be essential for Brucella replication. They infected knock-down Yip1A cells and 
they visualised that Brucella does not succeed to generate rBCVs, resting in endosomal 
compartments. This is consistent with the fact that Brucella was shown to fail to replicate 
without an IRE functional pathway [215], Yip1A is essential for IRE1 functionality and 
Yip1A is the linker between ERES dependent processes and UPR.  Moreover, authors have 
shown that Yip1A is required for the upregulation of Sar1, Sec23 and Sec24D during 
infection with B. abortus essential for formation of rBCVs and explaining why Brucella 
remains in endosomal compartments. 
In addition, authors finally showed that the formation of large vacuoles requires 
autophagic proteins as Atg9 and WIPI1. Based on the roles of UPR and more specifically 
IRE1α in autophagy or specialized ER-phagy, authors hypothesized Yip1A might coordinate 
the intersection between the secretory pathway, UPR and ER-phagy pathways at ERES by 
activating IRE1. The identification of autophagic proteins is consistent with early studies of 
BCV intracellular trafficking which already proposed the involvement of the autophagy 
pathway in rBCV biogenesis [345] and the study of Wang et al. [219] that found that COPII 
vesicles can be hijacked by the autophagic pathway to supply membranes for autophagosome 
formation. 
  We will now see in the that autophagy is also important for the end of the Brucella 
intracellular lifestyle, highlighting that fine-tuning of cellular pathways in a kinetically 
defined manner enables bacteria to highjack host mechanisms for their own benefit. 
? ???
 
5-) Autophagy for terminal BCV formation: time to say goodbye 
 
At the end of the bacterial replication (around 48h pi), B. abortus was demonstrated to 
exit cells by using an autophagy process in order to disseminate and to infect neighbouring 
cells or to spread in the environment [393]. rBCVs were shown to use organelle membranes 
as those from ER to form phagophores where there will be one or several bacteria. Unlike at 
other stages of BCV formation, these vesicles contain late endosomal and lysosomal markers 
and their formation depends on very specific autophagy-related proteins as ULK1, ATG14L 
and Beclin1 while rBCV required ATG9 and WIPI1 [392,393]. These final BCVs are thus 
called autophagic BCVs (aBCVs). However, aBCV formation was independent of the 
autophagy elongation proteins ATG5, ATG16L1, ATG4B, ATG7, and LC3B. Thus, Brucella 
ends its intracellular cycle with aBCVs by subverting only autophagy-initiation/nucleation 
complexes.  
This highlights how Brucella only uses what it needs for its intracellular cycle by selectively 
subverting autophagic components as it also selectively subverted a subset of endosomal 
markers earlier in its trafficking. 
This aBCV stage is important for Brucella pathogenesis because it allows exit from 
the infected cell by “bubbling” without killing the infected cell. Moreover, it has been shown 
in Starr et al that an alteration of aBCV formation process results in inhibition of bacterial 
egress. Indeed, authors visualized secondary bacterial infections while aBCV formation stage 
is still occurring in primary infected cells. All the cycle is summarized in the Figure 21-) 
extracted from Celli et al. [394].  
? ???
 
Figure 21 Model of the Brucella intracellular cycle in macrophages. 
Following phagocytic uptake by macrophages, Brucella spp. reside in the first 8 to 12 h post  
infection within a membrane bound vacuole that undergoes endosomal maturation via sequential interactions 
with early (EE) and late (LE) endosomes and lysosomes (LYS) to become an acidified, endosomal Brucella-
containing vacuole (eBCV). The host small GTPase Rab7 contributes to eBCV maturation, which provides 
physicochemical cues promoting expression of the VirB Type IV secretion system (T4SS), which translocates 
effector proteins (red) that mediate eBCV interactions with ER exit site and acquisition of ER and Golgi-derived 
membranes. These events lead to the biogenesis of replication permissive, ER-derived BCVs, called replicative 
BCVs (rBCVs). The host proteins Sar1, IRE1α, Yip1A, Atg9, WIPI1 and the COG complex contribute to rBCV 
biogenesis. Bacteria then undergo extensive replication in rBCVs between 12 and 48 h pi, after which rBCVs are 
captured within autophagosome-like structures in a VirB T4SS-dependent manner, to become autophagic BCVs 
(aBCVs). aBCV formation requires the host autophagy proteins Beclin1, ULK1 and Atg14. aBCVs harbors 
features of autolysosomes and are required for bacterial egress and new cycles of intracellular infections. Figures 
and legends extracted from [394]. 
 
6-) Brucella atypical niches 
 
The intracellular life cycle described above occurs in the vast majority of cell types 
studied to date. However, a few exceptions are worth mentioning. B. abortus and B. suis can 
replicate in large endosomal inclusions in extra-villous trophoblasts (EVTs) JEG-3 [395] 
whereas B. melitensis mostly replicated in the typical ER-derived compartment. These 
? ????
inclusions were shown to exclude LC3 and did not present with double membrane 
characteristic of autophagosomes, but it would be interesting to investigate if other autophagy 
proteins are involved in their formation. This phenotype was specific for EVT as B. abortus 
and B. suis still replicate within the ER in other trophoblast lineages as BeWo, JAR and 
HTR8 corresponding to villous trophoblasts [341,386]. Surprisingly, in JEG cells bacterial 
replication was partly independent from the T4SS [395]. So, EVTs represent another model 
cell line that is interesting to further explore to improve or knowledges on Brucella replication 
mechanisms. Interestingly, Brucella papionis (associated with stillbirth in primates) also 
infects human trophoblasts. However, it replicates actively in CTB, whereas its replication is 
very restricted within EVT; [396]. 
It is also important for me to note that Brucella does not have the same trafficking 
when it is Immunoglobulin G opsonized. Indeed, it has been shown that B. abortus is found in 
a LAMP-1 positive vacuole that will not be acidified in the human monocytic cell line THP1 
[379]. Thus, opsonization seems to alter the intracellular trafficking of the bacteria by 
changing the nature of the eBCV but further work needs to be carried out to confirm these 
results.  
Together these studies suggest Brucella presents some versatility and ability to adapt 
and replicate in alternative niches. How these niches are formed, what are the bacterial factors 
involved and the relevance of these atypical niches in vivo remains to be characterized. 
IV-) Brucella effectors a cold war arsenal 
 
This part does not aim to exhaustively list all the discovered Brucella effectors. This 
information can be found in Table (2) which regroups all the published effectors. But for this 
part of my thesis I class them given their mode of action or given the targeted process. 
 
? ????
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1-) Secreted effector protein A (SepA) interferes with the endosomal pathway  
 
SepA is an effector which was shown to be translocated in host cell in a virB 
dependent-manner and the only one that was shown to be important for Brucella trafficking in 
the endosomal pathway. Indeed, SepA seems to accumulate on the vacuolar membrane at the 
early stages of infection. Moreover, a ΔsepA mutant strain shows a significant defect in early 
stages of intracellular trafficking as it remains in a vacuole devoid of the typical eBCV 
marker LAMP1. Surprisingly, ΔsepA mutants are also more efficiently inactivated during the 
first stages of the replication process but have an increase capacity to invade host cells. Thus, 
the authors suggest that SepA could allow the bacteria to select the phagocytosis route, but 
this remains to be formally demonstrated [397]. 
 
2-) The secretory pathway targeted by multiple effectors 
 
In many ways, it has been shown eBCVs undergo T4SS-dependent, sustained 
interactions with ERES structures during the eBCV/rBCV conversion stage. The importance 
of the secretory pathway for Brucella is today well established and accepted in the field. This 
is why to date, several effectors (further described below) are already identified to interfere 
with host secretory pathway [391,398,399]. 
 
The first identified effector is Rab2 interacting conserved protein A (RicA) which was 
established to preferentially bind the GDP form of the GTPase Rab2. This is consistent with 
the essential role of Rab2 in Brucella pathogenesis, shown to be recruited on the BCVs during 
infection [390]. For the bacteria it has been demonstrated that Rab2 has to be functional to 
allow the bacteria to establish its ER-derived niche [398]. Indeed GDP-locked form of Rab2 
blocks the trafficking of the bacteria, which stay in late endosomal compartments. Although it 
is clear that Rab2 contributes to the maturation of the BCV its precise role and why it is the 
GDP-form of Rab2 that is preferentially bound by RicA remains to be determined.  
 
Afterwards several effectors were identified in the same study to be associated to the 
subversion of some secretory pathway processes [399]. After an in-silico screen and an 
experiment of TEM1-β-lactamase to confirm that identified proteins are effectors, Myeni et 
al. [399] co-transfected these new identified effectors with a secretion reporter: Secreted 
Enzyme Alkaline Phosphatase (SEAP) which is an excellent reporter of a functional ER 
? ????
secretion pathway. They showed that ectopically expressed Brucella secreted proteins A, B 
and F (BspA, B and F) inhibit the secretory pathway. The importance of BspB and F in the 
control of ER secretion was sustained in infection as cells infected with mutants of bspB and 
bspF did not show any secretion inhibition contrary to the bspA mutant. The importance of 
these Bsp proteins was further confirmed in infection as a bspA, bspB and bspF triple mutants 
failed to replicate as efficiently as the wild-type strain in murine macrophages [399]. 
 
In a more recent study, the same team more deeply investigated the mechanism of 
action of BspB. Indeed, they demonstrated that BspB interacts with the Conserved Oligomeric 
Golgi (COG) [391], a complex reported to be crucial for Golgi vesicular trafficking [400].  
Moreover, this COG complex was shown to be a regulatory “carrefour" for secretory Rab 
GTPases known to be important for Brucella virulence. 
Therefore, BspB modulates Golgi membrane traffic by interacting with COG. This 
interaction leads to a competition for Golgi-derived vesicles normally used for the protein 
secretion. Thus, the Golgi apparatus appears to be another source of membrane for rBCV 
biogenesis in addition to ER-derived membranes. 
Finally, the same study showed that an inhibition of Rab2 GTPase via depletion of 
Rab2 counteracts the deleterious effect of a ΔbpsB mutant suggesting that BspB may affect 
retrograde secretory traffic to redirect COG-dependent Golgi vesicular traffic to the BCV 
[391]. 
 
3-) Effectors that targets UPR: Playing with Fire 
 
Previously we have shown that UPR is necessary for Brucella replication. 
Consequently, several teams have tried to identify whether some effectors can be responsible 
of this phenotype. 
One major effector involved in the induction of ER stress is the effector VceC. This 
effector was identified in a study which wanted to identify virB-coregulated genes [401]. 
Indeed, in this study they hypothesized that associated T4SS effectors will be genetically 
encoded close to the virB operon for genetic ergonomy and this is in this way after β-
lactamase experiment that they identified 2 effectors VceA and VceC. 
 Few years later, they published another study regarding VceC. Transfection of VceC 
in HeLa cells showed extensive co-localization of this effector with ER markers. Moreover, 
they also observed a disruption of the ER morphology with the formation of particular 
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structures resulting in a vacuolation of the ER. Given the localization of the effector, they 
looked for putative partners of VceC and identified the ER chaperone BiP which is a major 
actor of ER stress process (see Chapter 1). Monitoring splicing of Xbp1 by RT-PCR and 
Western Blot they observed the apparition of 2 bands indicating an activation of the IRE1 
pathway [361]. They also observed in infection and dependent of the translocation of this 
effector an up-regulation of pro-inflammatory responses with an increase of IL-6 and TNF-α 
secretion [361]. Thus, this study was the first to associate an effector with the induction of 
inflammation in macrophages. 
 
To complete these first results the same team further investigated the importance of VceC for 
Brucella infection associated to ER stress, inflammation and immunity processes [138]. This 
study is very powerful as we have seen from work by Martinon et al. [137] PRRs are 
associated to ER stress but their exact involvement remained unclear. Interestingly, by 
studying the function of VceC, authors highlighted the association of NOD1 and NOD2, two 
NLRs that successfully associate to IRE1α via TRAF2 because NOD1/NOD2 both have 
TRAF2 motifs. When TRAF2 associates to IRE1 it leads to the induction of inflammation 
process with the translocation of NF-κB (see Chapter 1). Authors then elucidated if Brucella 
could induce the same pathways. As a control, they showed that the ER stress inducer 
thapsigargin induces IL-6 in a NOD1/NOD2 dependent manner, and they observed the same 
kind of induction with Brucella dependent of the T4SS identified effector VceC [138,361].  
Furthermore, they demonstrated the importance of TRAF2 in this new pathway with the 
transfection of VceC in HEK293 cells which induced NF-κB activation. Nevertheless, if 
VceC is ectopically expressed in cells with dominant negative forms of TRAF2 the induction 
of NF-κB is abrogated [138]. 
All these processes led by VceC trigger ER stress that induces the IRE1-NOD1/2-dependent 
pro-inflammatory branch of the UPR could be linked with the abortion phenomenon observed 
during B. abortus infection. Authors went further and extended their study to another 
pathogen Chlamydia muridarum a bacterial pathogen also known to induce ER stress [204]. 
They infected HeLa cells and they also observed an activation of the NOD1/NOD2 dependent 
pathway [138]. It took 13 years to have the complete story for this fascinating effector, but it 
highlights how the research on bacterial effectors can also allow a better understanding of 
cellular fundamental processes. 
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Surprisingly Smith et al. [161] is the only study that shows that B. melitensis infection up 
regulated expression of the 3 UPR pathways after measuring by qPCR the mRNA of target 
genes BiP, CHOP, ERdj4, and spliced XBP1 in murine macrophages [161]. 
They also showed that Brucella virB mutant harbors an intact UPR induction while a btpA 
mutant presented reduced BiP, CHOP and ERdj4 expression. These results are surprising 
when we have seen the importance of VceC or with the new effector that we will present in 
the next chapter of Results: Brucella secreted protein L (BspL). 
As what has been described for VceC they also showed that transfection of BtpA induced the 
overexpression of UPR genes and affects the morphology of the ER with again vacuolation of 
the ER network. Logically with their first results they observed that a btpA mutant less 
fragmented the ER [161].  
The identification of these 2 effectors involved in ER stress represents a hot topic for 
Brucella characterization. In addition, in Myeni et al. the authors identified 3 other effectors: 
BspC, G and K demonstrated to induce ER stress [399] with the upregulation of BiP 
chaperone which let us to think an involvement in UPR. Otherwise we will see in the next 
chapter that our team characterized a new effector that induces ER stress and surprisingly for 
a new function.  
4-) Effectors and host immunity processes: BtpA, BtpB and PrpA  
 
Brucella was shown to down-modulate the maturation of dendritic cells and to inhibit 
the production of pro-inflammatory cytokines (such as TNF-α). This was in part due to a 
translocated effector called BtpA because of its ability to interfere with TLR2 and TLR4 
signalling. 
After these first observations, other studies from several groups further investigated 
how BtpA acts on the TLR pathways identifying Myd88 and TIRAP as targets. It was shown 
that BtpA efficiently blocks TIRAP-induced NF-κB. Interestingly it was also shown that 
BtpA can induce degradation of phosphorylated TIRAP by enhancing its poly-ubiquitination 
[402]. Consequently, these first papers demonstrated that BtpA can interact with a same target 
in order to interfere in downstream processes. Moreover authors deduced that BtpA controls 
inflammatory responses because ectopic BtpA has been shown to interact with 
phosphoinositides at the plasma membrane and modulate microtubule dynamics to misplace 
some specific adaptor molecules within the cell [373]. 
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For the second target mentioned above, BtpA was shown to directly interact with 
MyD88 via the Death Domain and not the TIR domain of the adaptor. However, other groups 
have failed to detect an interaction with MyD88 [403]. Nevertheless, further work is now 
required to fully understand the molecular mechanism by which BtpA controls TLR 
signalling, which may involve interaction and/or competition with both MyD88 and TIRAP 
and maybe other immune players. 
As BtpA, BtpB also contributes to the control of DC activation during infection [404]. Indeed, 
btpB mutant strain presents higher translocation of NF-κB and higher level of MHC-II at the 
surface and co-stimulatory molecules when compared with WT strain infection27. Even if 
BtpB shares some similarity sequence with BtpA they do not act as the same manner as BtpB 
can block all TLR receptors in vitro and seems to more strongly impact IL12 production by 
infected inflammatory DCs. 
Interestingly susceptible IFNγ-/- mice infected with btpB mutant survived longer than those 
infected with the WT strain and this phenotype was even more striking for the double 
btp1btp2 mutants which were highly attenuated in this model which confirms the major 
importance of BtpA and BtpB in vivo.  
Otherwise another secreted protein was identified in Brucella abortus to induce the 
proliferation of B-cells. This protein is called Proline racemase protein A (PrpA) and was 
firstly demonstrated to induce the production of IL10 [405,406]. It induces a transient 
nonresponsive state of splenocytes, acts as a potent IL-10 inducer, and participates in the 
efficient establishment of a chronic infection in mice [406].  This protein is translocated 
during the replicative phase of Brucella and is able to bind macrophages through nonmuscular 
myosin IIA (NMM-IIA) in order to induce B-cell proliferation. Interestingly they also 
demonstrated that neutralization of NMM-IIA with the use of polyclonal antibody inhibits the 
interaction. Thus NMM-IIA can be considered either as a receptor or an adaptor for PrpA, in 
every case involved in a signaling process for B-cell proliferation [405]. 
 
V-) Brucella targets host metabolism 
1-) Brucella modulates host metabolic pathways 
?
As we have previously seen in the Chapter 1 with Orientia tsutsugamushi, 
intracellular pathogens are in competition with host cell metabolism process for nutrient 
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acquisition. In the study of Rodino et al. it was for the acquisition of amino acid, but it can be 
generalized to other metabolites as glucose or calcium [407]. Brucella is no exception as 
nutrient uptake is certainly vital during infection. Moreover, it is today known that some 
pathogens induce metabolic shift in the infected host cells reminiscent of the Warburg effect 
initially described in cancer cells and in immune cells (see Chapter 2). As a reminder the 
glycolysis without a fully functioning Krebs cycle leads to an over production of lactic acid 
which is a hallmark of Warburg effect (see Chapter 2). Understanding the capacity of 
Brucella to play with all the different metabolic pathways will be essential for obtaining a full 
picture of the intracellular life cycle and has recently started to be investigated with two main 
studies. The first one of Xavier et al. [297] perfectly illustrates the link between metabolism 
shift induced by Brucella abortus and the activation of some immune cells as macrophages 
that were separated in two groups: classically activated macrophages (CAMs or M1) and 
alternatively activated macrophages (AAM or M2). The nature of the macrophages depends 
of the host inflammatory response according to the produced cytokines. Indeed, CAMs are 
induced by IFN-γ and are known to exert an anti-microbicidal activity by secreting pro-
inflammatory cytokines. Whereas for AAMs it has been established the involvement of IL-4 
and 13 in their differentiation. AAMs are known to be less efficient in host immunity defense 
as they present a reduced microbicidal activity and secrete anti-inflammatory cytokines which 
is consistent with Brucella strategy infection mentioned with Btp proteins. As mentioned 
above the transition of CAMs to AAMs is accompanied by a metabolism shift [408]. It has 
been demonstrated that CAMs mainly use glucose for an anaerobic metabolism associated 
with Krebs cycle and oxidative phosphorylation. On the contrary it has been shown that 
AAMs use the β-oxidation pathways as nutrients to produce energy. Indeed, glucose levels 
are higher in AAMs than in CAMs so it is more interesting for the bacteria to differentiate 
macrophages in AAMs where there will be more available glucose. Moreover, in AAMs 
bacteria can use alternative pathway as β-oxidation or fermentation process for its own 
replication as it can use some metabolic substrates to produce energy. Nevertheless, and 
interestingly authors have shown that a gluP mutant strain defective for glucose transporter 
presented both a reduced intracellular survival in AAMs and persistence in mice. These 
results sustain the importance of glucose for Brucella proliferation even if the pathogen can 
adapt itself to different metabolisms.  
To go further Xavier et al. [297] identified the cellular actor that is responsible of the 
metabolic shift in AAMs: the peroxisome proliferator activated receptor γ (PPARγ). This 
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protein was demonstrated to be able to increase intracellular glucose availability. Indeed, 
Signal transduction through the nuclear peroxisome proliferator-activated receptors PPARγ 
and PPARδ orchestrates the patterns of gene expression required for the development of 
AAMs [409]. Thus, it is the increased availability of glucose as a carbon and energy source 
that makes AAMs a permissive site for intracellular replication of the brucellae during 
chronic infection rather than the fact that AAMs have reduced bactericidal activities 
compared to CAMs. Given the importance of PPARγ to promote chronic persistence and 
enhance bacterial survival of B. abortus within AAM it can represent an interesting target to 
counteract Brucella infection. 
The second study confirms in macrophage-like cells (Thp1) that Brucella induces a 
metabolic shift [410]. In this study, the Krebs cycle was shown to be altered which is 
correlated with a decrease of amino acid degradation and an increase of lactate level which 
looks like to a Warburg effect. Indeed, Brucella inhibits the Krebs cycle to force the cell to 
make more glucose available to increase glycolysis for their own benefit [410]. This 
inhibition of Krebs cycle forced the cell towards fermentation and production of alternative 
metabolites as lactate that can be used as a carbon source for Brucella.  
Authors demonstrated that B. abortus infection of Thp1 cells impairs mitochondrial 
function and localization, with a “polarization” of all the mitochondria. As explained in the 
previous chapter mitochondria are very important for metabolic processes because this is 
where the Krebs cycle undergo. This is why the authors of Czych et al. [410] tested the 
respiratory chain activity associated to mitochondria function. Their results demonstrated that 
B. abortus infection acts as mitochondrial inhibitors and inhibits human THP-1 cells to utilize 
amino acids as an energy source. Furthermore, they shown that an increased MOI of Brucella 
leads to an increase consumption of glucose [410]. And finally, B. abortus required lactate 
dehydrogenase for normal intracellular survival in THP-1 cells which is consistent with the 
increased concentration of lactate 
2-) Brucella and mitochondria: a new target for this pathogen 
?
Given the multiple functions ensured by mitochondria and the two previous studies on 
the metabolism it now appears crucial to investigate the connexion between Brucella and this 
organelle. In infected cells, Brucella was shown to be tightly associated to mitochondria by 
electron microscopy even if this close association does not result in any cytoskeleton 
? ????
reorganization [411]. Interestingly the experiment was reproducible with in vitro cell lines 
(HeLa cells) and primary cells (trophoblasts from BALB/c mice). They next used confocal 
microscopy to visualize the mitochondrial network. Surprisingly they observed fragmentation 
of the mitochondrial network in different cell lines after B. abortus and B. melitensis 
infection. In spite of this strong phenotype Brucella replication was not affected. Authors then 
tried to identify the cellular partner hijacked by Brucella to induce this fragmentation. They 
focused on Drp1 as it is connected with mitochondrial fission processes, but it appears that the 
fragmentation was Drp1 independent. As a final hypothesis, authors suggested the observed 
fragmentation may be related to defects in the fusion process during Brucella infection, which 
remains to be investigated. 
Because this paper came after those from Czych et al. [410] and Xavier et al. [297] they 
decided to study another process of the mitochondria the regulation mitochondrial reactive 
oxygen species (mtROS) production. But again, they did not observe any consequences for 
bacterial replication with the modulation of mtROS. In the continuity of the previous studies 
they blocked the mitochondrial respiration and without surprise they did not observe any 
effect which is consistent that Brucella not requiring oxidative phosphorylation and surviving 
with aerobic mitochondrial metabolism. Because mitochondria and ER are connected via 
MAMs and given the importance of the calcium in MAM-dependent processes, they also 
measured the impact on mitochondrial calcium uptake. But again, the calcium levels were not 
found to be responsible for the observed mitochondrial morphology. 
Finally, they tested if the fragmentation could be related to interference with apoptosis. 
Indeed, given the link of mitochondria to the intrinsic pathway of apoptosis they induced 
apoptosis with TNF-α to see if the mitochondrial fragmentation could confer to bacteria 
protection from apoptosis but they did not observe any protective effect of the induced 
mitochondrial fragmentation. 
Brucella-induced fragmentation does not impact replication nor TNF-α induced apoptosis, 
which would have been an interesting explanation of how Brucella controls host cell death as 
reported in several studies. It is important to note that a few studies, reported that in some cell 
lines Brucella can induce apoptosis but given their controversy, this topic remains to be 
further investigated and will be further discussed in the Chapter 6. 
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Abstract  25 
Perturbation of the endoplasmic reticulum (ER), a central organelle of the cell, can have critical 26 
consequences for cellular homeostasis. An elaborate surveillance system known as ER quality 27 
control ensures that cells can respond and adapt to stress via the unfolded protein response 28 
(UPR) and that only correctly assembled proteins reach their destination. Interestingly, several 29 
bacterial pathogens have been shown to hijack the ER to establish an infection. However, it 30 
remains poorly understood how bacterial pathogens exploit ER quality control functions to 31 
complete their intracellular cycle. Brucella spp. replicate extensively within an ER-derived 32 
niche, which evolves into specialized vacuoles suited for exit from infected cells. Here we 33 
present BspL, a new Brucella abortus type IV secretion system effector that targets Herp, a key 34 
component of ER-associated degradation (ERAD) machinery. We found that BspL strongly 35 
enhances ERAD, independently of the UPR. Targeting of Herp allows tight control of the 36 
kinetics of autophagic Brucella-containing vacuole formation, delaying the last step of its 37 
intracellular cycle and preventing premature bacterial egress from infected cells. This study 38 
highlights a new mechanism by which an intracellular bacterial pathogen hijacks ERAD 39 
components for fine regulation of its intracellular trafficking.  40 
 41 
 42 
 43 
 44 
 45 
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Introduction 48 
The endoplasmic reticulum (ER) is the largest organelle in the cell and plays numerous 49 
functions vital for maintaining cellular homeostasis. It is the major site for protein synthesis of 50 
both secreted and integral membrane proteins as well as exporting of newly synthesised proteins 51 
to other cellular organelles. Disturbance or saturation of the folding-capacity of the ER leads to 52 
a complex stress response that has evolved to help cells recover homeostasis or, if necessary, 53 
commit them to death. The ER relies on a complex surveillance system known as ER quality 54 
control that ensures handling of misfolded, misassembled or metabolically regulated proteins 55 
1. Once retained in the ER, these proteins are retrotranslocated into the cytosol to be 56 
ubiquitinated and degraded by the proteasome, a process known as ER-associated degradation 57 
(ERAD) 2. Alternatively, ERAD-resistant proteins can be degraded via ER-phagy 3. In response 58 
to perturbations of ER quality control, ER stress ensues and cells activate a set of inter-59 
connected pathways that are collectively referred to as the unfolded protein response (UPR), 60 
critical for restoring homeostasis 4. 61 
 62 
The homocysteine-inducible ER stress protein (Herp) is an ER membrane protein that is highly 63 
upregulated during ER stress by all UPR branches 5,6. Herp is a key component of ERQC that 64 
plays a protective role in ER stress conditions 7,8. It is an integral part of the ERAD pathway, 65 
enhancing the protein loading and folding capacities of the ER. In addition, it acts as a hub for 66 
membrane association of ERAD machinery components, stabilizing their interactions with 67 
substrates at ER quality control sites 9 and facilitating their retrotranslocation 10. Furthermore, 68 
as Herp is also in a complex with the proteasome it may aid delivery of specific 69 
retrotranslocated substrates to the proteasome for degradation 11,12.  70 
 71 
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Given its importance for cellular homeostasis, the ER quality control represents a prime target 72 
for microbial pathogens. Indeed, a  growing number of bacterial pathogens have been shown to 73 
modulate UPR 13. This is the case of Brucella spp., a facultative intracellular pathogen that 74 
causes brucellosis, a zoonosis still prevalent worldwide. Brucella abortus has been shown to 75 
induce UPR 14,15, and more specifically the IRE1 pathway, contributing to enhanced 76 
inflammation, a process particularly relevant in the context of colonization of the placenta and 77 
abortion 16. However, activation of IRE1 is also important for Brucella trafficking and 78 
subsequent Brucella multiplication 15,17. After cellular uptake, Brucella is found in a membrane 79 
bound compartment designated endosomal Brucella-containing vacuole (eBCV) which 80 
transiently interacts with early and late endosomes, undergoing limited fusion with lysosomes 81 
18. Bacterial are then able to sustain interactions with ER exit sites (ERES) a process that 82 
requires the activity of the small GTPases Sar1 19 and Rab2 20 and results in the establishment 83 
of an ER-derived compartment suited for multiplication (replicative or rBCV)21. UPR induction 84 
by Brucella is necessary for this trafficking step, as the formation of rBVCs is dependent on 85 
IRE1 activation by the ERES-localized protein Yip1A, which mediates IRE1 phosphorylation 86 
and dimerization 22. Once rBCVs are established, Brucella is capable of extensive intracellular 87 
replication, without induction of cell death. Instead, at late stages of the intracellular cycle, 88 
rBCVs reorganize and fuse to form large autophagic vacuoles (aBCVs) that will mediate 89 
bacterial exit from infected cells 23. The bacterial factors behind the switch between rBCVs and 90 
aBCVs remain uncharacterized.   91 
Brucella relies on a type 4 secretion system (T4SS), encoded by the virB operon and induced 92 
during eBCV trafficking to translocate bacterial effectors into host cells and directly modulate 93 
cellular functions, including the biogenesis of rBCVs 24-26 and formation of aBCVs 27. However, 94 
only a few effectors have been characterized and for which we have a full grasp of how they 95 
contribute towards pathogenesis. This system has been implicated in the induction of UPR 96 
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during infection and a subset of these effectors has been shown to modulate ER-associated 97 
functions. VceC interacts with the ER chaperone BiP to activate the IRE1 pathway, which 98 
results in NOD1/NOD2 activation and up-regulation of inflammatory responses 14,16. BspA, 99 
BspB and BspF have all been implicated in blocking of ER secretion 28. In particular, BspB was 100 
shown to interact with the conserved oligomeric Golgi (COG) complex to redirect vesicular 101 
trafficking towards the rBCVs 29. Several other effectors that localize in the ER when 102 
ectopically expressed have been shown to induce UPR or control ER secretion, but the 103 
mechanisms involved remain uncharacterized. 104 
 105 
In this study, we identify a new T4SS effector of Brucella abortus, that we designate as 106 
Brucella-secreted protein L (BspL) that targets a component of the ERAD machinery, Herp.  107 
BspL enhances ERAD and delays the formation of aBCVs, preventing early bacterial release 108 
from infected cells which helps maintain cell to cell spread efficiency.  109 
 110 
 111 
Results 112 
 113 
BspL is a Brucella T4SS effector protein  114 
Bacterial effectors often contain domains and motifs that are characteristic of eukaryotic 115 
proteins. This is the case for example of SifA from Salmonella enterica 30,31 and AnkB from 116 
Legionella pneumophila 32,33 that contain a carboxyl-terminal CAAX tetrapeptide motif (C 117 
corresponds to cysteine, A to aliphatic amino acids and X to any amino acid) that serves as a 118 
lipidation site to facilitate membrane attachment. Previous work highlighted several Brucella 119 
encoded proteins that contain putative CAAX motifs 32 which could therefore be T4SS 120 
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effectors. In this study, we focused on one of these proteins encoded by the gene BAB1_1533 121 
(YP_414899.1), that we have designated BspL for Brucella-secreted protein L.  122 
 123 
We first determined if BspL was translocated into host cells during infection. We constructed 124 
a strain expressing BspL fused to the C-terminus of the TEM1 ß-lactamase (encoded by bla) 125 
and infected RAW macrophage-like cells for different time-points. A Flag tag was also included 126 
for control of protein expression. The fluorescent substrate was added and the emission of 127 
coumarin, resulting from cleavage by the cytosolic TEM1 lactamase, was detected by confocal 128 
microscopy. This assay is widely used in the Brucella field and we included the T4SS effector 129 
VceC as a positive control 34, which showed the highest level of secretion at 24h post-infection 130 
in our experimental conditions (Figure 1A). We found that TEM1-BspL was secreted into host 131 
cells as early as 4h post-infection, with a slight peak at 12h post-infection, CCF2 cleavage was 132 
still detected at 24h post-infection (Figure 1A). This phenotype was fully dependent on the 133 
T4SS as a ΔvirB9 mutant strain did not show any coumarin fluorescence (Figure 1A and B). 134 
This was not due to lack of expression of TEM1-BspL as both the wild-type and the ΔvirB9 135 
strains carrying the bla::bspL plasmid showed equivalent levels of TEM1-BspL (Figure 1C). 136 
Together, these results show BspL is a T4SS effector.  137 
 138 
Ectopically expressed BspL accumulates in the ER, does not interfere with host protein 139 
secretion but induces the UPR 140 
BspL is very well conserved in the Brucella genus, it is 170 amino acids long (Figure S1A) and 141 
is approximately 19 kDa. BspL does not share any homology to eukaryotic proteins nor to other 142 
bacterial effectors. Its nucleotide sequence encodes for a sec secretion signal, a feature 143 
commonly found in other Brucella effectors 35. In addition, it contains a hydrophobic region as 144 
well as a proline rich domain, with seven consecutive prolines. To gain insight into the function 145 
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of BspL we ectopically expressed HA, myc or GFP-tagged BspL in HeLa cells. We found BspL 146 
accumulated in the ER, as can be seen by the co-localization with calnexin (Figure 2A and S1B, 147 
S1C), an ER membrane protein and chaperone. Unlike what has been reported for VceC 14, the 148 
structure of the ER remained relatively intact upon BspL expression. Deletion of the C-terminal 149 
tetrapeptide sequence had no effect on the ER localization of BspL in transfection (Figure S1B, 150 
bottom panel), as it significantly overlapped with the full-length protein when co-expressed in 151 
the same cell (Figure S1C). 152 
 153 
Our observations suggest BspL is part of a growing number of Brucella effectors that 154 
accumulate in the ER when ectopically expressed, including VceC, BspB and BspD 14,28. We 155 
therefore investigated if BspL shared any of the ER modulatory functions described for other 156 
effectors, notably interference with ER secretion as BspB 28,29 or induction of ER stress as VceC 157 
14,16. 158 
To determine the impact of BspL on host protein secretion we used the secreted embryonic 159 
alkaline phosphatase (SEAP) as a reporter system. HEK cells were co-transfected with the 160 
vector encoding SEAP and vectors encoding different Brucella effectors. We chose to work 161 
with HA-BspL, to allow direct comparison with previously published HA-BspB that blocks ER 162 
secretion and HA-BspD as a negative control 28. Expression of the GDP-locked allele of the 163 
small GTPase Arf1[T31N], known to block the early secretory pathway, was used as a control 164 
for efficient inhibition of secretion (Figure S1D). As previously reported, we found that 165 
expression of HA-BspB drastically reduced SEAP secretion (Figure S1D). In contrast, HA-166 
BspL did not impact SEAP secretion to the same extent as BspB, having an effect equivalent 167 
to HA-BspD previously reported not to affect host protein secretion 28. 168 
 169 
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We next investigated whether ER targeting of BspL was accompanied with activation of the 170 
UPR, an important feature of Brucella pathogenesis 16,17,22. In the case of B. abortus, IRE1 is 171 
the main pathway activated 14 which leads to splicing of the mRNA encoding the transcription 172 
factor X-box-binding protein 1 (XBP1) which in turn induces the expression of many ER 173 
chaperones and protein-folding enzymes. The second branch of the UPR dependent on PERK 174 
may also be of relevance in Brucella infection 15. Under prolonged stress conditions, this UPR 175 
branch leads to the up-regulation of the transcription factor C/EBP-homologous protein 176 
(CHOP) which induces expression of genes involved apoptosis. We therefore monitored XBP1s 177 
and CHOP transcript levels following ectopic expression of HA-BspL, in comparison to HA-178 
VceC, established as an ER stress inducer and HA-BspB, known not to induce ER stress. 179 
Treatment with tunicamycin, a chemical ER stress inducer was also included. We found that 180 
over-expression of HA-BspL induced an increase of both XBP1s and CHOP transcription, to 181 
levels even higher than HA-VceC (Figure 2B and C). These results suggest BspL may induce 182 
ER stress.  183 
 184 
BspL is not involved in establishment of an ER-derived replication niche but is implicated 185 
in induction of ER stress during infection 186 
As UPR has been implicated in the establishment of rBCVs 22 and intracellular replication 187 
15,17,22 of Brucella we next investigated the intracellular fate of a B. abortus 2308 strain deleted 188 
for bspL in comparison with the wild-type. Two cellular models were used, HeLa cells and an 189 
immortalized cell line of bone marrow-derived macrophages (iBMDM). We found that the 190 
ΔbspL strain replicated as efficiently as the wild-type in both iBMDM (Figure S2A) and HeLa 191 
cells (Figure S2B). In terms of intracellular trafficking no obvious differences were observed 192 
in the establishment of rBCVs at 24 and 48h post-infection, as ΔbspL BCVs were nicely 193 
decorated with the ER marker calnexin in both cell types (Figure 2D and E) as observed for the 194 
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wild-type strain (Figure S2C and D). As this is the first report to our knowledge to use iBMDM 195 
in Brucella infections, we confirmed this observation by quantifying the percentage of BCVs 196 
positive for calnexin and the lysosomal associated membrane protein 1 (LAMP1) in comparison 197 
with the wild-type at 24 and 48 post-infection (Figure S2E and F, respectively). The wild-type 198 
strain in this cellular model behaved as expected forming the typical rBCVs. 199 
 200 
As in transfected cells we found that BspL induced UPR, we next monitored the levels of XBP1s 201 
and CHOP transcripts during infection. Since the rate of infected cells is too low to detect ER 202 
stress in HeLa cells, these experiments were only performed in iBMDMs. As expected, the 203 
wild-type B. abortus strain induced an increase in the levels of transcription of XBP1s in 204 
relation to the mock-infected control iBMDM at 48h post-infection (Figure 2F). In contrast, 205 
ΔbspL infected macrophages showed decreased XBP1s transcript levels compared to the wild-206 
type (Figure 2F). Furthermore, the wild-type phenotype could be fully restored by expressing 207 
a chromosomal copy of bspL in the ΔbspL strain, confirming that BspL specifically contributes 208 
towards induction of the IRE1 branch of the UPR during infection (Figure 2F). We did not 209 
observe an increase in CHOP transcript levels in iBMDM infected with the wild-type nor ΔbspL 210 
strains in comparison to the mock-infected cells (Figure 2G), suggesting that B. abortus does 211 
not significantly induce the PERK-dependent branch of the UPR at this stage of the infection.  212 
 213 
BspL interacts with Herp, a key component of ERQC 214 
To gain insight into the function of BspL we set out to identify its interacting partners. A yeast 215 
two-hybrid screen identified 7 candidates: eukaryotic translation initiation factor 4A2 216 
(EIF4A2), pyruvate dehydrogenase beta (PDHB), MTR 5-methyltetrahydrofolate-217 
homocysteine methyltransferase, Bcl2-associated athanogene 6 (BAG6), ARMCX3 armadillo 218 
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repeat containing protein (Alex3), homocysteine-inducible ER protein with ubiquitin like 219 
domain (Herpud1 or Herp) and Ubiquilin2 (Ubqln2). 220 
 221 
In view of our previous results for BspL showing ER localization and induction of UPR we 222 
decided to focus on Alex3, Herp and Ubiquilin2 which are rarely present or even absent in the 223 
database of false positives for this type of screen (http://crapome.org/). Alex3 is a mitochondrial 224 
outer membrane protein that has been implicated in regulation of mitochondrial trafficking 36. 225 
As ER and mitochondria extensively interact, Alex3 could constitute an interesting target. Herp 226 
is an ER membrane protein playing a role in both the UPR and the ERAD system whereas 227 
Ubiquilin2 is implicated in both the proteasome and ERAD and, interestingly, shown to interact 228 
with Herp 37. In view of these different targets we decided to carry out an endogenous co-229 
immunoprecipitation in cells expressing HA-BspL. As controls for detecting non-specific 230 
binding, we also performed co-immunoprecipitations from cells expressing two other ER-231 
targeting effectors, HA-BspB and HA-VceC. We then probed the eluted samples with 232 
antibodies against Alex3, Ubiquilin2 or Herp to detect if any interactions could be observed. 233 
We found that Alex3 was co-eluted with all 3 effectors suggesting a potentially non-specific 234 
interaction with the effectors or the resin itself (Figure 3A). In contrast, no interactions were 235 
observed with Ubiquilin2, which was detected only in the flow through fractions. However, we 236 
found that endogenous Herp specifically co-eluted with HA-BspL and not the other effectors 237 
(Figure 3A), suggesting Herp and BspL form a complex within host cells. To confirm these 238 
results, we co-expressed GFP-BspL with Flag-Herp in HeLa cells and carried out a co-239 
immunoprecipitation. Despite much higher levels of GFP expression, only GFP-BspL was able 240 
to co-immunoprecipitate Flag-Herp (Figure 3B) confirming they are part of the same complex. 241 
Taken together with the yeast two-hybrid data, we can conclude that BspL directly interacts 242 
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with Herp. Consistently, over-expressed BspL co-localized with Herp by microscopy (Figure 243 
3C).  244 
 245 
BspL facilitates degradation of TCRα via ERAD independently of ER stress 246 
Herp is a key component of ERAD, strongly up-regulated upon ER stress 6. Indeed, during B. 247 
abortus infection we observed an up-regulation of HERP transcripts (Figure S3A), consistent 248 
with XBP1s induction, although these differences were not statistically significant with the 249 
number of replicates carried out. However, inhibition of Herp using siRNA (Figure S3B) 250 
showed that ER stress induced following ectopic expression of BspL was not dependent on 251 
Herp (Figure S3C and D), suggesting BspL interaction with Herp is mediating other functions 252 
in the cell.  253 
 254 
Therefore, we next investigated if BspL could directly impact ERAD. We used expression of 255 
T cell receptor alpha (TCRα) as reporter system, as this type I transmembrane glycoprotein has 256 
been shown to be a canonical ERAD substrate, quickly degraded 38,39. TCRα is transferred 257 
across the ER membrane, where is becomes glycosylated and fails to assemble. This in turn 258 
induces its retrotranslocation to the cytosol to be degraded by the proteasome. Cycloheximide 259 
treatment for 4 h was used to block protein synthesis, preventing replenishment of TCR pools 260 
and allowing for visualization of ERAD-mediated degradation of TCRα. When HEK-293T 261 
cells, which do not naturally express TCR were transfected with HA-TCRα and treated with 262 
cycloheximide, a decrease in HA-TCRα was observed, indicative of degradation (Figure 4A, 263 
red arrow). Strikingly, expression of BspL induced very strong degradation of TCRα (Figure 264 
4A). This is accompanied by the appearance of a faster migrating band at around 25 KDa (blue 265 
arrow), that nearly disappears upon cycloheximide treatment suggesting this TCRα peptide is 266 
efficiently degraded by the proteasome. It is important to note that the 25 KDa band is also 267 
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present when HA-TCRα is expressed alone (lane 2 of Figure 4A, blue arrow) suggesting it is a 268 
natural intermediate of HA-TCRα degradation. 269 
 270 
To determine if the enhanced effect of BspL on TCRα degradation is a side-effect of ER stress, 271 
cells were treated with TUDCA which strongly inhibited both XBP1s and CHOP transcript 272 
levels induced by either tunicamycin, BspL or VceC (Figure S3E and F). In the presence of 273 
TUDCA, BspL was still found to enhance HA-TCRα degradation showing this is occurring in 274 
an ER stress-independent manner (Figure S4).  275 
 276 
As the TCRα subunit undergoes N-glycosylation in the ER, we wondered if the faster migrating 277 
band of TCRα induced by BspL corresponded to non-glycosylated form of TCRα. We 278 
therefore treated samples with EndoH, which deglycosylates peptides. Upon EndoH treatment 279 
we observed deglycosylated HA-TCRα (second lane, Figure 4B, black arrow), confirming the 280 
reporter system is being processed normally. In the BspL expressing samples (lanes 3 and 4, 281 
Figure 4B), a slight band corresponding to the non-glycosylated TCRα could also be detected 282 
particularly after EndoH treatment, confirming that BspL does not prevent TCRα from entering 283 
the ER and being glycosylated. The dominant TCRα band induced upon BspL expression 284 
(around 25 KDa, blue arrow) migrates faster than the non-glycosylated form resulting from 285 
EndoH treatment (black arrow) and does not appear to be sensitive to EndoH. This may 286 
therefore correspond to a natural truncated non-glycosylated form of HA-TCRα. Consistently, 287 
this band is also present in the absence of BspL (lane 1, Figure 4B, blue arrow). 288 
 289 
Together these data indicate that BspL is a strong inducer of ERAD, implicating for the first 290 
time this process in Brucella pathogenesis. We therefore decided to block ERAD during 291 
infection using eeyarestatin, an established inhibitor of this system that targets the p97-292 
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associated deubiquinating process and sec61-dependent protein translocation at the ER. 293 
Unfortunately, prolonged treatment at the concentration necessary for full inhibition of ERAD 294 
induced detachment of infected iBMDM. Nonetheless, we were able to carry out this 295 
experiment in HeLa cells, which showed significant resistance to the eeyarestatin treatment. 296 
Total CFU counts after addition of eeyarestatin at 2h post-infection showed a significant 297 
decrease in bacterial counts at 48h, suggesting a potential inhibition of replication (Figure S5A). 298 
However, microscopy observation of infected cells at this time-point clearly showed extensive 299 
replication of bacteria even in the presence of eeyarestatin (Figure S5B). To confirm this 300 
possibility, we counted by microscopy the number of bacteria per cell at 24h post-infection and 301 
indeed found a higher replication rate upon eeyarestatin treatment (Figure S5C). These results 302 
suggest that blocking of ERAD during early stages of infection favour intracellular replication, 303 
a phenotype clearly not dependent on BspL, as we have shown it is not implicated in the 304 
establishment of rBCVs and when ectopically expressed it induces ERAD. Therefore, we 305 
hypothesized that the drop of CFU observed upon inhibition of ERAD at 48h post-infection 306 
was a result of enhanced exit of bacteria from infected cells rather than inhibition of intracellular 307 
replication.  308 
 309 
BspL delays premature bacterial egress from infected cells  310 
The late stage of the intracellular cycle of Brucella relies on induction of specific autophagy 311 
proteins to enable the formation of aBCVs characterized as large vacuoles decorated with 312 
LAMP1 containing multiple bacteria 23. In our experimental conditions aBCVs could be clearly 313 
observed in iBMDM infected for 65h with wild-type B. abortus (Figure 5A).  We therefore 314 
investigated if BspL was involved in formation of aBCVs. Strikingly, ΔbspL aBCVs could be 315 
detected as early as 24h, with nearly 30% of infected cells showing aBCVs at 48h post-infection 316 
compared to less than 10% for wild-type infected cells (Figure 5B and C). Importantly, 317 
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complementation of the ΔbspL strain fully restored the wild-type phenotype. These results show 318 
that BspL is involved in delaying the formation of aBCVs during B. abortus macrophage 319 
infection. As aBCV formation was previously linked to Brucella exit from infected cells and 320 
spread to neighbouring cells 23,27 we next searched for re-infection events. Wild-type infected 321 
iBMDM at 48h post-infection showed none or few signs of re-infection with most cells showing 322 
extensive perinuclear ER-like distribution of bacteria (Figure 5D). In contrast, imaging of 323 
ΔbspL infected iBMDM at the same time-point revealed the presence of high numbers of 324 
extracellular bacteria as well as cells with single bacteria or a single aBCV (Figure 5D), 325 
suggestive of re-infection and reminiscent of what was previously described for wild-type B. 326 
abortus at 72 h post-infection 23.  327 
 328 
In view of our results and the fact that BspL interacts with Herp, we hypothesized that secretion 329 
of BspL during Brucella infection modulates ERAD machinery to control aBCV formation and 330 
prevent premature bacterial egress from infected cells. To test this hypothesis, we next analysed 331 
aBCV formation in cells either depleted for Herp or upon blocking ERAD with eeyarestatin. 332 
We took advantage of our HeLa cell model, in which aBCVs can still be monitored although 333 
the vacuoles formed are much smaller in size 23. We first confirmed that BspL was also 334 
implicated in formation of aBCV in this cell type by quantifying the number of cells containing 335 
aBCVs, in our case defined as a vacuole with a least 4 bacteria surrounded by a single LAMP-336 
positive membrane. We found that at 48h post-infection a strain lacking bspL formed 337 
significantly more aBCVs than the wild-type and complemented strains (Figure 6A), as we 338 
observed for iBMDM.  339 
As initial blocking of ERAD enhances intracellular replication and may therefore impact early 340 
trafficking events we decided to inhibit ERAD and Herp at 24h post-infection to allow normal 341 
establishment of rBCVs. Interestingly, we found eeyarestatin enhanced aBCV formation at 65h 342 
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(Figure 6B). These results suggest ERAD contributes towards aBCV formation at late stages 343 
of the cell cycle. However, these results contrasted with the observations made for ΔbspL, in 344 
which aBCV formation is precocious.  In contrast, inhibition of Herp at 24h post-infection 345 
resulted in higher percentage of cells with aBCVs being formed at 48h compared to siControl 346 
treated cells (Figure 6C), perfectly mimicking the results obtained with ΔbspL. Together these 347 
results show that blocking of ERAD impacts aBCV formation but is not sufficient to account 348 
for the aBCV phenotypes observed at 48h, which require full inhibition of Herp. Therefore, we 349 
propose that BspL delays aBCV formation by directly modulating Herp functions.  350 
 351 
Discussion 352 
In this study, we characterize a previously unknown T4SS effector of B. abortus and its role in 353 
virulence. We found this effector hijacks the Herp, a component of the ERAD machinery to 354 
regulate the late stages of the Brucella intracellular cycle. Although many bacterial pathogens 355 
have been shown to control UPR, very little is known about the impact of ERAD, a downstream 356 
process following UPR, in the context of intracellular bacterial infections. To our knowledge 357 
there are only two examples. The obligatory intracellular pathogen Orientia tsutsugamushi, the 358 
cause of scrub thypus, is an auxotroph for histidine and aromatic amino acids and was shown 359 
to transiently induce UPR and block ERAD during the first 48h of infection 40. This in turn 360 
enables release of amino acids in the cytosol, necessary for its growth 40. The second example 361 
is Legionella pneumophila, that recruits the AAA ATPase Cdc48/p97 to its vacuole, that 362 
normally recognizes ubiquitinated substrates and can act as a chaperone in the context of ERAD 363 
to deliver misfolded proteins to the proteasome. Recruitment of Cdc48/p97 to the Legionella 364 
vacuole is necessary for intracellular replication and helps dislocate ubiquitinated proteins from 365 
the vacuolar membrane, including bacterial effectors 41. 366 
 367 
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In the case of BspL we found it directly interacts with Herp, a component of ERAD which is 368 
induced upon UPR. Our data suggest that BspL enhances ERAD and this prompted us to further 369 
investigate the role of ERAD during Brucella infection.  Interestingly, we found that inhibition 370 
of ERAD is beneficial during early stages of intracellular trafficking and enhances bacterial 371 
multiplication. It is possible that Brucella is transiently blocking ERAD during rBCV formation 372 
and initial replication, potentially via a specific set of effectors or a particular cellular signal yet 373 
to be identified. This could, as demonstrated for Orientia, release amino acids into the cytosol 374 
that would be critical for bacterial growth. Alternatively, or in parallel, a block of ERAD could 375 
potentially enhance autophagy 42 to deal with the ER stress that would in turn favour rBCV 376 
formation.  377 
 378 
As a permanent block of ERAD could become damaging to the cell under prolonged stress and, 379 
as we observed, speed up the bacterial release from infected cells potentially prematurely, 380 
Brucella translocation of BspL could counteract these effects by enhancing ERAD and slowing 381 
down aBCV formation.  We could not directly show BspL ERAD induction is dependent on 382 
Herp as its depletion would itself block ERAD 12,43. However, in the presence of BspL no 383 
glycosylated ER loaded HA-TCRα was observed indicative of enhanced processing through 384 
the ERAD pathway. Instead, only a truncated unglycosylated TCRα intermediate was detected, 385 
which disappeared in the presence of cycloheximide suggesting it is efficiently degraded. These 386 
likely correspond to a backlog of peptides awaiting proteasomal degradation, generated by an 387 
abnormal ERAD flux induced by BspL.  388 
 389 
Further work is now required to establish the precise mechanisms that enables BspL to facilitate 390 
ERAD. It is possible that BspL interaction with Herp stabilizes it, preventing its degradation 391 
and would therefore help sustain ERAD. Indeed, ER stress significantly induces Herp levels 392 
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but Herp was shown to be quickly degraded, enabling efficient modulation of ERQC 44. 393 
Alternatively, BspL may favour Herp accumulation at ERQC sites that would also enhance its 394 
ability to assist protein retrotranslocation and delivery to proteasomes.  395 
 396 
This study focuses on BspL-Herp interactions, nevertheless we cannot exclude the participation 397 
of other potential targets identified in the yeast-two hybrid screen, notably Ubiquilin2 and Bag6. 398 
Ubiquilin2 functions as an adaptor protein between the proteasome and ubiquination machinery 399 
and therefore participates in ERAD. Ubiquilin2 also interacts with Herp 37 and very 400 
interestingly has been shown to play a role in control of autophagy 45. Our co-401 
immunoprecipitation experiment did not reveal any binding but perhaps a weak or transient 402 
interaction is taking place not detectable with our current in vitro conditions. Another 403 
interesting target is Bag6, (also known as Bat3) a chaperone of the Hsp70 family that is also 404 
involved in delivery of proteins to the ER or when they are not properly folded to the 405 
proteasome. Bag6 was shown to be the target of the Orientia Ank4 effector that blocks ERAD 406 
40 and to be targeted by multiple Legionella effectors to control host cell ubiquitination 407 
processes 46. Therefore, it is possible that Bag6 may contribute towards BspL control of ERAD 408 
functions during Brucella infection.  409 
 410 
In addition to ERAD, we found that BspL itself was implicated in induction of UPR. However, 411 
this phenotype was independent of Herp and may be an indirect effect due to its ER 412 
accumulation or via another cellular target yet to be characterized. Furthermore, the increased 413 
ERAD activity upon BspL expression was not a result of increased ER stress; suggesting that 414 
BspL is independently controlling these two pathways. There is growing evidence that the 415 
induction of IRE1-dependent UPR by multiple effectors is linked to modulation of Brucella 416 
intracellular trafficking and intracellular multiplication 15,22. Our data allow us to add another 417 
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piece to this complex puzzle, and place for the first time the ERAD pathway at the centre of 418 
Brucella regulation of its intracellular trafficking. Further work is now required to decipher all 419 
the molecular players involved. 420 
 421 
In conclusion, our results show that Herp modulation by BspL enables Brucella to temporarily 422 
delay the formation of aBCVs and avoid premature egress from infected cells, highlighting a 423 
new mechanism for fine-tuning of bacterial pathogen intracellular trafficking. 424 
 425 
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Figure Legends 456 
Figure 1. BspL is a T4SS effector translocated into host cells during B. abortus infection.  457 
(A) Macrophage-like cell line (RAW) was infected with B. abortus carrying a plasmid encoding 458 
for bla fused with BspL (pbla::bspL) to enable expression of TEM-BspL. Cells were infected 459 
with either wild-type B. abortus or ΔvirB9 carrying this plasmid. A positive control of wild-460 
type expressing bla::vceC was included. At 4, 12 or 24h post-infection, cells were incubated 461 
with fluorescent substrate CCF2-AM, fixed and the percentage of cells with coumarin emission 462 
quantified using an automated plugin. More than a 1000 cells were quantified for each condition 463 
from 3 independent experiments and data represent means ± standard deviations. Kruskal-464 
Wallis with Dunn’s multiple comparisons test was used and P = 0.0019 between wild-type 465 
pbla::bspL and ΔvirB9 pbla::bspL at 12h (**) and 0.171 at 24h (*). Not all statistical 466 
comparisons are shown.   467 
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(B) Representative images of cells infected for 24h with B. abortus wild-type or ΔvirB9 468 
carrying pbla::bspL. Cells were incubated with CCF2 and the presence of translocated TEM1-469 
BspL detected by fluorescence emission of coumarin (red). Scale bars correspond to 5 µm.  470 
(C) The expression of TEM1-BspL in the inocula of wild-type and ΔvirB9 strains was 471 
controlled by western blotting thanks to the presence of a FLAG tag in the construct. The 472 
membrane was probed with an anti-Flag antibody (top) or anti-Omp25 (bottom) as a loading 473 
control. A sample from wild-type without the plasmid was included as a negative control.  474 
Molecular weights are indicated (KDa). 475 
 476 
Figure 2. BspL does not impact early BCV trafficking but contributes to UPR induction 477 
at late stages of the infection.  478 
(A) Confocal microscopy image showing the intracellular localization of HA-BspL expressed 479 
in HeLa cells labelled with an anti-HA antibody (green) and ER marker calnexin (red). 480 
Phalloidin (cyan) was used to label the actin cytoskeleton and Dapi (white) for the nucleus. 481 
(B) Quantification of mRNA levels of XBP1s and (C) CHOP by quantitative RT-PCR obtained 482 
from HeLa cells expressing HA-BspL, HA-VceC or HA-BspB for 24h. Cells transfected with 483 
empty vector pcDNA3.1 were included as a negative control and cells treated tunicamycin at 484 
1µg/µl for 6h as a positive control. Data correspond to the fold increase in relation to an internal 485 
control with non-transfected cells. Data are presented as means ± standard deviations from at 486 
least 4 independent experiments. One-way ANOVA with Dunnett’s multiple comparisons test 487 
was used to compare each value to the negative control. In the case of XBP1s, P = 0.0045 for 488 
HA-BspL (**). In the case of CHOP, P = 0.0001 for tunicamycin (****); 0.0001 for HA-BspL 489 
(****); 0.0018 for HA-VceC (**). All other comparisons ranked non-significant.   490 
(D) Representative images of rBCVs from ΔbspL-expressing DSred infected iBMDM or (E) 491 
HeLa cells at 24 and 48h post-infection, labelled for calnexin (green).  492 
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(F) Quantification of mRNA levels of XBP1s and (G) CHOP by quantitative RT-PCR obtained 493 
from iBMDMs infected with wild-type, ΔbspL or the complemented ΔbspL::bspL strains for 494 
48h. Mock-infected cells were included as a negative control. Data correspond to the fold 495 
increase in relation to an internal control with non-infected cells. Data are presented as means 496 
± standard deviations from at least 3 independent experiments. One-way ANOVA with 497 
Dunnett’s multiple comparisons test was used to compare each value to the negative control. In 498 
the case of XBP1s, P = 0.0201 for wild-type infected cells (*) and 0.0048 for the complemented 499 
ΔbspL::bspL infected cells (**). All other comparisons ranked non-significant with this test.   500 
 501 
Figure 3. BspL specifically interacts with the ERAD component Herp.  502 
(A) Co-immunoprecipitation (co-IP) from cell extracts expressing either HA-BspL, HA-BspB 503 
and HA-VceC using HA-trapping beads. Flow through and elutions were probed with 504 
antibodies against Alex3, Ubiquilin (Ubqln) and Herp in succession. The level of each effector 505 
bound to the beads was revealed with an anti-HA antibody and 15% of the input used for the 506 
co-IP shown (at the bottom). Molecular weights are indicated (KDa). 507 
(B) Co-IP assay from cells expressing GFP-BspL and Flag-Herp. GFP was used as a control 508 
for non-specific binding. The co-IP was revealed using an anti-Herp antibody, the fraction 509 
bound to GFP-trapping beads using an anti-GFP antibody and the inputs (shown on the bottom 510 
two images) using both anti-Herp and anti-GFP antibodies. Molecular weights are indicated 511 
(KDa). 512 
(C) Representative confocal micrograph of HeLa cells expressing HA-BspL (green) and 513 
labelled for Herp (red). Scale bar corresponds to 5 µm. 514 
 515 
Figure 4. BspL enhances ERAD degradation of TCRα. 516 
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(A) HEK 293T cells were transfected with HA- TCRα in the absence or presence of myc-BspL 517 
for 24h. Where indicated, cells were treated with 50 µg/ml cycloheximide for the last 4h. The 518 
blot was probed first with an anti-TCR antibody followed by anti-actin. The same samples were 519 
loaded onto a separate gel (separated by dashed line) for probing with an anti-myc and anti-520 
actin to confirm the expression of myc-BspL. Molecular weights are indicated (KDa) and 521 
relevant bands described in the text highlighted with different coloured arrows. 522 
(B) HEK 293T cells were transfected with HA- TCRα in the absence or presence of myc-BspL 523 
for 24h and samples treated with EndoH where indicated. The blot was probed first with an 524 
anti-TCR antibody followed by anti-actin. The same samples were loaded onto a separate gel 525 
(separated by dashed line) for probing with an anti-myc and anti-actin to confirm the expression 526 
of myc-BspL. Molecular weights are indicated (KDa) and relevant bands described in the text 527 
highlighted with different coloured arrows. 528 
 529 
Figure 5. BspL is implicated in delay of aBCV formation. 530 
(A) Representative confocal images of iBMDM infected with wild-type DSred for 65h labelled 531 
for LAMP1 (green). Scale bar corresponds to 5 µm. 532 
(B) Representative confocal images of iBMDM infected with ΔbspL DSred for 24h (top), 48h 533 
(middle) and 65h (lower), labelled for LAMP1 (green). Scale bars correspond to 5 µm. 534 
(C) Quantification of the percentage of cells with aBCVs, in iBMDMs infected with either wild-535 
type, ΔbspL or the complemented ΔbspL::bspL strains for 24, 48 or 65h. Data correspond to 536 
means ± standard deviations from 5 independent experiments. A two-way ANOVA was used 537 
yielding a P < 0.0001 (****) between wild-type and ΔbspL as well as ΔbspL and ΔbspL::bspL 538 
at 48h. Other comparisons are not indicated. 539 
(D) Representative confocal image of iBMDM infected with either wild-type DSRed or ΔbspL 540 
for 48h, labelled for calnexin (red). Bacteria shown in white. Scale bars correspond to 5 µm. 541 
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 542 
Figure 6. Delay of aBCV formation is dependent on Herp. 543 
(A) Quantification of the percentage of cells with aBCVs, in HeLa cells infected with either 544 
wild-type, ΔbspL or the complemented ΔbspL::bspL strains for 24, 48 or 65h. Data correspond 545 
to means ± standard deviations from at least 3 independent experiments. A two-way ANOVA 546 
was used yielding a P = 0.0422 (*) between wild-type and ΔbspL and P = 0.0445 (*) for ΔbspL 547 
and ΔbspL::bspL at 48h. 548 
(B) Quantification of the percentage of cells with aBCVs, in HeLa cells infected with wild-type 549 
B. abortus for 24, 48 or 65h either untreated or in the presence of eeyarestatin added at 24h post 550 
infection. Data correspond to means ± standard deviations from 3 independent experiments. A 551 
two-way ANOVA was used yielding at 65h post-infection, P = 0.0074 (**) for wt and wt+ 552 
eeyarestatin added at 24h. 553 
(C) siControl or siHerp were added at 24h post-infection. A two-way ANOVA was used 554 
yielding a P = 0.0001 (***) between wild-type (wt) and wt+siHerp and P = 0.0031 (**) for 555 
wt+siControl and wt+siHerp at 48h. In the case of 65h, P < 0.0001 (****) between wild-type 556 
(wt) and wt+siHerp and P = 0.0032 (**) for wt+siControl and wt+siHerp. A non-specific effect 557 
of the siControl was observed at this time point in relation to untreated cells P = 0.0063. 558 
 559 
 560 
Supplementary Figure Legends 561 
 562 
Figure S1. BspL targets the ER independently of its CAAX motif without impacting ER 563 
secretion. 564 
(A) Schematic diagram of BspL and its domains, namely the Sec secretion signal, hydrophobic 565 
region, Prolin-rich region (PRR) and potential CAAX motif with amino acid C, T, A and N.  566 
? ????
?
 24 
(B) Representative confocal images of HeLa cells expressing myc-BspL (top panel) or myc-567 
BspLΔCAAX (bottom panel) labelled for the ER marker calnexin (red). Scale bars correspond 568 
to 2 µm. 569 
(C) HeLa cells were co-transfected with GFP-BspL (green) and myc-BspLΔCAAX (cyan) for 570 
24h and labelled for the ER marker calnexin (red).  571 
(D) Quantification of SEAP secretion in HEK 293T cells expressing either control empty vector 572 
(pcDNA3.1), dominant negative form of Arf1 (HA-ARF[T31N]), HA-BspL, HA, BspB or HA-573 
BspD. Measurements were done at 24h after transfection and the secretion index corresponds 574 
to means ± standard deviations. Kruskal-Wallis with Dunn’s multiple comparisons test was 575 
used and P = 0.0164 between pcDNA control and HA-ARF[T31N] (*) and 0.0005 between 576 
pcDNA and HA-BspB (***). All other comparisons ranked non-significant.   577 
 578 
Figure S2. Equivalent intracellular trafficking of wild-type and bspL mutant strains. 579 
(A) Bacterial counts using colony forming units (CFU) at 2, 24 and 48h post-infection with 580 
either the wild-type (red) or ΔbspL strains (black) of iBMDM or (B) HeLa cells. Data 581 
correspond to means ± standard deviations from 3 independent experiments. 582 
(C) iBMDM or (D) HeLa cells were infected with wild-type B. abortus DSRed (red) for 24 or 583 
48h and labelled for the ER marker calnexin (green). Zoomed insets are indicated. Scale bars 584 
correspond to 5 µm. 585 
(E) Quantification of the percentage of BCVs positive for calnexin or (F) LAMP1 at 24 or 48h 586 
post-infection of iBMDM with either wild-type or ΔbspL DSRed-expressing strains. Data are 587 
presented as means ± standard deviations from at 6 independent experiments. Kruskal-Wallis 588 
with Dunn’s multiple comparisons test was used and all comparisons between the wild-type 589 
and the mutant strain yielded P > 0.05, considered as non-significant.  590 
 591 
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Figure S3. BspL induction of ER stress is independent of Herp.  592 
(A) Quantification of mRNA levels of HERP by quantitative RT-PCR obtained from iBMDMs 593 
infected with wild-type, ΔbspL or the complemented ΔbspL::bspL strains for 48h. Mock-594 
infected cells were included as a negative control. Data correspond to the fold increase in 595 
relation to an internal control with non-infected cells. Data are presented as means ± standard 596 
deviations from 3 independent experiments. Kruskal-Wallis with Dunn’s multiple comparisons 597 
test was used and yielded non-significant differences.   598 
(B) Western blot of cell lysates from HeLa cells treated with siRNA control (siCtrl) or siRNA 599 
Herp (siHerp) for 48h. A sample from non-treated cells was included as a negative control. 600 
Membrane was probed with an anti-Herp antibody followed by anti-actin for loading control.  601 
(C) Quantification of mRNA levels of XBP1s or (D) CHOP by quantitative RT-PCR obtained 602 
from HeLa cells expressing HA-BspL or HA-VceC for 24h. Where indicated, HeLa cells were 603 
treated with siRNA control (siCtrl) or siRNA Herp (siHerp). Cells transfected with empty 604 
vector pcDNA3.1 were included as a negative control and cells treated tunicamycin at 1µg/µl 605 
for 6h as a positive control. Data correspond to the fold increase in relation to an internal control 606 
with non-transfected cells. Data are presented as means ± standard deviations from at least 3 607 
independent experiments. Kruskal-Wallis with Dunn’s multiple comparisons test was used and 608 
yielded P=0.0184 (*) between negative siCtrl and BspL siCtrl, 0.0277 (*) between negative 609 
siHerp and BspL siHerp and 0.0485 (*) between negative siCtrl and tunicamycin siCtrl. No 610 
significant differences for observed for CHOP.   611 
(E) Quantification of mRNA levels of XBP1s or (F) CHOP by quantitative RT-PCR obtained 612 
from HeLa cells expressing HA-BspL, HA-VceC or HA-BspB for 24h. Were indicated, cells 613 
were treated with 0.5 nM of TUDCA for 22h. Cells transfected with empty vector pcDNA3.1 614 
were included as a negative control and cells treated tunicamycin at 1µg/µl for 6h as a positive 615 
control. Data correspond to the fold increase in relation to an internal control with non-616 
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transfected cells. Data are presented as means ± standard deviations from 3 independent 617 
experiments. One-way ANOVA with Tukey’s correction was used for multiple comparisons 618 
and yielded P=0.0287 (*) between BspL and BspL+TUDCA. For CHOP, P=0.0018 (**) 619 
between tunicamycin and tunicamycin+TUDCA, 0.0032 (**) between BspL and 620 
BspL+TUDCA and 0.0185 (*) between VceC and VceC+TUDCA. Not all comparisons are 621 
indicated.   622 
 623 
Figure S4. BspL induction of ERAD is ER stress-independent. 624 
HEK 293T cells were transfected with HA- TCRα in the absence or presence of myc-BspL for 625 
24h. Where indicated, cells were treated with 50 µg/ml cycloheximide for the last 6h or 0.5 nM 626 
of TUDCA for 22h. The blot was probed first with an anti-TCR antibody followed by anti-627 
actin. The same samples were loaded onto a separate (separated by dashed line) for probing 628 
with an anti-myc and anti-actin to confirm the expression of myc-BspL. Molecular weights are 629 
indicated (KDa) and relevant bands described in the text highlighted with different coloured 630 
arrows. 631 
 632 
Figure S5. Blocking of ERAD at early stages of the infection enhances intracellular 633 
replication and accelerates bacterial release. 634 
(A) Bacterial counts (CFU) at 2, 24 and 48h post-infection with either the wild-type without 635 
any treatment (wt, black) or in the presence of 8 µM eeyarestatin (wt+Eeya, red) or the 636 
equivalent amount of DMSO (wt+DMSO, green). Data correspond to means ± standard 637 
deviations from 6 independent experiments. A two-way ANOVA was used yielding a P < 638 
0.0001 (****) between wild-type+DMSO with wild-type+Eeya at 48h. Other comparisons are 639 
not indicated.  640 
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(B) Representative confocal images of HeLa cells infected with the wild-type DSRed or 641 
following treatment eeyarestatin at 48h post-infection.  642 
(C) Microscopy bacterial counts at 24h post-infection with either the wild-type with DMSO or 643 
in the presence of 8 µM eeyarestatin. Data is presented as the percentage of cells containing 1 644 
to 5 bacteria per cell (red), 6 to 30 (black), 30 to 40 (blue) or more than 50 (green). Data 645 
correspond to means ± standard deviations from 3 independent experiments. A two-way 646 
ANOVA test was used yielding a P= 0.0003 (***) between wild-type+DMSO with wild-647 
type+Eeya at 48h. Other comparisons are not indicated. 648 
 649 
 650 
Material and methods  651 
 652 
Cell culture 653 
HeLa, RAW and HEK293T cells obtained from ATCC were grown in DMEM supplemented 654 
with 10% of fetal calf serum. Immortalized bone marrow-derived macrophages from C57BL/6J 655 
mice were obtained from Thomas Henry (CIRI, Lyon, France) and were maintained in DMEM 656 
supplemented with 10% FCS and 10% spent medium from L929 cells that supplies MC-CSF. 657 
 658 
Transfections and siRNA 659 
All cells were transiently transfected using Torpedo® (Ibidi-Invitrogen) for 24 h, according to 660 
manufacturer’s instructions. siRNA experiments were done with Lipofectamine® RNAiMAX 661 
Reagent (Invitrogen) according the protocol of the manufacturers. Importantly, siRNA 662 
depletion of Herp was done by treatment with 3μM siRNA the day after seeding of cells and 663 
again at 24h. Depletion was achieved after 48h total. Depletion was confirmed by western 664 
blotting with an antibody against Herp. ON-TARGETplus siRNA SMARTpool (L-020918) 665 
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were used for Herp and for the control ON-TARGETplus Non-targeting pool (D-001810) both 666 
from from Dharmacon. For both transfections and siRNA cells were weeded 18h before at 667 
2x104 cells/well and 1x105 cells/well for 24 and 6 well plates, respectively. 668 
 669 
Bacterial strains and growth conditions 670 
Brucella abortus 2308 was used in this study. Wild-type and derived strains were routinely 671 
cultured in liquid tryptic soy broth and agar. 50 μg/ml kanamycin was added for cultures of 672 
DSRed or complemented strains.  673 
 674 
Construction of BspL eukaryotic expression vectors  675 
The BspL constructs were obtained by cloning in the gateway pDONRTM (Life Technologies) 676 
and then cloned in the pENTRY Myc, HA or GFP vectors. The following primers were used 677 
5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAATCGATTTTTGAAGATCACTAT-3’ and 5’-678 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGTTGGCCGTGCAGAAATG-3’. For the construct 679 
without CAAX the following reverse primer was used: 5’-680 
GGGGACCACTTTGTACAAGAAAGCTGGGTCCTAGAAATGGTCGCGACCGTCA-3’. The final 681 
constructs were verified by sequencing and expression of tagged-BspL verified by western 682 
blotting. 683 
 684 
Construction of bspL mutant and complementing strain 685 
B. abortus 2308 knockout mutant ΔbspL was generated by allelic replacement. Briefly, 686 
upstream and downstream regions of about 750 bp flanking the bspL gene were amplified by 687 
PCR (Q5 NEB) from B. abortus 2308 genomic DNA using the following primers: (i) 688 
SpeI_Upstream_Forward: actagtATGTCGAGAACTGCCTGC, (ii) 689 
BamHI_XbaI_Upstream_Reverse: CGGGATCCCGGCTC 690 
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TAGAGCGCGGCTCCGATTAAAACAG, (iii) BamHI_XbaI_Downstream_Forward: 691 
CGGGATCC CGGCTCTAGAGCACCGAACCGATCAACCAG and (iv) 692 
SpeI_Downstream_Reverse: actagtCC CTATACCGAGTTGGAGC. A joining PCR was used 693 
to associate the two PCR products using the following primers pairs: (i) and (iv). Finally, the 694 
ΔBspL fragment was cloned in a SpeI digested suicide vector (pNPTS138). The acquisition of 695 
this vector by B. abortus after mating with conjugative S17 Escherichia coli was selected using 696 
the kanamycin resistance cassette of the pNPTS138 vector and the resistance of B. abortus to 697 
nalidixic acid. The loss of the plasmid concomitant with either deletion of a return to the wild 698 
type phenotype was then selected on sucrose, using the sacB counter selection marker also 699 
present on the vector. Deletant (Δ) strain was identified by diagnostic PCR using the following 700 
primers: Forward: CACTGGCAATGATCAGTTCC and Reverse: 701 
CTGACCATTATGTGTGAACAGG (Amplicon length: WT-2000 bp, Δ - 1500 bp).    702 
The complementing strain was constructed by amplifying BspL and its promoter region (500 703 
bp upstream) with the PrimeStar DNA polymerase (Takara) using the following primers: Fw: 704 
AAAGGATCCGACAATCAGAAGGTTTCCTATGAAACG and Rev:?705 
AAAACTAGTTCAGTTGGCCGTGCAGAAATG. Insert and pmini-Tn7 28 were digested 706 
with BamHI and SpeI and ligated overnight. Transformants were selected on kanamycin 50 707 
μg/mL and verified by PCR and sequencing. To obtain the complementing strain the ΔbspL 708 
mutant was electroporated with pmini-Tn7-bspL with the helper plasmid pTNS2. 709 
Electroporants were selected on tryptic soy agar plates with kanamycin 50 μg/mL and verified 710 
by PCR. 711 
 712 
HA-TCRα 713 
The pcDNA-TCRα was obtained from Linda Hendershort (St Judes Medical School, USA) and 714 
it corresponds to the A6-TCRα 38. The HA tag was introduced by sequence and ligation 715 
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independent cloning (SLIC) method with the following primers: TCR-Fw: 716 
CGAGCTCGGATCCACTAGTCCAGTGTGGTGGAATTCTACCCATACGATGTTCCAG717 
ATTACGCTATGGGCATGATCAGCCTG and TCR-718 
Rv:GAGCGGCCGCCACTGTGCTGGATATCTGCAGAATTCTTACTAGCTAGACCACA719 
G. Briefly, pcDNA-TCRα was digested with EcoRI and incubated with purified PCR product 720 
amplified with the PrimeStar DNA polymerase (Takara – Ozyme) for 3 min at RT followed by 721 
10 min on ice. The following ratio was used for the reaction: 100 ng vector + 3x PCR insert. 722 
 723 
Infections 724 
Bacterial cultures were incubated for 16h from isolated colonies in TSB shaking overnight at 725 
37 °C. Culture optical density was controlled at 600 nm. Bacterial cultures diluted to obtain the 726 
appropriate multiplicity of infection (MOI) for HeLa 1:500 and iBMDMs 1:300 in the 727 
appropriate medium. Infected cells were centrifuged at 400 x g for 10 minutes to initiate 728 
bacterial-cell contact followed by incubation for 1h at 37°C and 5% CO2 for HeLa cells and 729 
only 15 min for iBMDMs. After the cells were washed 3 times with DMEM and treated with 730 
gentamycin (50 μg/mL) to kill extracellular bacteria for 1h. At 2 hours pi the medium was 731 
replaced with a weaker gentamycin concentration 10 μg/mL. Cells are plated 18h before 732 
infection and seeded at 2x104 cell / well and 1x105cells/well for 24 and 6 well plates 733 
respectively. For qRT-PCR experiments, 10 mm cell culture plates were used at a density of 734 
1x106cell/plate. At the different time points cells were either harvested of coverslips fixed for 735 
immunostaining. In the case of bacterial cell counts, cells were lysed in 0.1% Triton for 5 min 736 
and a serial dilution plated for enumeration of bacterial colony forming units (CFU). 737 
 738 
Immunofluorescence microscopy 739 
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At the appropriate time point, coverslips were washed twice with PBS, fixed with AntigenFix 740 
(MicromMicrotech France) for 15 minutes and then washed again 4 times with PBS. For ER 741 
and Herp immunostaining, permeabilization was carried out with a solution of PBS containing 742 
0.5% saponin for 30 minutes followed by blocking also for 30 minutes in a solution of PBS 743 
containing 1% bovine serum albumin (BSA), 10% horse serum, 0.5% saponin, 0.1% Tween 744 
and 0.3 M glycine. Coverslips were then incubated for 3h at room temperature or at 4 °C 745 
overnight with primary antibody diluted in the blocking solution. Subsequently, the coverslips 746 
were washed twice in PBS containing 0.05% saponin and incubated for 2h with secondary 747 
antibodies. Finally, coverslips were washed twice in PBS with 0.05 % saponin, once in PBS 748 
and once in ultrapure water. Lastly, they were mounted on a slide with ProLongGold (Life 749 
Technologies). The coverslips were visualized with a Confocal Zeiss inverted laser-scanning 750 
microscope LSM800 and analyzed using ImageJ software. For Lamp1 immunostaining no pre-751 
permeabilization and blocking were done and coverslips were directly incubated with antibody 752 
mix diluted in PBS containing 10% horse serum and 0.5% saponin for 3h at room temperature. 753 
The remaining of the protocol was the same as described above.  754 
 755 
Western blotting 756 
Cells were washed 1x with PBS and the 1x with ice-cold PBS. Cells were scrapped ince-cold 757 
PBS, centrifuged for 5 min at 4 °C at 80 g. Pellets where then ressuspended in cell lysis buffer 758 
(Chromotek) supplemented with phenylmethylsulfonyl fluoride (PMSF) and proteinase 759 
inhibitors tablet cocktail (complete Mini, Roche). Samples resolved on SDS-PAGE and 760 
transferred onto PVDF membrane Immobilon-P (Millipore) using a standard liquid transfer 761 
protocol. Membranes were blocked using PBS with 0.1% Tween 20 and 5% skim milk for 30 762 
min and the probed using relevant primary antibodies overnight at 4 °C, washed 3 times with 763 
PBS with 0.1% Tween 20 and then incubated with HRP-conjugated secondary anti-goat, mouse 764 
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or rabbit antibodies, diluted in PBS with Tween 20 0.1% and 5% skim milk for 1 h. Western 765 
blots were revealed using ECL Clarity reagent (BioRad). Signals were acquired using a Fusion 766 
Camera and assembled for presentation using Image J. 767 
 768 
TEM1 translocation assay 769 
RAW cells were seeded in a 96 well plates at 1x104 cells/well overnight. Cells were then 770 
infected with an MOI of 300 by centrifugation at 4 °C, 400 g for 5 min and 1 at 37 °C 5% CO2. 771 
Cells were washed with HBSS containing 2.5 mM probenicid. Then 6 µl of CCF2 mix (as 772 
described in the Life Technologies protocol) and 2.5 mM probenicid were added to each well, 773 
and incubated for 1.5 h at room temperature in the dark. Cells were finally washed with PBS, 774 
fixed using Antigenfix and analysed immediately by confocal microscopy (Zeiss LSM800).  775 
 776 
RNA isolation and real-time quantitative polymerase chain reaction (qRT-PCR) 777 
HeLa cells were seeded in 100x100 culture dishes at 1x106 cells/plate for each condition and 778 
were either transfected with HA-tagged BspL, VceC or BspB for 24h or infected with wild-779 
type, mutant or complemented strains for 48h. Cells were then washed 1x in PBS, scrapped in 780 
buffer RLT (Qiagen) supplemented with ß-mercaptoethanol and transfered on a Qiashredder 781 
column (Qiagen). Then several wash steps were performed and total RNAs were extracted 782 
using a RNeasy Mini Kit (Qiagen). 500 ng of RNA were reverse transcribed in a final volume 783 
of 20 µl using QuantiTect Reverse Transcription Kit (Qiagen). Real-time PCR was performed 784 
using SYBR Green PowerUp (ThermoScientific) with an QuantiTect Studio 3 785 
(ThermoScientific). Specific primers for human cells: HERP fw: 786 
CGTTGTTATGTACCTGCATC and HERP rev: TCAGGAGGAGGACCATCATTT ; XBP1s 787 
fw: TGCTGAGTCCGCAGCAGGTG and XBP1s rev: GCTGGCAGGCTCTGGGGAAG; 788 
CHOP fw: GCACCTCCCAGAGCCCTCACTCTCC and CHOP rev: 789 
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GTCTACTCCAAGCCTTCCCCCTGCG. The HPRT, and GAPDH expressions were used as 790 
internal controls for normalization and fold change calculated in relation to the negative control. 791 
Primers were HPRT fw: TATGGCGACCCGCAGCCCT and HPRT rev: 792 
CATCTCGAGCAAGACGTTCAG; GAPDH fw: GCCCTCAACGACCACTTTGT and 793 
GAPDH rev: TGGTGGTCCAGGGGTCTTAC.  794 
For murine cells: HERP fw: CAACAGCAGCTTCCCAGAAT and HERP rev: CCGCAGTTG 795 
GAGTGTGAGT; XBP1s fw: GAGTCCGCAGCAGGTG and XBP1s rev: 796 
GTGTCAGAGTCCATGGGA; CHOP fw: CTGCCTTTCACCTTGGAGAC and CHOP rev: 797 
CGTTTCCTGGGGATGAGATA and for the internal controls for normalization primers were 798 
18S fw: GTAACCCGTTGAACCCCATT and 18S rev: CCATCCAATCGGTAGTAGCG; 799 
GAPDH fw: TCACCACCATGGAGAAGGC and GAPDH rev: 800 
GCTAAGCAGTTGGTGGTGCA. Data were analyzed using Prism Graph Pad 6. 801 
 802 
ERAD evaluation 803 
HEK293T cells seeded in 100 mm culture plates at 8x105 cells/plate overnight and then co-804 
transfected for 24h with Torpedo (Ibidi) with vectors encoding HA-TCR (5 µg) and myc-BspL 805 
(5 µg). Cycloheximide 50 µg/ml was added 6h before lysis. Where indicated, TUDCA was 806 
added 2h after transfection at 0.5 mM. Cells were harvested as described above (western 807 
blotting) and lysed in 200 µl of lysis buffer (Chromotek). EndoH (New England Biolabs) 808 
treatment was carried out following the manufacturers protocol for 1h at 37 °C. Sample buffer 809 
was then added (30 mM Tris-HCl pH 6.8, 1% SDS, 5% glycerol, 0.025% bromophenol blue 810 
and 1.25 ß-mercaptoethanol final concentration). Western blotting was done as described above 811 
using anti-TCR antibody. Actin levels were also analyzed as a loading control.  812 
 813 
Secretion assay 814 
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HEK293T cells were harvested and seeded in 6-well plates at 1x105 cells/well and co-815 
transfected with plasmids encoding Brucella secreted proteins (300 ng DNA) and the secreted 816 
embryonic alkaline phosphatase (SEAP) (300 ng DNA) provided by Jean Celli. Total amount 817 
of transfected DNA was maintained constant using an empty vector pcDNA 3.1 for the positive 818 
control. At 18 h post transfection, the transfection media was removed and then cells were still 819 
incubated at 37°C 5% CO2. Fourty-eight hours later, media containing culture supernatant 820 
(extracellular SEAP) was removed and collected. To obtain intracellular SEAP, each well was 821 
washed with PBS and then incubated with a solution of PBS-Triton X-100 0.5% for 10 minutes. 822 
An incubation of each fraction was performed at 65 °C following a centrifugation at maximum 823 
speed for 30 seconds. Then cells were incubated with a provided substrate 3-(4-methoxyspiro 824 
[1,2-dioxetane-3,2’(5’-chloro)-tricyclo(3.3.1.13,7) decane]-4-yl)phenyl phosphate  (CSPD) by 825 
SEAP reporter gene assay, chemiluminescent kit (Roche Applied Science). 826 
Chemiluminescence values were obtained with the use of a TECAN at 492 nm. Data are 827 
presented as the SEAP secretion index, which is a ratio of extracellular SEAP activity to 828 
intracellular SEAP activity.  829 
 830 
Yeast two-hybrid 831 
BspL was cloned into pDBa vector, using the Gateway technology, transformed into MaV203 832 
and used as a bait to screen a human embryonic brain cDNA library (Invitrogen). Media, 833 
transactivation test, screening assay and gap repair test were performed as described 47-49. 834 
 835 
Antibodies  836 
For immunostaining for microscopy the following antibodies were used: 837 
Rat anti-HA antibody clone 3F10 (Roche, #1867423) was used at a dilution 1/50 and mouse 838 
anti-HA (Covance, clone 16B12, #MMS-101R), at 1/500. Rabbit anti-calnexin (Abcam, 839 
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#ab22595) was used at 1/250. Rabbit anti-Herp EPR9649 (Abcam, #ab150424) at 1/250. The 840 
mouse anti-myc antibody clone 9E10 (developed by Bishop, J.M.) was used at 1/1000. Rat anti-841 
LAMP1 clone ID4B (developed by August, J.T.) was used 1/100 for mouse cells and mouse 842 
anti-LAMP1 clone H4A3 (developed by August, J.T. / Hildreth, J.E.K.) was used 1/100 for 843 
human cells. All LAMP1 and Myc antibodies were obtained from the Developmental Studies 844 
Hybridoma Bank, created by the NICHD of the NIH and maintained at the University of Iowa. 845 
Secondary anti-mouse, rabbit and rat antibodies were conjugated with Alexas-555, -488 or -846 
647 fluorochromes all from Jackson Immunoresearch at a dilution 1/1000. Phallodin Atto-647 847 
(Sigma, #65906) was used at a dilution of 1/1000. Dapi nuclear dye (Invitrogen) was used at a 848 
dilution of 1/1000. 849 
For western blotting the following antibodies were used: 850 
rabbit anti-FLAG (Sigma, #F7425) at 1/1000 ; rabbit anti-Alex3 (Sigma, # HPA000967) at 851 
1/100; rabbit anti-Ubiquilin 2 (Abcam, #ab217056) at 1/1000; rabbit anti-Herp EPR9649 852 
(Abcam, # ab150424) at 1/1000; mouse anti-HA (Covance, clone 16B12, ref. MMS-101R) at 853 
1/1000; rabbit anti-TCR clone 3A8 (Invitrogen, #TCR1145) at 1/1000; mouse anti-myc 854 
antibody clone 9E10 at 1/1000 ; mouse anti-actin AC-40 (Sigma, #A4700) at 1/1000. Anti-855 
mouse (GE Healthcare) or rabbit-HRP (Sigma) antibodies were used at 1/5000. 856 
 857 
Drug treatments 858 
All drug treatments are indicated in the specific protocols. To summarize the concentrations 859 
used were: TUDCA (Focus Biomolecules) at 0.5 nM; Cycloheximide (Sigma) at 50 µg/ml; 860 
Eeyarstatin (Sigma) at 8 µM; Tunicamycin (Sigma) at 1 µg/µl; Probenicid (Sigma) at 2.5 mM. 861 
 862 
Co-immunoprecipitation 863 
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HeLa cells were cultured in 100 mm x 20 mm cell culture dishes at 1x106 cells/dish overnight. 864 
Cells were transiently transfected with 30 uL of Torpedo DNA (Ibidi) for 24h for a total of 10 µg 865 
of DNA/plate. On ice, after 2 washes with cold PBS cells were collected with a cell scraper and 866 
centrifuged at 80g at 4 °C during 10 min. Cell lysis and processing for co-immunoprecipitation 867 
were done as described with the PierceTM HA Epitope Antibody Agarose conjugate (Thermo 868 
scientific) or GFP-Trap (Chromotek). 869 
 870 
Statistical analysis 871 
All data sets were tested for normality using Shapiro-Wilkinson test. When a normal 872 
distribution was confirmed we used a One-Way ANOVA test with a Dunnett correction for 873 
statistical comparison of multiple data sets with the negative control or Tukey’s correction for 874 
multiple comparisons. For two independent variables, a Two-Way ANOVA test was used. For 875 
data sets that did not show normality, a Kruskall-Wallis test was applied, with Dunn’s 876 
correction, or Mann-Whitney U-test for two sample comparison. All analyses were done using 877 
Prism Graph Pad 6. 878 
 879 
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Chapter 5 Results Part2: BspL fragments 
mitochondrial network  
 
This work was initiated in parallel of the characterization of BspL impact on the 
endoplasmic reticulum presented in the Chapter 4. Before presenting these results, I would 
like to explain why we investigated a potential impact of BspL on the mitochondrial network. 
The first reason was the significant amount of data that support mitochondria and ER are very 
closely connected organelles. Indeed, ER and mitochondria can be physically associated as 
the ER participates in the mitochondrial fission process, by constricting the organelle [232]. 
In addition, the identification of the point of contacts called MAMs of theses 2 organelles 
strengthens this connection. 
The second reason was that ER stress induction is known to affect mitochondria and 
we observed early on during our studies that BspL was a strong inducer of stress [423]. 
The third reason was that at the time we started this project, the laboratory of Thierry 
Arnould contacted us with evidence that Brucella was inducing mitochondrial fragmentation 
during infection and we wanted to test if BspL could be the effector mediating this phenotype.  
The fourth and last reason was that one of the putative targets of BspL identified by 
yeast two-hybrid was the mitochondrial protein Alex3. Indeed, when we started this second 
project, we did not know yet the result of the co-immunoprecipitation experiment where we 
found non-specific interactions of Alex3 with BspB and VceC effectors.  
This work was done with the help of an excellent M2 student, Magali Bonici, that I 
supervised. She performed the majority of counting microscopy experiments of mitochondrial 
fragmentation after Brucella infection in HeLa and trophoblasts cells. 
?
 
I-) Results 
1-) BspL induces mitochondrial fragmentation 
 
First of all, we overexpressed BspL to see if there was some colocalization between 
mitochondria and our effector that could suggest an action of BspL on this organelle. 
Although we did not observe any significant co-localization, we observed BspL induces 
mitochondrial fragmentation (Figure 1A). To quantify this phenotype, 65 images of 
transfected cells labeled with an antibody against the mitochondrial chaperone Grp75were 
? ????
taken by confocal fluorescence microscopy and submitted to the Fiji software to calculate the 
Aspect Ratio, which nicely reflects the state of the mitochondrial network as it measure the 
connectivity of the network and particularly the elongation of the network (Figure 1B) [424]. 
We decided to attribute a rank for each value of aspect ratio that better reflects the tendency 
of the aspect of the mitochondrial network. In non-transfected HeLa cells (negative control), 
mitochondria form a network throughout the cell covering the whole cytoplasm and the aspect 
ratio is therefore high (with a mean value around 2.5, data not shown). However, in HeLa 
cells transfected with BspL, the connectivity of the mitochondrial network is perturbed, 
forming disparate dots in the cytoplasm (Figure 1A,). In some cases, we observed that 
mitochondria were absent from the periphery of the cell, with all fragmented mitochondria 
seemed to be close to the nucleus. We found that, cells expressing BspL had a low aspect 
ratio value (with a mean value around 1,5, data not shown) compared to the negative control 
indicating a strong fragmentation of the mitochondria (Figure 1B). We next sought to 
determine if expression of other Brucella effectors that accumulate in the ER when over-
expressed in HeLa cells resulted in mitochondrial fragmentation. We chose VceC, known to 
localize to the ER and induce ER vacuolation as well as ER stress [361].. We also compared 
with BspB, another ER-targeting Brucella effector in transfection but that does not induce ER 
stress and instead modulates ER to Golgi transport [391,399].  Interestingly, fragmentation of 
mitochondria in HeLa cells transfected with VceC was also observed when compared to the 
negative control but at much lower levels than those induced by BspL (Figure 1B), and only 
in cells expressing high levels of VceC (data not shown). In contrast, in cells expressing BspB 
the mitochondrial network was intact (Figure 1A) and the aspect ratio was similar to that of 
negative cells (Figure 1B). Therefore, BspB does not induce mitochondrial fragmentation. 
These results indicate that BspL induces a strong mitochondrial fragmentation. Moreover, we 
found the same results using a different tag for BspL (Figure 1C), indicating that the 
observed phenotype is not due to the tag but to the effector. 
? ????
 
Figure 1- BspL induces mitochondrial fragmentation. (A) HeLa were transiently transfected for 24 h with 
plasmids encoding HA-BspL, BspB or VceC and fixed. Cells were labeled for mitochondrial chaperone protein 
Grp75 (red) and an antibody against the HA tag was used to label the effectors (green). Representative of 
confocal microscopy images are shown. Scale bars correspond to 10 μm. Zoom insets of mitochondria are 
indicated with white boxes. (B) Aspect ratio of the mitochondrial network was calculated with the software 
ImageJ in transfected cells. Non-transfected cells were also quantified as a control (Neg). A total of 65 cells were 
counted for the control and each effector. Results represent the rank of each aspect ratio from 3 independent 
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experiments. The bar corresponds to the mean of the ranks. Statistical analysis was done with a Kruskal-Wallis: 
“****” for p <0.0001, “***” for p < 0.001. (C) HeLa were transiently transfected for 24 h with plasmids 
encoding GFP-BspL or myc-BspL and fixed. Cells were labeled for mitochondrial chaperone protein Grp75 
(red) and an antibody against the myc tag was used to label the effector (green). Representative of confocal 
microscopy images are shown. Scale bars correspond to 10 μm. Zoom insets of mitochondria are indicated with 
white boxes. 
 
2-) BspL still induces mitochondrial fragmentation independently of ER stress 
 
Although our results suggest that BspL may induce fragmentation of the mitochondrial 
network, it is possible that the observed fragmentation was a secondary effect of the ER stress 
induced by BspL or VceC and not a direct action of the effector. Therefore, we next 
investigated if inhibition of ER stress, using a well-established treatment with TUDCA, would 
impact the phenotypes observed in cells expressing BspL and VceC. As seen in the previous 
chapter, in our conditions TUDCA can counteract ER stress induced by tunicamycin and also 
inhibited ER stress induced by BspL and VceC as seen by a decrease in transcript of CHOP 
and spliced XBP1 (Chapter 4, Figure S3E and F). These results show that TUDCA inhibits 
stress not only induced by tunicamycin but also by VceC and BspL effectors. We next 
quantified the aspect ratio of mitochondria of HeLa cells transfected with different effectors 
and treated with TUDCA. As observed previously, the aspect ratio for the negative control 
cells and BspB transfected cells was high and the mitochondrial network remained intact 
(Figure 2A and B). These results also allow us to conclude that treatment with TUDCA does 
not impact mitochondrial aspect ratio. Interestingly, incubation with TUDCA following 
transfection with VceC resulted in normal aspect ratio values equivalent to those obtained for 
negative control and BspB transfected cells (Figure 2B), suggesting this treatment prevents 
mitochondrial fragmentation induced by VceC. In contrast, even in the presence of TUDCA, 
the aspect ratio of mitochondria in HeLa cells transfected with BspL was significantly lower 
than the negative control and mitochondria were still clearly heavily fragmented (Figure 2A 
and B). Furthermore, the aspect ratio was similar between cells transfected with BspL and 
cells transfected with BspL and treated TUDCA which clearly shows that this phenotype is 
independent of ER stress. In conclusion, VceC-induced mitochondrial fragmentation is mostly 
likely due to the induction of ER stress as it was abrogated by TUDCA treatment. However, 
the fact that, even in the absence of ER stress, BspL is still able to induce mitochondrial 
fragmentation suggests that this effector may act directly on mitochondrial integrity. 
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Figure 2- BspL still induces mitochondrial fragmentation independently of ER stress. (A) HeLa cells were 
transiently transfected for 24 h with plasmids encoding HA-BspL, BspB or VceC effectors. 2 h after transfection 
cells were treated with 0.5 mM TUDCA and fixed. Cells were labeled for mitochondria with an anti-Grp75 
antibody (red) and an antibody against the HA tag (green). Representative images obtained by confocal 
microscopy are shown. Scale bars correspond to 10 μm. Zoom insets of mitochondria are indicated with white 
boxes. (B) A total of 65 cells were counted for the control and each effector. Results represent the rank of each 
aspect ratio from 3 independent experiments. The control is non-transfected and non-treated with TUDCA. The 
bar corresponds to the mean of the ranks. Statistical analysis was done with a Kruskal-Wallis test: “****” for p < 
0.0001.  
 
3-) BspL contributes to mitochondrial fragmentation in infection 
 
As the previous experiments all relied on ectopic expression of BspL, we next 
investigated the mitochondrial fragmentation during Brucella infection. HeLa cells were 
infected 24h or 48h with Brucella abortus WT strain expressing DSRed (Figure 3A) and, as 
previously, the aspect ratio was quantified (Figure 3C). We found that the aspect ratio of 
mitochondria in infected HeLa cells after 24h and 48h were lower than that of uninfected cells 
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(Figure 3C). Therefore, we can conclude that Brucella infection results in fragmentation of 
the mitochondria at 24h post-infection. Similar results were also observed in BeWo cells, a 
trophoblast cell line established as a model for this pathogen [341], in which slight 
fragmentation was observed at 24h, which significantly increased at 48h (Figure 4A-B). 
Together, these results show that Brucella induces mitochondrial fragmentation during 
infection. 
We next investigated if this mitochondrial fragmentation was dependent on BspL by 
infecting HeLa cells with the ΔbspL strain. At 24 h after infection, the ΔbspL mutant infected 
cells displayed lower fragmentation than those infected with the WT strain. However, this 
was no longer the case at 48h after infection (Figure 3B). These results suggest that the 
ΔbspL mutant is still able to induce strong mitochondrial fragmentation during infection, but 
this phenotype is delayed compared to WT (Figure 3C), suggesting BspL is contributing to 
induction of mitochondrial fragmentation early on during infection. 
As it is well established that Brucella induces ER stress, especially at late stages of the 
infection, which could explain the induction of mitochondrial fragmentation, we next tested 
the impact of adding TUDCA to block ER stress during infection. Indeed, we found a low 
aspect ratio, equivalent to that of untreated wt-infected cells and therefore a high 
fragmentation of the mitochondria induced by Brucella infection (Figure 3C). This result 
indicates that during infection with the WT strain, the observed fragmentation is not a side 
effect of Brucella-induced ER stress. Interestingly, we also found a reduction of the aspect 
ratio and therefore a high fragmentation of the mitochondria induced by Brucella ΔbspL 
infection following TUDCA treatment in comparison to the untreated ΔbspL infected cells 
(Figure 3C). However, this fragmentation is significantly less than that induced by the WT 
Brucella strain in the presence of TUDCA (Figure 3C). Together, these results suggest that 
BspL may play a role in the fragmentation of mitochondria during infection, but we must now 
complement the mutant phenotype to confirm these results. 
? ????
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Figure 3- BspL contributes to mitochondrial fragmentation in infected HeLa cells. HeLa cells were infected 
with WT B. abortus (A) and ΔbspL DsRed (B) strains for 24h (top panel) and 48h (bottom panel). Cells were 
fixed and labelled for mitochondria with antibody against Grp75 (green). (C) Aspect ratio of the mitochondrial 
network was determined in HeLa infected for 24h or 48h with either Brucella abortus WT or with ΔbspL, treated 
or not with TUDCA 0.5 mM. A total of 60 cells were counted for the control and each infection condition. 
Results represent the rank of each aspect ratio from 3 independent experiments. The control is non-infected and 
non-treated with TUDCA. The bar corresponds to the mean of the ranks. Statistical analysis was done with a 
Kruskal-Wallis test, “****” for p <0.0001, “***” for p < 0.001, “**” for p < 0.01. 
 
Figure 4- BspL also contributes to mitochondrial fragmentation in infected BeWo cells. (A) BeWo cells 
were infected with WT DsRed strain for 24h or 48h. Cells were fixed and labelled for mitochondria with 
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antibody against Grp75 (green). Scale bars correspond to 10 μm. (B) Aspect ratio of the mitochondrial network 
was determined in BeWo infected or non-infected cells. Non-infected cells were used as the negative control. A 
total of 65 cells were counted for the control and each infection condition. Results represent the rank of each 
aspect ratio from 3 independent experiments. The bar corresponds to the mean of the ranks. Statistical analysis 
was done with a Kruskal-Wallis test: “****” for p <0.0001, “***” for p < 0.001, “**” for p < 0.01 
 
4-) BspL induces mitochondrial network fragmentation independently of Herp 
 
Previously we identified Herp as a partner of BspL (see Chapter 4). Herp is 
connected to many cellular processes as described in the chapter 2 and 4, namely regulating 
ERAD and also protecting mitochondrial dysfunctions and ER stress induced apoptosis [170]. 
Therefore, we hypothesized that BspL could induce mitochondrial fragmentation by targeting 
Herp. To test this hypothesis, we used siRNA to down regulate the expression of Herp in cells 
expressing BspL. In addition, we used tunicamycin to induce ER stress as it is well 
established ER stress can result in mitochondrial fragmentation. First of all, we observed in 
BspL transfected cells that the mitochondrial network is still fragmented after siRNA control 
(ctrl) treatment (Figure 5A and B). Similarly, as expected, after tunicamycin treatment in 
siRNA ctrl treated cells, the mitochondrial network is fragmented. However, down-regulation 
of Herp did not significantly prevent BspL-induced mitochondrial fragmentation (Figure 5A 
and B) suggesting BspL interaction with Herp does not impact mitochondria. In contrast, 
Tunicamycin was no longer able to induce mitochondrial fragmentation following Herp 
silencing, highlighting an important link between Herp and mitochondria stability.  This is 
particularly interesting, as we know from our previous study that silencing of Herp in 
tunicamycin treated cells in fact enhances ER stress. We are now in the process of quantifying 
additional experiments and including other Brucella effectors. We will also analyze this 
phenotype in infected cells.  
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Figure 5- BspL induces mitochondrial network fragmentation independently of Herp. HeLa were 
transiently transfected for 24 h with siRNA control (A) or against HERP (B) and 22h later for plasmid encoding 
HA-BspL or treated with tunicamycin at 1 μg/μL 6h before harvested. Cells were labeled for mitochondrial 
chaperone protein Grp75 (red) and an antibody against the HA tag was used to label the effectors (green). Scale 
bars correspond to 10 μm. Zoom insets of mitochondria are indicated in the white box. (C) Aspect ratio of the 
mitochondrial network was calculated with the software ImageJ in HeLa transfected cells 24h with either siRNA 
against Herp or control and either BspL or tunicamycin treated cells. Non-transfected cells were also quantified 
as a control (Neg). A total of 30 cells were counted for the control and BspL-transfected cells. Only 7 cells for 
tunicamycin and siRNA control treated cells and 15 cells for tunicamycin and siRNA against Herp treated cells. 
Results represent the rank of each aspect ratio from 1 experiment. The bar corresponds to the mean of the ranks. 
Statistical analysis was done with a Kruskal-Wallis test: “****” for p <0.0001 
 
5-) BspL does not induce apoptosis 
 
Mitochondrial fragmentation is often associated to apoptosis induction [217] and Brucella is 
known to inhibit apoptosis process [411]. This is why we decided next to test if BspL could 
be involved in the control of apoptosis or more generally cell death processes. We first 
measured the level of activation of caspases 3 and 7, key mediators of mitochondrial induced 
apoptosis, after infection with WT and ΔbspL mutant strains (Figure 6A). For this assay we 
infected 2 kinds of cells HeLa and iBMDM to ensure Brucella would not be differentially 
modulating these host cell processes depending on the nature of the infected cell line. We did 
not observe any differences in apoptosis induction between the WT strain and the mutant 
strain in both cell types (Figure 6A). To ensure we were not simply missing a phenotype for 
specifically focusing on caspase 3 and 7 we next carried a broader cytotoxicity test by 
measuring LDH release. We obtained the same results, with no differences observed between 
the 2 strains and the 2 kinds of infected cells (Figure 6B). Thus, BspL is not involved in the 
? ????
control of apoptosis.
 
Figure 6- BspL does not induce apoptosis. (A) HeLa (left panel) and iBMDM (right panel) cells were infected 
with WT B.abortus and ΔbspL DsRed strains for 48h. Non-infected were also quantified as a negative control 
and treated cells with a high concentration of 50 μM of Eeyarestatin were quantified as a positive control. Then 
the coverslips were visualized by confocal microscopy to see if caspase 3 or 7 are activated. More than 100 cells 
were quantified for each condition from 2 independent experiments and data represent mean +/- standard 
deviations. (B) HeLa (left panel) and iBMDM (right panel) cells were infected with WT B. abortus and ΔbspL 
DsRed strains for 48h. Non-infected were also quantified as a negative control and treated cells with a high 
concentration of 50 μM of Eeyarestatin were quantified as a positive control. Absorbance were quantified after 
an enzymatic reaction with release LDH and the synthetic substrate, with a TECAN spectrophotometer at 490 
nm. Data was obtained from 3 independent experiments and correspond to means +/- standard deviations. 
 
6-) General conclusion 
 
In this chapter we have demonstrated that BspL participates in the induction of 
mitochondrial fragmentation following transfection and in infected cells. Indeed, with the 
comparison with the other effectors VceC and BspB and the quantification of the aspect ratio 
it is clear that BspL specifically impacts the mitochondrial network and independently from 
an induced ER-stress. Besides, this phenotype is observed in different cell lines, so it will be 
interesting to determine what kind of mitochondrial functions are targeted by BspL as a result 
of this induced fragmentation. Furthermore, we found that Herp is not the molecular partner 
of BspL implicated in these phenotypes as its knockdown does not prevent the mitochondrial 
fragmentation in BspL transfected cells. We are still in the process of repeating some of the 
experiments to allow us to perform statistical analysis as well as complementing the mutant 
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phenotype during infection to validate BspL involvement. Further experiments investigating 
the impact of different mitochondria functions are also ongoing. 
 
II-) MATERIALS AND METHODS 
 
Cell culture 
 
HeLa epithelial cell line was maintained in Dulbecco's Modified Eagle Medium (DMEM) and 
Bewo trophoblast cell line in Ham’s Nutrient Mixture F12 (Kaighn’s) Medium (F12K) with 5 
mM of L-glutamine and 10% fetal calf serum (FCS) at 37°C and 5% CO2.  
 
Bacterial strains 
 
Brucella abortus 2308 is a CO2-independent, virulent, smooth strain. The B. abortus 2308 
DsRed strain constitutively expresses fluorescent DsRed due to the integration of the DsRed 
coding sequence and a kanamycin resistance cassette. DsRed Brucella abortus wild-type and 
mutant strains were grown into tryptic soy agar (TSA) with kanamycin plates for 5 days and 
then inoculated for 16 hours in tryptic soy broth (TSB) with kanamycin (50 μg/mL). 
B. abortus 2308 knockout mutant ΔbspL was generated by allelic replacement. Briefly, 
upstream and downstream regions of about 750 bp flanking the bspL gene were amplified by 
PCR (Q5 NEB) from B. abortus 2308 genomic DNA using the following primers: 
(i) SpeI_Upstream_Forward: actagtATGTCGAGAACTGCCTGC,  
(ii) BamHI_XbaI_Upstream_Reverse: CGGGATCCCGGCTC 
TAGAGCGCGGCTCCGATTAAAACAG, (iii) BamHI_XbaI_Downstream_Forward: 
CGGGATCCCGGCTCTAGAGCACCGAACCGATCAACCAG  
(iv) SpeI_Downstream_Reverse: actagtCC CTATACCGAGTTGGAGC.  
A joining PCR was used to associate the two PCR products using the following primers pairs: 
(i) and (iv). Finally, the ΔBspL fragment was cloned in a SpeI digested suicide vector 
(pNPTS138). The acquisition of this vector by B. abortus after mating with conjugative 
S17 Escherichia coli was selected using the kanamycin resistance cassette of the pNPTS138 
vector and the resistance of B. abortus to nalidixic acid. The loss of the plasmid concomitant 
with either deletion of a return to the wild type phenotype was then selected on sucrose, using 
the sacB counter selection marker also present on the vector. Deletant (Δ) strain was 
identified by diagnostic PCR using the following primers: Forward: 
? ????
CACTGGCAATGATCAGTTCC and Reverse: CTGACCATTATGTGTGAACAGG 
(Amplicon length: WT-2000 bp, Δ - 1500 bp). Deletion was also confirmed by sequencing. 
 
Cell infection 
 
Bacterial growth was measured by monitoring the culture optical density at 600 nm. Bacterial 
cultures were seeded for appropriate multiplicity of infection (MOI) (for HeLa 1:500, BeWo 
1:500, iBMDMs 1:50) in the appropriate medium. Infected cells were centrifuged at 400 x g 
for 10 minutes to initiate bacterial-cell contact followed by incubation for 1h at 37°C and 5% 
CO2 for HeLa and BeWo cells and only 10 min for iBMDMs . After the cells were washed 3 
times with DMEM or F12K free media. At 1h post-infection (pi), cells were treated with 
gentamycin (50 μg/mL) to kill extracellular bacteria and at 2 hours pi the medium was 
replaced with a weaker gentamycin concentration 10 μg/mL. Cells are plated 18h before 
infection and seeded at 2.104 cell / well and 1.106cell for 24 and 6 well plates respectively. 
 
Transfection, TUDCA treatment and siRNA treatment 
 
The cells were plated and seeded respectively at 1x105 (for HeLa cells) in culture plates of 6 
wells and at 1x106 in 100mm dish. Plasmids coding for different tagged and secreted Brucella 
proteins were introduced into the cells with the transfection reagent Torpedo (Ibidi). The cells 
were then incubated for 24h at 37°C and 5% C02, to be then harvested. For TUDCA treatment 
cells were incubated 18h before transfection or infection experiments with TUDCA (0,5 mM). 
For siRNA treatment, HeLa were incubated for 48 h with 3 μM ON-TARGETplus 
SMARTpool siRNAs (GE Dharmacon) directed against human Herp or a non-targeting (si 
ctrl). For the siRNA transfection Lipofectamine (Thermo Fisher Scientific) reagent was used. 
siRNA have been bought in the manufacturer Dharmacon, consequently the sequences are not 
available for confidentiality reasons. Nevertheless, here are the references of the manufacturer  
siRNA against Herp: ON-TARGETplus Human Herpud1 Reference L-020918-00 
siRNA control: ON-TARGETplus Non-targeting Pool Reference D-001810-10-20 
 
Microscopy and immunofluorescence 
 
? ????
After transfection, the coverslips were washed twice with 1X PBS, fixed with Antigen Fix for 
15 minutes and then washed again 4 times with PBS. Permeabilization was carried out with a 
solution of PBS containing 0.5% saponin for 30 minutes and blocking also for 30 minutes was 
carried out in a solution of PBS containing 1% bovine serum albumin (BSA), 10% horse 
serum, 0.5% saponin, 0.1% Tween and 0.3 M glycine. Coverslips were then incubated for 3h 
at room temperature with primary antibody solution, which is the same that blocking solution, 
or overnight at 4°C. Subsequently, the coverslips were washed twice in PBS containing 
0.05% saponin and incubated for 2h with secondary antibodies. Finally, coverslips were 
washed twice in PBS with 0.05 % saponin, once in PBS and once in ultrapure water. Lastly, 
they were dried and mounted on a slide with ProLongGold (Life Technologies). The 
coverslips were visualized with a Confocal Zeiss inverted laser-scanning microscope LSM800 
and analyzed using ImageJ software. The bacterial effectors were tagged with either the green 
fluorescent protein (GFP) or HA tags. We therefore used anti-HA antibodies from rat 
(dilution 1/50; Sigma). Mitochondria was stained with an antibody against the mitochondrial 
chaperone Grp75 from mouse (dilution 1/250; Abcam). Secondary anti-mouse and rat 
antibodies were conjugated with Alexa555 or Alexa 488 fluorochromes (dilution 1/1000).  
 
RNA isolation and real-time polymerase chain reaction (qRT-PCR) 
 
HeLa cells were seeded in Petri Dish at 1.106 for each condition were transfected with BspL, 
VceC or BspB and treated or not with TUDCA (0,5 mM). Next, cells were scrapped to be 
harvested and to be places on a Qiashredder column in order to isolate nucleic acids and 
proteins. Then several wash steps were performed and total RNAs were extracted using a 
RNeasy Mini Kit (Qiagen). 500ng of RNA was reverse transcribed in a final volume of 20 ul 
to cDNA using QuantiTect Reverse Transcription Kit (Qiagen). Real-time PCR was 
performed using Brilliant III SYBR Green QPCR (Agilent Technologies, Santa Clara, CA, 
USA) with an AriaMx Real-Time PCR System (Agilent Technologies). Specific primers are 
listed in Table 1. The HPRT, and GAPDH expressions were used as internal controls for 
normalization and fold change calculated in relation to the DMSO control. Data were 
analyzed using Prism Graph Pad 5 with a Kruskal-Wallis test (n = 3). 
 
LDH and Apoptosis assays 
 
? ????
Apoptosis was monitored in both HeLa and iBMDM cells. To perform this experiment, we 
used the commercial kit from Thermofisher CellEventTM Caspase-3/7 Green Detection 
Reagent. This kit contains a fluorescent reagent which is the association of 4 amino acids 
DEVD conjugated to a nucleic acid that indicates if the caspases 3 and 7 are activated. Cells 
were infected with WT or mutant strains for 48h. As a positive control of apoptosis induction, 
the chemical drug Eeyarestatin was used at a lethal concentration of 50 μM.  After incubation 
of the drug or infection with the different strains, the medium was removed to add the reagent 
for 30 minutes at 37 °C at 10 μM. Then the cells were fixed with the 3% paraformaldehyde 
solution and the coverslips were visualized with a Confocal Zeiss inverted laser-scanning 
microscope LSM800. LDH assay was monitored in both HeLa and iBMDM cells with the 
help of a commercial kit from Roche company. It is composed of 2 reagents: one that will be 
catalyzed by the release LDH and one dye solution. The absorbance was monitored with a 
Tecan spectrophotometer.  Several controls were performed with the addition of Triton-X100 
at 1% in 1 well as a positive control of cytotoxicity, another well only has untreated cells as a 
negative control and a last well only contains the used medium to estimate the background. 
Absorbance background was then subtracted to all the samples. Then the % of cytotoxicity 
was calculated by normalizing with the positive control and the negative control for both 
HeLa and iBMDM cells. Positive control is considered at 100% of cytotoxicity. 
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Chapter 6 Discussion 
I-) Infectiology a neglected research topic  
 
The 20th century was considered as the cancer century because of its discovery and its 
incidence on public health. I think the 21st century will be that of microbiological infections 
and could represent a step back into the past. In part this is due to extensive anti-vaccination 
campaigns around the world that are responsible for the reemergence of some bacterial 
pathogens [425]. Although antibiotherapy has allowed countries to fight against major 
bacterial infections, nowadays this is becoming more and more difficult due to the increase in 
antibiotic resistance. Indeed, extreme antibiotic resistance has been observed for several 
bacterial pathogens as Acinetobacter baumannii and Mycobacterium tuberculosis, with strains 
that resist to 90% of antibiotics [426,427].  
Furthermore, there is an alarming tendency of re-emerging infectious diseases in the 
world as the plague caused by Yersinia pestis a serious human infection [428] as well as 
animal diseases as brucellosis, considered by the WHO as an re-emerging zoonosis. 
Brucellosis was considered eradicated in most of Europe, notably in France, but the 2 
outbreaks in 2012 and 2014 in “le massif du Bargy” highlight its presence even in previously 
considered “brucellosis-free” countries [429].  
Re-emergence of human and animal diseases act as a reminder for us continue 
studying these kinds of pathogens, improve disease control and enforce better human and 
animal vaccination programs. In the case of animal diseases as brucellosis, the study of local 
wildlife is often neglected which in my opinion is a mistake because they represent an 
important reservoir of bacteria that can become a threat.  The perfect illustration of the 
importance of this biodiversity is the identification of new Brucella species in wildlife hosts, 
including amphibians, marine mammals, baboons and wild rodents [430]. It is therefore, in 
my opinion, important that the scientific community continue to convince governments of the 
importance of studying these kinds of pathogens because zoonotic bacteria represent a public 
health issue with important economic consequences.  
In recent years, our knowledge on bacterial pathogenesis has consistently increased 
with for instance the identification and characterization of secretion systems. However, 
secreted effectors still require further studies so we can understand the eukaryotic pathways 
targeted during disease. Indeed, one could compare secretion systems as molecular guns 
where effectors are their bullets with a very high specificity in the targeting. It is fascinating 
? ????
from an evolution and functional point of view how secretion systems are relatively well 
conserved between bacteria but not the associated secreted effectors making the challenge 
harder. Moreover, it is also surprising to see a bacterium as Legionella which has more than 
300 identified effectors compared with Helicobacter pylori which seems to control its 
infection process with a very restricted catalog of effectors.  
 
II-) Impact of BspL on Brucella pathogenesis and ERQC processes  
 
BspL could have been yet another Brucella effector that is located in the ER to induce 
stress and disorder for the cell. This was in fact what we were thinking at the beginning of our 
project after the obtention of our first data about its localization and the induction of ER stress 
in transfection. But, the identification of Herp as a target of BspL lead us to investigate the 
cellular pathways targeted further. Indeed, it is known that Herp is over-regulated during ER 
stress, but why would be BspL induce ER stress if interacting with Herp?  
Analyzing previously described functions of Herp allowed us to find the role of BspL 
for Brucella. Indeed, as presented in the Chapters 1 and 4 Herp is involved in several ERQC 
processes as ERAD and autophagy. Concerning ERAD process, and with the help of a TCR 
reporter we clearly demonstrated that ERAD is affected by BspL with a higher degradation of 
glycosylated TCR. It will be important now to investigate which step of the ERAD BspL is 
targeting. Herp is involved in multiple stages, including stabilization of ER complexes at 
specific sites, retrotranslocation and delivery to the proteasome. Further molecular studies are 
required and use of pulse-chase experiments essential to follow in greater detail the ERAD 
pathway. In my opinion, it would also be interesting to analyze other reporters, for example, 
unglycosylated proteins or Herp-independent targets for ERAD.  
 
We also highlighted the importance of ERAD at different stages of infection for 
Brucella. We were surprised to observe that ERAD blocking enhanced replication whilst 
BspL has a clear opposite effect on the ERAD process. It would be interesting to test all ER-
targeting effectors, VceC, BspA-K and BtpA to determine if one of more effectors could be 
blocking ERAD at earlier stages of the infection. Our results with BspL make it clear that 
ERAD is finely controlled by Brucella to have the time to ensure its replication in the infected 
cell.  
Thanks to the study by Starr et al. for aBCV formation and the associated role of Herp 
of autophagy regulation we were prompted to investigate if BspL could be involved in the 
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formation of aBCVs. The difference in the kinetics of aBCV formation between the mutant 
strain and the wild-type strain clearly sustains an implication of BspL in the process of aBCV 
formation. However, as it stands, the connection with ERAD remains circumstantial. It will 
be essential to monitor ERAD throughout the infection cycle and pinpoint when HERP-
dependency mediated via BspL is occurring. Experiments using siRNA in macrophages could 
be useful but are technically challenging. Herp has a very quick turnover and we cannot 
successfully do siRNA treatments throughout 48 and 65h, the time points in which aBCVs 
begin to be formed. Unfortunately, we did not succeed to make CRISPR KO of Herp. This 
would have been the ideal tool. 
  
As discussed in the discussion of Chapter 4, our study highlighted for the first time a 
role for hijacking of ERAD in control of intracellular trafficking. This may be a more 
widespread topic in bacterial pathogenesis. Most papers that study interference of pathogens 
on ERQC mainly focus on UPR and particularly the 3 UPR sensors and the associated 
chaperone BiP. The identification and the characterization of HERP in infection context as the 
importance of ERAD for Brucella bring an important novel concept to the Brucella field. 
 
III-) Impact of BspL on mitochondria  
 
In parallel, the implication of BspL in the fragmentation of mitochondrial network is 
also an exciting set of data as this is the first Brucella effector shown to fragment in different 
cell lines as HeLa and trophoblast BeWo. As MitF Legionella effector [431], there is no 
induced cell death after ectopic expression or Brucella infection. Consequently, it will be 
interesting to test also the concentration of some metabolites as glucose or lactate. Indeed, 
some studies referred that some pathogens including Brucella are able to induce a metabolic 
shift [297,410]. So, it will be very interesting to determine if BspL is the responsible effector 
of the shift that allows the differentiation of macrophages [297]. It will be also interesting to 
find how BspL induces mitochondrial fragmentation by identifying the mitochondrial partner. 
We have seen that this is not subverted via Herp interaction as its downregulation by RNA 
interference did not prevent mitochondrial fragmentation after BspL ectopic expression. In 
addition, with the study of Lobet et al. [411] we also know that it is not dependent on DRP1 
contrary to Legionella [294]. To try to address this question I would focus on Alex3 which is 
one of the putative BspL targets identified after the yeast two-hybrid presented in the 
Chapter 4. Indeed, Alex3 is an interesting candidate because of its localization in the OMM 
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and it has been shown to be involved in mitochondrial dynamics and trafficking [421]. At the 
beginning of my Ph.D., we have tried to perform co-immunoprecipitation and microscopy 
experiments. However, it was not possible to co-transfect BspL with Alex3 because of 
cytotoxicity. We found endogenous Alex3 to interact with BspL, VceC and BspB. 
Consequently, we did not pursue our experiments because we conclude there the interaction 
between BspL and Alex3 may not be specific. However, it is also a possibility that we did not 
succeed to set the right experimental conditions to analyze Alex3 interactions. Thus, it would 
be worth to take more time to try to better characterize this mitochondrial protein with BspL 
overexpression and in Brucella infection context. If Alex3 is a false positive that often occurs 
in yeast two-hybrid experiments, we should use a global approach to find other putative 
partners of BspL as co-immunoprecipitation coupled to mass spectrometry, such as using a 
BioID approach. 
Finally, to conclude with this axis, it is important to note that in infected cells, mitochondrial 
fragmentation is significantly enhanced at late stages of the infection and when the cell is full 
of bacteria. It is possible that the space occupied by these bacteria results in perturbation of 
the network just by mechanical force as shown by Helle et al [316] . Further work has to be 
done to confirm this hypothesis and determine if lack of significant difference in 
mitochondrial fragmentation at 48h is due to replication-induced space restrictions or the 
action of other unknown effectors. 
 
As mentioned in the end of the Chapter 3, we have to be careful interpreting data on effectors 
that target both the ER and mitochondria. To further characterize BspL it will be interesting to 
try to localize the effector in infection by building a 4HA-tag effector which could be 
followed by microscopy, a strategy now successfully implemented in the lab for other 
Brucella effectors. Indeed, we could precisely determine when and where this effector is 
translocated and then where it is located during infection. We could see if the effector 
uniquely resides in the ER or moves or transiently interacts with mitochondria. Moreover, and 
in the same aim, we could make a subcellular fractionation as an alternative technic to 
localize BspL. It will be good to succeed to isolate ER, mitochondria and MAM fractions 
because it could give us important details to further investigate. However, it remains 
nowadays very complicated to perfectly separate these 3 fractions as ER is often found in all 
subcellular fractions. Besides it is also hard to have an enough quantity of purified MAMs 
especially when we are working on single cells. Thus, the investigation of BspL localization 
will require to overcome technical challenges to answer these questions on BspL 
? ????
 
Otherwise, as illustrated in the Chapter 2 the variation of calcium flux is crucial as it was 
demonstrated to impact several processes as apoptosis and metabolism. Several tools are 
available as some fluorescent probes as Fluo4-AM or Fura2. With the help of these probes, it 
is possible to visualize calcium concentration at contact sites of ER mitochondria but also the 
calcium that is coming from ER [432]. I think we can apply this kind of study in the context 
of Brucella infection. Indeed, given the link with cellular metabolism and the impact of 
Brucella on major metabolic pathways, I think it is of utmost importance to study how 
Brucella impacts calcium concentration and even the associated flux. 
 
IV-) Bacterial effectors and eukaryotic motifs 
 
Since a few years many researchers have highlighted the presence of motifs or eukaryotic 
domains in bacterial effector proteins [359,433]. This is also the case for BspL which presents 
a putative eukaryotic CAAX motif whose the function remains to be determined in context of 
Brucella infection. This tetrapeptide most often corresponds to the enchainment of 1 cystein, 
2 aliphatic amino acids and any amino acid. This motif in eukaryotic cell is known to be a 
posttranslational lipid modified termed prenylation. Prenylation is the addition of either 
farnesyl or geranylgeranyl lipid groups to the cysteine [434]. For eukaryotic proteins this 
modification is important for the anchoring of the protein into cellular membranes as 
illustrated by the G proteins or Rho GTPases. Consequently, it is intriguing to find this motif 
in bacterial protein even if the anchoring function could explain why bacteria keep this motif 
in their protein. Several effectors have been shown to contain CAAX motifs, or derivatives 
such as SifA identified in Salmonella enterica [418] or AnkB from Legionella penumophila 
[407,419,435]. In some cases, such as for SifA from Salmonella, there is no need for two 
aliphatic acids for it to be a functional CAAX. The key residue is the cysteine that in the case 
of SifA is modified by isoprenoid addition by a host geranylgeranyl transferase I and is 
required for virulence. We tested the impact of this protein signature on the ER localization of 
BspL and we did not find any change. Nevertheless, a study has shown that the palmitoylation 
(another lipid modification) of the ER calnexin chaperone was shown to interact with MAMs 
with an ER located pump participating in Ca2+ regulating signaling. In contrast, its non-
palmitoylated form remains in the ER to mediate protein folding and quality control [436]. 
Consequently, it would be great to perform other experiments with BspL depleted for its 
CAAX motif and to test the consequences on mitochondria or more generally in MAMs. It is 
? ????
possible that the CAAX motif contributes to sub-ER localization or accumulation in MAMs. 
Alternatively, this CAAX might not be involved in the localization of the effector but rather 
in some specific protein interactions.  
In our case, this eukaryotic-like domain led us to identify BspL as a new effector following 
from an in-silico screen, a widely used approach to identify new secreted bacterial proteins in 
genome database. From an evolution point of view, it is reasonable to think that these 
bacterial proteins with eukaryotic domains may result from a horizontal gene transfer from 
eukaryotes to bacteria [399]. Furthermore, the possession of eukaryotic domains is certainly 
likely to be involved in interaction and / or modulation of host factors. We must now further 
investigate if BspL undergoes any lipid modifications to determine if this C-terminal 
tetrapeptide is indeed a CAAX motif with relevance during infection. 
 
V-) Brucella effectors: a potential new direction following UPR and intracellular 
trafficking studies  
 
 This last decade the studies on Brucella effectors mainly focused on those that induce 
ER stress or are involved in the intracellular trafficking especially between the maturation of 
eBCV to rBCV. Nevertheless, there are still some gaps in knowledge regarding Brucella 
pathogenesis that could be explained by the identification and the characterization of new 
effectors. I would like to discuss two recent studies, that characterized 2 effectors that may 
provide another path of research in terms of the control of innate immunity and more 
excitingly immunometabolism processes. 
 The first one is BPE005 that directly impacts innate immunity in special cells from the 
liver. Authors demonstrated that the effector induces a fibrotic phenotype [437]. This 
particular phenotype is important in the establishment of chronic infection as it contributes to 
a reduction of antibiotic penetration because it seems to induce granuloma formation of liver 
cells. They have also shown that the effector inhibits in transfection and infection the 
metalloproteinase 9 (MMP9). This result is particularly interesting because this kind of 
proteins are linked to innate immunity as they allowed the recruitment of inflammatory cells 
and consequently regulate their functions [438]. Thus, the identification of this effector 
initially described in 2011 has added a new complexity to the pathogenicity of Brucella after 
the characterizations of VceC, BtpA, BtpB and PrpA. Indeed, it seems that according to the 
infected cell type or tissue there are some different strategies that are used by Brucella to 
decrease or induce specific immune responses [437]. Although the functions of the effector 
? ????
are not related to my work, it is important to keep in mind that only the full characterization 
of all Brucella effectors will be able to provide a comprehensive understanding of the cellular 
pathways targeted during infection. 
 
In another study more relevant in the context of the work presented in this thesis, the BPE123 
effector was found to participate in the recruitment of Enolase 1 (ENO-1 or ENO-α) on BCVs 
[439]. Briefly enolases or 2-phospho-D-glycerate hydrolases are enzymes that are involved in 
glycolysis and gluconeogenesis metabolic pathways. There are three different enolase 
isoforms alpha or 1, beta or 2 and gamma or 3-enolase. Interestingly ENO-1 is associated 
mitogenic stimulation in lymphocytes [440] and after inflammatory stimuli and cytokines 
production [441]. Thus, ENO1 is as bound to metabolism processes as to immune responses. 
Moreover, given the link of ENO1 with glycolysis it perfectly sustains the involvement or a 
possible hijacking of glycolysis during Brucella infection as previously demonstrated by 
Xavier et al. [297] and Czych et al. [410] Furthermore, BPE123 is the first effector that is 
associated to metabolic processes. It will be interesting to investigate more its precise role on 
metabolic intermediates and at which stage of infection it is contributing the most. 
Interestingly authors have shown that ENO-1 depletion by siRNA impaired B. abortus 
replication in HeLa cells which confirms again the importance of glycolysis for Brucella and 
particularly ENO1 as ENO-1 activity levels were enhanced upon B. abortus infection of THP-
1 macrophagic cells, and this activation is highly dependent on BPE123. Furthermore, the 
depletion of this effector impacts the bacterial replication. This suggests that this effector is 
involved in early stages of infection. Control of host metabolism during infection is a topic 
that deserves additional research in the context of Brucella infection [439]. To support this, 
recent work from our lab has highlighted that BtpA and BtpB, the TIR domain-containing 
effectors retain NAD consuming activity during infection inducing a decrease in intracellular 
NAD+ levels. This coenzyme plays not only a key role in bioenergetics namely glycolysis but 
has also been found to have a prominent function in cell signalling and immunomodulation. 
In addition, as BspL induces fragmentation of mitochondria it is likely to play a role in 
immunometabolism regulation during infection. Therefore, this is, in my opinion, a very 
interesting topic to pursue in the future. 
 
VI-) 2011-2019 What is new on Brucella? 
 
In 2011, at the end of the review of Atluri et al. six questions were raised by the authors [341] 
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in the discussion about future perspectives to investigate for a better understanding of 
Brucella pathogenesis. I decided to select a subset of these questions to illustrate the recent 
advances in the field. Among the questions, there was: “What is the role of the previously and 
newly described T4SS substrates in promoting intracellular persistence?” and “Are there 
additional T4SS substrates that mediate ER localization of Brucella?” In 2011, only 10 T4SS 
effectors had been identified and remained weakly characterized. Today, there are 25 
referenced effectors (see Table 2). So, I think that during this last decade the Brucella 
community has succeeded to increase our knowledge on the “previously described T4SS 
substrates”, identify new ones that are still being characterized (BPE123 for example) and in a 
few cases undertake the deep molecular functional study such as the case of BspB and VceC. 
I am excited that my work on BspL, once published, will also contribute towards 
advancement of our comprehension of Brucella pathogenesis. BspL was identified in 2014 
and it took my full thesis work to propose a function for this effector and its first 
characterization. One interesting area to explore in Brucella pathogenesis is the association of 
effector functions and their kinetics. As I mentioned above, there are several effectors that 
manipulates ER stress processes as VceC, BspL and some Bsp proteins. Although several of 
them induce ER stress, they have distinct functions during infection with VceC inducing 
inflammation and BspL modulating ERAD. It is necessary now to determine the 
chronological action of Brucella effectors particularly regarding trafficking and ER stress. It 
is very likely that the function of several effectors is to compensate the activity of others. This 
has become particularly obvious having studied BspL that slows down aBCV formation and 
induces ERAD, most likely to compensate for the action of another effector blocking ERAD 
at an earlier stage of the intracellular cycle. Indeed, we have demonstrated at early stage that 
inhibition of ERAD could be beneficial for replication. However, a permanent inhibition of 
ERAD seems to result in a truncated cell cycle with premature aBCVs formation. We have 
unfortunately not been able to block ERAD long enough to monitor aBCV formation in 
macrophages due to the toxicity of the drug used but we could observe in epithelial cells 
premature exit from infected cells at 48h post-infection. In summary, it would not be 
surprising to find in the future different effectors that modulate ERAD in a different manner 
and at different time point post infection. 
 
The second question of the review was “How does residence in the ER-associated 
compartment provide an intracellular growth advantage to Brucella?”. I think the 
identification of ER targeted effectors including BspL, helps to begin answering this question. 
? ????
As explained in the first chapter of my introduction, the ER is crucial for eukaryotic cells. 
Brucella establishes its niches in ER that are prolongment of ER cisternae as shown in the 
paper of Sedzicki et al. [386] Thus, the interest in Brucella to be close with this organelle is to 
rapidly target specific components to subvert many associated functions. This location allows 
Brucella control of UPR to modulate the inflammation process, control of ERAD to regulate 
its proliferation and the control of ER secretion to impact protein maturation and intercept 
vesicular trafficking as a source of membrane or nutrients. To conclude, this ER localization 
niche is a great advantage for Brucella because at this place the pathogen can totally control 
the cell given its connection to almost all the cell processes. In this context, I think we should 
address how other organelles than ER are triggered by the bacteria. This has already begun for 
the ERGIC [391] and us, with characterizations of fragmented mitochondria. 
 
Finally, I will end with a last question which remains unsolved: “How do Brucella 
inhibit apoptosis of infected host cells?”.  
Indeed, I selected this last question even though with BspL characterization, I do not 
contribute to answer this question. Despite the fact that BspL contributes to fragmentation of 
the mitochondrial network, we did not observe any apoptosis induction or inhibition. Indeed, 
as described in the chapter 3 section III-5-) Brucella does not induce cell death to quit the 
cells at the end of its cycle. Moreover, what I did not mention previously is it has also been 
shown that Brucella actively prevents apoptosis in few studies [442,443]. Indeed, in 2000, it 
was already shown that Brucella infection upregulated BCL2A1, a member of the BCL2 
family known to have an antiapoptotic activity [443]. Few years later another study has 
shown that globally Brucella melitensis represses mitochondrial genes involved in apoptosis 
induction [444]. To date some studies are published to try to identify the Brucella 
mechanisms to inhibit apoptosis. Cui et al. [442] also worked on this topic where they also 
found an inhibition of apoptosis in macrophages via the degradation of the calcium dependent 
protein Nedd4. Thus, even if there are some attempts to determine that apoptosis is inhibited 
by different mechanisms in different cell lines or different Brucella strains we still do not 
know if this is dependent of T4SS effectors or other bacterial molecules. This topic remains 
open and unexplored and will require perhaps large-scale approach to identify several putative 
proteins involved in the control of cell death. 
 
For the future, it will be very important in my opinion to use system biology 
approaches which regroup several disciplines to better answer these biological questions 
? ????
particularly in the context of host-pathogen relationships. Indeed, today this topic of research 
requires a deep characterization of the molecular mechanisms when studying bacterial 
effectors. In addition, it is important when we try to characterize the impact on bacterial 
proteins on cell eukaryotic process, to ensure that the observed consequences are directly due 
to the effector and not a side effect of the infection itself or due to experimental procedures as 
for example in the case of transfections. Furthermore, interactions between components of a 
system such as individual effectors with individual targets, is beginning to reveal numerous 
phenotypes and properties that cannot be understood from the study of each component 
individually. To understand the infection process as a whole, a more comprehensive 
understanding of the relationships between different effectors and Brucella components 
within the host cell or even the whole organism will allow for more accurate knowledge of the 
system's behavior. Thus, system biology approaches may help to connect all the data 
generated, molecular and cellular, all the pathways targeted and each effector function in the 
timeline of the infection cycle.  Combined with artificial intelligence for processing all the 
data and decipher its complexity maybe one day we will have a full understanding of the 
molecular mechanisms governing Brucella infection! 
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Chapter 7 Secondary Projects and 
Contributions  
?
In this chapter I include the papers where I had the opportunity to take part in. Before the pdf 
of the article, I briefly summarize bellow the context of the studies and the main results. I also 
include a description of what experiments I carried out to show my precise contribution for 
each of these publications. 
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Acinetobacter baumannii (Ab) is a nosocomial emerging pathogen representing an 
increasing threat for public health because of its incidence in hospitals [445,446]. Indeed, 
Acinetobacter can persist on abiotic and biotic surfaces for several weeks and can resist to 
dessication or chemical treatments used for disinfection [445](Peleg 2008 Clinical 
Microbiology Reviews). Ab strains have shown a significant increase antimicrobial resistance, 
with prevalence of Multiple Drug Resistant (MDR) and even Extensively Drug Resistant 
(XDR) strains in certain countries. For all these reasons, WHO has placed Ab as top research 
priority from the “ESKAPE” pathogen list which regroups 6 bacterial pathogens 
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas 
aeruginosa and Enterobacter spp.). These pathogens are becoming extremely difficult to treat 
and therefore will represent an increasing problem if we cannot find alternative therapies 
[447]. 
In this study authors highlighted a potentially promising treatment against Ab with the 
use of palmitoleic (PoA) and myristoleic (MoA) fatty acids. Indeed, the authors demonstrated 
an efficient antibiofilm activity and a biofilm dispersing effect after the use of these drugs. 
? ????
Moreover, they also showed an impairment on the bacterial motility. We found that these 
small molecules down regulate the expression of abaR, a gene from the LuxIR-type quorum 
sensing (QS) communication system AbaIR [448] [449]). The consequence of this is a 
reduction of the N-acyl-homoserine lactone production which is a crucial compound in the 
development of the biofilm [450]. 
 
My contribution for this paper was to perform quantitative PCR to measure the level of the 
regulator abaR after different treatments with Virstatin, PoA and MoA on Acinetobacter 
baumannii cultures. I had to establish the protocol for RNA extraction from Acinetobacter as 
well as test multiple housekeeping genes to find those best suited for internal controls under 
the experimental conditions tested. These results are presented in the Figure 2A in the 
published paper below. This study was mainly led by the Principal Investigator Dr. 
Emmanuelle Dé, so I thank her to have given me the chance to take part in this project??
? ????
?
?
 International Journal of 
Molecular Sciences
Article
Unsaturated Fatty Acids Affect Quorum Sensing
Communication System and Inhibit Motility and
Biofilm Formation of Acinetobacter baumannii
Marion Nicol 1,2, Stéphane Alexandre 1,2, Jean-Baptiste Luizet 3, Malena Skogman 4,
Thierry Jouenne 1,2, Suzana P. Salcedo 3 and Emmanuelle Dé 1,2,*
1 Normandie University, Unirouen, 76000 Rouen, France; marion.nicol@etu.univ-rouen.fr (M.N.);
stephane.alexandre@univ-rouen.fr (S.A.); thierry.jouenne@univ-rouen.fr (T.J.)
2 CNRS, UMR 6270, Polymers, Biopolymers, Surfaces Laboratory, F-76821 Mont-Saint-Aignan, France
3 Laboratory of Molecular Microbiology and Structural Biochemistry, University of Lyon,
Centre National de la Recherche Scientifique, F-69367 Lyon, France; jean-baptiste.luizet@ibcp.fr (J.-B.L.);
suzana.salcedo@ibcp.fr (S.P.S.)
4 Department of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E,
FI-00014 Helsinki, Finland; malena.skogman@helsinki.fi
* Correspondence: emmanuelle.de@univ-rouen.fr; Tel.: +33-2-35-14-66-99
Received: 21 November 2017; Accepted: 8 January 2018; Published: 10 January 2018
Abstract: The increasing threat of Acinetobacter baumannii as a nosocomial pathogen is mainly
due to the occurrence of multidrug-resistant strains that are associated with the real problem
of its eradication from hospital wards. The particular ability of this pathogen to form biofilms
contributes to its persistence, increases antibiotic resistance, and promotes persistent/device-related
infections. We previously demonstrated that virstatin, which is a small organic compound known to
decrease virulence of Vibrio cholera via an inhibition of T4-pili expression, displayed very promising
activity to prevent A. baumannii biofilm development. Here, we examined the antibiofilm activity
of mono-unsaturated chain fatty acids, palmitoleic (PoA), and myristoleic (MoA) acids, presenting
similar action on V. cholerae virulence. We demonstrated that PoA and MoA (at 0.02 mg/mL) were
able to decrease A. baumannii ATCC 17978 biofilm formation up to 38% and 24%, respectively,
presented a biofilm dispersing effect and drastically reduced motility. We highlighted that these
fatty acids decreased the expression of the regulator abaR from the LuxIR-type quorum sensing (QS)
communication system AbaIR and consequently reduced the N-acyl-homoserine lactone production
(AHL). This effect can be countered by addition of exogenous AHLs. Besides, fatty acids may have
additional non-targeted effects, independent from QS. Atomic force microscopy experiments probed
indeed that PoA and MoA could also act on the initial adhesion process in modifying the material
interface properties. Evaluation of fatty acids effect on 22 clinical isolates showed a strain-dependent
antibiofilm activity, which was not correlated to hydrophobicity or pellicle formation ability of the
tested strains, and suggested a real diversity in cell-to-cell communication systems involved in
A. baumannii biofilm formation.
Keywords: palmitoleic acid; myristoleic acid; biofilm; pellicle; quorum sensing
1. Introduction
Acinetobacter baumannii is a bacterial pathogen causing nosocomial outbreaks worldwide and
is responsible for many infections, such as pneumonia and bloodstream infections, especially
in intensive cares units [1,2]. Due to its exceptional adaptability to detrimental environmental
conditions, this bacterial species has rapidly emerged as a Multi-Drug Resistant (MDR), but also
XDR (extensively-DR) and now, more and more often, as a PDR (Pan-DR) organism. This led the
Int. J. Mol. Sci. 2018, 19, 214; doi:10.3390/ijms19010214 www.mdpi.com/journal/ijms
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World Health Organization to classify A. baumannii among the “Critical” bacterial agents (priority 1),
for which research and development of new and effective antibiotic treatments are urgently required.
Besides, this pathogen is also problematic for its long-time survival in hospital settings owing to its
great ability to survive desiccation [3] or treatment with disinfectants [4]. This persistence is mostly
linked to its capacity to form biofilms [5,6]. Virstatin is known to inhibit expression of cholera toxin
(encoding by ctx genes) and toxin co-regulated pilus (a type IV pilus, T4P, encoding by tcp genes),
two major virulence factors of Vibrio cholerae. We previously demonstrated that this small organic
molecule prevents A. baumannii biofilm production possibly via inhibition of pili biosynthesis [7–9].
Virstatin antibiofilm activity was recently confirmed on Acinetobacter nosocomialis [10], and could be due
to an inhibition of the Quorum-sensing (QS) system. QS is a communication system that orchestrates
bacterial behaviors within a microenvironment to promote community establishment by the regulation
of specific genes. In most gram-negative bacteria, signal molecules, called acyl-homoserine lactones
(AHLs), are diffusible autoinducers that are characterized by a length variable acyl-chain coupled with a
homoserine lactone ring [11]. In A. baumannii, different type of AHLs have been described [12], the most
commonly described ones are long chain AHLs with C10 or C12 acyl chains [13–15]. When considering
its crucial involvement in biofilm development, QS is an interesting target for the development of
antibiofilm strategies that can act either by inhibiting the signal molecule synthesis, or by degrading or
quenching this signal in the external environment [12]. Some mono-unsaturated fatty acids (UFAs) as
palmitoleic (cis-9-hexadecenoïc, C16:1Δ9, PoA) and myristoleic (cis-9-tetradecenoïc, C14:1Δ9, MoA)
acids were shown to inhibit tcp genes expression in V. cholerae [16,17]. These molecules prevent the
interaction between their transcriptional regulator ToxT and the DNA [18]. Bactericidal activity of
UFAs, in particular against cutaneous pathogens, has already been described [19–21]. Besides, UFAs
can also affect virulence factor expression, initial adhesion, or motility [20]. In this study, we evaluated
the efficacy of unsaturated fatty acids, PoA and MoA, as antibiofilm compounds and investigated their
effect on A. baumannii QS system.
2. Results and Discussion
2.1. Effect of UFAs on A. baumannii ATCC 17978 Biofilm Growth and Motility
Activity of PoA and MoA was preliminary tested on A. baumannii ATCC 17978 reference strain
forming both a biofilm at the solid-liquid interface and a pellicle. In the planktonic growth mode, MICs
of 4 mg/mL were obtained for each UFA. To investigate the antibiofilm activity of these compounds,
we used sub-inhibitory concentrations at least 100-fold lower than the MICs, i.e., 0.01, 0.02 and 0.05
mg/mL, concentrations in agreement with those used to decrease production of T4P in V. cholerae [17].
At these concentrations, fatty acids did not modify bacterial growth (Figure S1). The biofilm formation
inhibition by fatty acids is clearly depicted by the Figure 1a. Addition of PoA reduced significantly
the biofilm formation at the three tested concentrations (up to 37% and 39% reduction at 0.02 and
0.05 mg/mL, respectively), whereas MoA exhibited a significant activity only at 0.02 and 0.05 mg/mL
(decrease of 28% and 42% respectively). These results showed that UFAs display a biofilm inhibition
activity that is similar to that of virstatin, for which the decrease reached 32%, MoA being however
less active than PoA at lower concentrations. Biofilm dispersion activity of UFAs was investigated
on 24 h-static biofilms. Incubation of biofilms with MoA or PoA for anadditional 24 h demonstrated
that these UFA displayed significant dispersive activity as compared to virstatin (decrease of 24%
for MoA and PoA at 0.05 mg/mL, Figure 1a). Finally, A. baumannii surface motility was tested on
semi-solid medium plate (0.3% agar) with or without UFAs (Figure 1b at 0.02 mg/mL and Table S1).
PoA impeded motility when added at 0.02 and 0.05 mg/mL and MoA also significantly decreased the
motility up to 73% at 0.05 mg/mL.
? ????
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Figure 1. UFAs activity on A. baumannii ATCC 17978 motility and biofilm formation. (a) Inhibition and
dispersion of biofilms quantified by crystal violet staining method. 24 h-biofilms were treated with or
without virstatin (100 μM), palmitoleic acid (PoA) or myristoleic acid (MoA) at different concentrations
(0.01 (UFA-1), 0.02 (UFA-2) or 0.05 (UFA-5) mg/mL) and DMSO as control; (b) Activity on motility.
Blue arrows measure the diameter of surface motility. Results are presented as (mean ± standard error
of mean). “***” for p < 0.0001, “**” for p < 0.01, “*” for p < 0.05 and “NS” for non-significant difference.
These results showed that UFAs prevent significantly motility and biofilm formation on
A. baumannii ATCC 17978 at sub-inhibitory concentrations (0.01, 0.02 and 0.05 mg/mL) with a better
activity of PoA (C16:1Δ9) than MoA (C14:1Δ9). This is in agreement with the observation that,
in V. cholera, UFAs activity, reducing the tcp gene expression, was improved by an increase of the length
chain and was also related to the presence of unsaturated bond and to the conformation (cis/trans) of
the molecule [16,17]. Moreover, unlike virstatin, PoA and MoA were shown to significantly disperse
24 h-biofilms. Some Gram-bacteria produced cis-UFAs, also called Diffusible Signaling Factors (DSF).
These QS signals have been shown to be involved in cell-to-cell communication and could regulate
biofilm lifestyle [22]. For example, the UFA cis-2-decenoic acid (CDA) from the DSF family was shown
to be an autoinducer of the biofilm dispersion in P. aeruginosa and in many others species [23–26].
PoA and MoA might possess similar activity in A. baumannii biofilms. It was already shown that the
addition of an exogenous DSF, i.e., cis-2-dodecenoic (BDSF), inhibits P. aeruginosa biofilm formation by
interfering with the production of AHL [27]. This prompted us to further examine the impact of UFAs
on A. baumannii QS.
2.2. Impact of UFAs on Quorum Sensing
It was previously shown that virstatin could interfere with QS system of A. nosocomialis,
by decreasing the expression of the anoR regulator of the LuxI/R-type AnoIR system [10]. This decrease
of anoR expression, in reducing the activation of anoI, gene that codes for the autoinducer synthase,
could decrease AHLs production. In order to determine if virstatin or UFAs could also impact the QS
? ????
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system in A. baumannii ATCC 17978, we examined the expression of the regulator abaR gene of the
AbaIR system (homologue of the anoR gene in A. nosocomialis). We found that virstatin, MoA or PoA
significantly decreased abaR expression suggesting these UFAs can interfere with the AbaIR QS system
of A. baumannii (Figure 2a and Table S1).
Figure 2. UFAs activity on A. baumannii ATCC 17978 quorum sensing system. (a) abaR gene expression
quantified by real time PCR of the total RNA isolated from bacteria grown in the presence of virstatin
(100 μM, Vir-100), PoA or MoA at 0.02 mg/mL (PoA-2 and MoA-2) relative to that of the bacteria
grown in DMSO alone; (b) UFAs activity on biofilm formation in presence of AHLs (500 nM) quantified
by crystal violet staining method. 24 h-biofilm formation with or without virstatin (100 μM), PoA or
MoA at 0.02 mg/mL and DMSO as control. Results are presented as (mean ± standard error of mean).
“***” for p < 0.0001, “**” for p < 0.01 and “NS” for non-significant difference.
To confirm the impact of these compounds on the production of AHLs, we first performed
cross-streaking of A. tumefaciens and C. violaceum biosensors against A. baumannii ATCC 17978 to
determine the type of AHLs, i.e., short or/and long-type, which are produced by this strain [28].
In agreement with previous studies [13,14], we only detected the production of long-AHLs by
A. baumannii ATCC 17978 (Figure S2). To further examine the activity of UFAs and virstatin on
AHLs production, we evaluated the activity of these compounds on the A. baumannii biofilm formation
in presence of 500 nM of the main AHLs already described, i.e., OH-C12-HSL or N-C10-HSL [13–15]
(Figure 2b). If OH-C12-HSL addition completely restored the biofilm formation when A. baumannii was
treated by MoA, it only partially counteracted the activity of virstatin and PoA (recovery of 54 and
38% of the phenotype, respectively). The addition of N-C10-HSL also totally inhibited the effect of
MoA as well as the effect of virstatin (98% and 100% of recovery, respectively), whereas no significant
activity of N-C10-HSL was shown on biofilms treated with PoA (only 4% of recovery, Figure 2b).
Addition of AHLs on motility plates did not restore the motility of A. baumannii ATCC 17978 abolished
by virstatin or UFAs. Finally, we tested virstatin and UFAs via the QS screening platform developed
by Skogman et al. [29]. Neither virstatin nor UFAs (up to 400 μM) could be characterized as quorum
quencher or quorum inhibitor of short AHLs production.
In line with the previous data obtained on A. nosocomialis [10], these overall results indicate that
virstatin, but also UFAs, could prevent biofilm formation via an inhibition of abaR gene expression.
The consequent abaI autoinducer synthase gene repression could thus lead to an inhibition of the
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long-AHLs production. It has been shown that a deletion of the abaI in A. baumannii M2 displayed a
40% reduction of biofilm formation [13], a decrease that is similar to the one induced by virstatin or
UFAs. For PoA, the partial recovery of biofilm formation after addition of C10- or C12-HSL suggests
that this UFA alters the AHLs production, but could also act on another QS communication system not
yet characterized.
2.3. UFAs Affect Biofilm Architecture
We next investigated pellicles formed by ATCC 17978 after treatment with either virstatin or
UFAs. The pellicle formed by the ATCC 17978 strain showed aggregates on the air-facing side
(the “ball-shaped” morphogroup according to [30]) in control growth or in the presence of virstatin.
After 24 h of UFA treatment, these aggregates disappeared (Figure 3a). Pellicles were further
characterized by AFM. After 6 h of growth, control and virstatin-treated pellicles exhibited a similar
macroscopic aspect with merging microcolonies characterized by a diameter of about 50–100 μm
and an average thickness of (360–460 ± 40) nm (Figure 3b). However, with UFAs, tridimensional
architecture was abolished, leading to a monolayer structure with an average thickness of (230 ± 40)
nm and (150± 40) nm with PoA and MoA, respectively. This monolayer cellular organization appeared
to be less cohesive after PoA treatment than after the MoA one. We also observed elongated cells inside
the pellicle formed with and without UFAs (up to 20 μm of length versus 1 μm average for normal
cells, Figure 3b). When these elongated cells were inside the biofilm, they exhibited the same thickness
than normal cells (black circles in Figure 3b). However, in the presence of PoA or MoA, a large part of
these atypical cells seem to be lysed and their membranes expelled from the community (white arrows
in Figure 3b). UFC counts in the biofilms after 24 h with or without the presence of UFAs or virstatin
were similar (Figure S1).
Figure 3. UFAs activity on air-liquid biofilm organization. Pellicles were observed after growth with
or without virstatin, PoA or MoA. (a) Visual aspect of pellicle surface after 24 h treatment (b) Atomic
Force Microscopy (AFM) images of pellicle water-facing sides after 6 h treatment. From left side to
right side: DMSO control, pellicle formation with 100 μM virstatin, with 0.02 mg/mL MoA and with
0.02 mg/mL PoA. Elongated cells with a normal thickness are black encircled and lysed elongated cells
are pointed out with white arrows.
? ????
?
Int. J. Mol. Sci. 2018, 19, 214 6 of 10
These observations suggest a specific action of UFAs during the initial steps of biofilm formation,
i.e., on the cell adhesion. Indeed, due to their amphiphilic nature, UFAs go spontaneously at
the air-liquid interface where they could locally accumulate and lead to a first antibiofilm action.
In agreement with this hypothesis, it was previously shown that oleic acid (C18:1Δ9, OA) inhibited the
primary adhesion step of S. aureus on polystyrene surfaces [31]. We also observed that the addition
of UFAs in MH medium significantly reduced the air/liquid surface tension. It has been already
demonstrated that this type of interface alteration, due to addition of biosurfactants, for an example,
significantly reduced pellicle formation or induced biofilm dispersion [32,33]. Finally, the observation
of the air-liquid interface by Brewster Angle Microscopy [30] demonstrates that if DMSO did not
influence the organization of the monolayer formed by the growth medium molecules, in the presence
of UFAs, the fluidity of this monolayer drastically increased. The influence of this parameter on the
pellicle formation is difficult to evaluate, but one might suggest that the irreversible adhesion step,
preluding microcolony formation during biofilm development, might be more difficult to achieve for
bacteria on fluid surface. Taken together, these overall results suggest that, besides its action on QS
system, the antibiofilm activity of UFAs could also be due, at least in initial steps of biofilm formation,
to several modifications of the interfaces on which the biofilm settles.
2.4. UFAs Effect on Biofilm Formation and Mobility of Clinical Isolates
To evaluate more broadly the UFAs activity on A. baumannii biofilms, we tested MoA and PoA
on 22 clinic isolates from different origins [34]. We quantified the biofilm formation of these strains
grown with or without UFAs at 0.02 mg/mL. PoA decreased significantly the biofilm formation in
13 of strains with a maximum reduction of 44% (Figure S3). With MoA, eight strains exhibited a
significant reduction of their biofilm formation ability. As observed with the ATCC 17978 strain, PoA
displayed a better antibiofilm activity than MoA, but no relationship between the antibiofilm activity
of virstatin and the one of UFAs could be emphasized [7]. UFAs antibiofilm activity seems not to be
correlated to the pellicle formation ability or hydrophobicity of the strain (Figure S3). For some strains,
UFAs addition slightly promoted the biofilm formation. Cross-streaking of A. tumefaciens biosensor
against these isolates confirmed the efficiency of the AHL QS system by long AHL production.
Several hypotheses can be proposed to explain this increase. In S. aureus, it was shown that OA
could promote biofilm formation, probably by interaction between positive charges of adhesion
factors and negative charges of UFAs [31,35]. Expression of adhesion factors in A. baumannii was
shown to be strain-dependent [36] and might explain this increasing effect. One can notice also
that the quorum quencher enzyme MomL displayed on A. baumannii biofilms a similar activity
as UFAs, with a maximum 42% decrease of the biomass formation and a strain-dependence of its
activity [37], suggesting that other cell-to-cell communication systems or factors could be recruited
during A. baumannii biofilm formation. In V. cholerae, UFAs (PoA and OA) were shown to interact and
prevent the DNA interaction of the AraC-type regulator, ToxT [17]. Additional interaction of UFAs with
such regulators in clinical isolates may also explain an increased biofilm formation. This demonstrates
that the UFAs activity is not limited to an activity an abaR gene.
3. Materials and Methods
3.1. Bacterial Strains and MICs Determination
To evaluate fatty acid activity, we used two reference strains of A. baumannii (i.e., ATCC
17978 and ATCC 19606) and a panel of 22 A. baumannii clinical isolates previously described [7,34].
Fatty acids, cis-9-hexadecenoic acid (C16:1Δ9, palmitoleic acid, PoA, Sigma Aldrich, Lyon, France)
and cis-9-tetradecenoic acid (C14:1Δ9, myristoleic acid, MoA, Sigma Aldrich, France) and virstatin
(4-[N-(1,8-naphthalimide)]-n-butyric acid, Bachem, Bubendorf, Germany) were solubilized in dimethyl
sulfoxide (DMSO, Sigma, St. Louis, MO, USA). Determination of UFAs minimal inhibitory
concentrations (MIC) were performed by the microdilution method, as previously described by [7].
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3.2. UFAs Activities on Biofilm Formation and Motility of A. baumannii Strains
A. baumannii biofilms were grown on 24-well plates in Mueller Hinton broth (MHB, Difco, Sparks,
NV, USA) at 37 ◦C as previously described [7]. To test their inhibition activity on A. baumannii biofilms,
fatty acids were introduced at final concentration of 0.02 mg/mL (as well as 0.01 and 0.05 mg/mL for
ATCC 17978 strain), using DMSO as negative control and 100 μM virstatin as positive control [7,17].
In case of strains forming pellicle in addition to biofilms on plate walls, the sub-phase was gently
removed allowing the pellicle to stick onto the plate walls, then the overall remaining biomass
(i.e., biofilm on solid surface and pellicle) was quantified, as described by [38]. Biofilm dispersion
activity of UFAs was investigated only on 24 h-biofilms formed by ATCC 17978 strain in MHB.
Twenty four-hour biofilms were incubated in fresh medium for an additional 24 h in the presence of
fatty acids (at 0.01, 0.02, or 0.05 mg/mL) using DMSO or virstatin 100 μM as controls. Surface motility of
A. baumannii strains was investigated in 0.3% Luria Bertani agar (LB; Difco) Petri dishes supplemented
or not with UFAs and DMSO as control and incubated overnight at 37 ◦C [39]. All of the experiments
were performed at least in triplicate. Data were statically analyzed using Prism Graph Pad 5 with a
t-test to determine a significant effect of UFAs.
3.3. Effect of Virstatin and UFAs on Quorum Sensing
The N-acyl-homoserine lactone (AHL) production in A. baumannii ATCC 17978 or A. baumannii
clinical isolates was determined, as described by [28] with P. aeruginosa PAO1 and E. coli ATCC 10536
as positive and negative controls, respectively. To investigate the potential quorum-quenching activity
of UFAs and virstatin on short-HSLs, we used the screening platform described by [29]. The effect
of the addition of long-HSLs, i.e., N-(3-hydroxydodecanoyl)-DL-homoserine lactone (OH-C12-HSL,
Sigma Aldrich) and N-decanoyl-DL-homoserine lactone (N-C10-HSL, Sigma Aldrich) solubilized in
DMSO, on biofilms pretreated by virstatin and UFAs was investigated. Five hundred nM of each
HSL were added concomitantly to 0.02 mg/mL of UFAs and 100 μM virstatin. DMSO enriched with
HSL (500 nM) was used as control. Biofilm formation was quantified and the results significance was
analyzed, as described in the previous section. The effect of virstatin and UFAs on abaR gene expression
using q-RT-PCR was also investigated. A. baumannii was grown overnight in MH medium and diluted
to OD600 of 0.01 and incubated for 24 h under agitation at 37 ◦C with DMSO (negative control), virstatin
(100 μM), MoA (0.02 mg/mL), or PoA (0.02 mg/mL). Total RNAs were extracted using RNeasy-Mini
kit (Qiagen, Valencia, CA, USA), followed by a supplementary DNase treatment (Ambion, Carlsbad,
CA, USA), and a verification of absence of contaminating DNA by PCR. RNAs were reverse-transcribed
using QuantiTect Reverse Transcription Kit (Qiagen). Real-time PCR was performed using Brilliant
III SYBR Green QPCR (Agilent Technologies, Santa Clara, CA, USA) with an AriaMx Real-Time PCR
System (Agilent Technologies). Specific primers are listed in Table S1. The rpoB expression was used
as an internal control for normalization and fold change calculated in relation to the DMSO control.
Data were analyzed using Prism Graph Pad 5 with a one-way ANOVA (n = 4).
3.4. Impact of UFAs on A. baumannii Biofilm Morphology
Morphological changes of liquid-facing sides of A. baumannii ATCC 17978 pellicles were visualized
by Atomic Force Microscopy (AFM) after 6h of growth with or without 0.02 mg/mL of UFAs or
100 μM virstatin, DMSO being used as control [7]. Modifications of air-water interfaces in presence of
UFAs and virstatin, were determined either by Brewster’s angle microscopy [30] or by surface tension
measurements using a Wilhelmy pressure sensor with a filter paper plate (R & K, Wiesbaden, Germany).
4. Conclusions
Involved in device-related infections and in persistence in hospital settings, the biofilm formation
is a major cause of concern in the battle against A. baumannii and deserves the research of new
therapeutic compounds. In this context, we previously demonstrated that virstatin, a factor decreasing
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T4P-pili expression in V. cholera [17], inhibits A. baumannii biofilm formation [7]. In this study,
we demonstrated that MoA and PoA also decreasing T4P-pili expression in V. cholera [16,17], inhibit
the biofilm formation and motility in A. baumannii. By decreasing the expression of the QS system
regulator, abaR, these three compounds inhibit AHLs production that could be restored by AHL
exogenous addition. However, UFAs, as hydrophobic compounds, also modify material interfaces, as
shown here by the modification of the air-liquid interface, precluding initial steps of biofilm formation.
Additional bacterial responses that are uncorrelated to QS communication system or sensing of
surfaces might also be induced by the use of these compounds, like overexpression of genes involved
in stress response, or the regulation of peptidoglycan biosynthesis highlighted in S. aureus under OA
treatment [40], and merit further investigation.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/19/1/214/s1.
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AFM Atomic force microscopy
AHL N-acyl-homoserine lactone
ATCC American type culture collection
DMSO Dimethyl sulfoxide
HSL Homoserine lactone
MIC Minimal inhibitory concentration
MoA Myristoleic acid
PoA Palmitoleic acid
OA Oleic acid
PCR Polymerase chain reaction
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Bacterial pathogens developed several strategies to escape innate immunity of their 
hosts to enable them to succeed to colonize the host [451]. Pseudomonas aeruginosa is also in 
the ESKAPE list mentioned above, known to cause hospital acquired infections but also to be 
a major cause of morbidity and mortality in cystic fibrosis patients [447]. One of the research 
axis in the team of my supervisor Dr Suzana Salcedo is the characterization of bacterial 
proteins that contain a TIR domain which are well known to interfere with components of 
innate immunity as it was described in Chapter3 with BtpA and BtpB. In our laboratory 
another PhD student Paul Imbert identified a new TIR protein in the nosocomial pathogen 
Pseudomonas aeruginosa called Pseudomonas UBAP1 Modulator A (PumA). To sum up 
PumA inhibits the translocation of an important activator of the innate immunity, NF-κB. As 
Btp Brucella proteins, PumA was shown to interact with TIR adaptors TIRAP and Myd88. In 
addition, Ubiquitin Associated Protein 1 (UBAP1) was also shown to be a partner of PumA, a 
very interesting result. Indeed, UBAP1 was mainly characterized and associated to endosomal 
components especially in endosomal-sorting complex required for transport I (ESCRT-I) 
[452]. This complex is associated to diverse functions as the transport of ubiquitinated 
endosomal cargo for degradation [452].  We showed that PumA was able to interfere with 
TNF receptor signaling in addition to TLRs. Moreover, a few months before this paper 
another team characterized the role of UBAP1 in TNF receptor activation [453](Maminska 
2016 Cell Biology). The identification and characterization of the new bacterial protein PumA 
was very interesting the interaction between PumA and UBAP1 constituted a new strategy for 
bacterial inhibition of innate immune signaling during infection.  
 
My contribution for this work was to perform qPCR to show no differences in the induction 
of NF-κB between the wild-type, mutant and complemented strains. And in second time for 
the review process I performed co-immunoprecipitation between the C-Terminal (C-Ter) part 
of PumA and full-length TIRAP, MyD88 and UBAP1 to confirm that the interactions do not 
involved the C-ter extremity of PumA. All these results are presented in supplementary data.  
? ????
 
Article
A Pseudomonas aeruginosa TIR effector mediates
immune evasion by targeting UBAP1 and
TLR adaptors
Paul RC Imbert1, Arthur Louche1, Jean-Baptiste Luizet1, Teddy Grandjean2, Sarah Bigot1, Thomas E
Wood3, Stéphanie Gagné1, Amandine Blanco1, Lydia Wunderley4, Laurent Terradot1,
Philip Woodman4, Steve Garvis5, Alain Filloux3 , Benoit Guery2 & Suzana P Salcedo1,*
Abstract
Bacterial pathogens often subvert the innate immune system to
establish a successful infection. The direct inhibition of down-
stream components of innate immune pathways is particularly
well documented but how bacteria interfere with receptor proxi-
mal events is far less well understood. Here, we describe a Toll/
interleukin 1 receptor (TIR) domain-containing protein (PumA) of
the multi-drug resistant Pseudomonas aeruginosa PA7 strain. We
found that PumA is essential for virulence and inhibits NF-jB, a
property transferable to non-PumA strain PA14, suggesting no
additional factors are needed for PumA function. The TIR domain is
able to interact with the Toll-like receptor (TLR) adaptors TIRAP
and MyD88, as well as the ubiquitin-associated protein 1 (UBAP1),
a component of the endosomal-sorting complex required for trans-
port I (ESCRT-I). These interactions are not spatially exclusive as
we show UBAP1 can associate with MyD88, enhancing its plasma
membrane localization. Combined targeting of UBAP1 and TLR
adaptors by PumA impedes both cytokine and TLR receptor signal-
ling, highlighting a novel strategy for innate immune evasion.
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Introduction
Microbial pathogen recognition by innate immune receptors initiates
a progression of molecular interactions and signalling events assur-
ing host defence. In bacterial infections, detection of surface
components, such as peptidoglycan, lipopolysaccharides and
flagellin by Toll-like receptors (TLR) 2, 4 and 5, respectively, is
essential for induction of pro-inflammatory cytokines and type I
interferon (IFN) responses. Specific sorting and signalling adaptor
proteins bridge activated receptors with downstream kinases to initi-
ate signalling cascades via Toll/interleukin 1 receptor (TIR) domains
present on both the adaptors and the cytosolic face of TLRs
(Brubaker et al, 2015). Upon TLR2 or TLR4 activation, the TIR-
containing adaptor protein (TIRAP) recruits myeloid differentiation
primary response 88 (MyD88) that interacts with the TLR via its TIR
domain (Fitzgerald et al, 2001; Horng et al, 2001; Kagan &
Medzhitov, 2006). MyD88 oligomerization and recruitment of
specific kinases leads to the formation of myddosomes, signalling
platforms that induce NF-jB translocation into the nucleus and
subsequent transcription of pro-inflammatory associated genes
(Nagpal et al, 2011; Bonham et al, 2014). TLR4 activation also
results in induction of a type I IFN via another set of adaptors,
TRAM and TRIF (Fitzgerald et al, 2001; Yamamoto et al, 2002;
Kagan et al, 2008). In the case of the MyD88-dependent TLR5, the
identity of a sorting adaptor remains undefined and the role of
TIRAP unclear although it has been implicated in proper TLR5
signalling in epithelial cells (Choi et al, 2013).
Microbial pathogens have been shown to counter these host
defence pathways. Most bacterial immune-modulatory proteins
described to date rely on inhibition of downstream signalling
components, such as MAP kinases and transcription factors (re-
viewed in Rosadini & Kagan, 2015). In contrast, few examples of
direct blocking at the level of initial receptor–adaptor complexes are
known. Some bacterial pathogens rely on TIR domain-containing
proteins to perturb TIR-dependent interactions (Newman et al,
2006; Cirl et al, 2008; Salcedo et al, 2008, 2013), essential in innate
immune signalling. The growing number of bacterial TIR proteins
recently identified in both Gram-negative and Gram-positive human
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pathogens (Spear et al, 2012; Askarian et al, 2014; Zou et al, 2014)
highlights the importance of this immune evasion strategy in
disease. However, the molecular mechanisms underlying most
TIR-dependent virulence strategies remain to be defined.
We focused on a previously uncharacterized TIR domain-
containing protein of the multi-drug resistant pathogen Pseu-
domonas aeruginosa PA7, that we called PumA. P. aeruginosa PA7
lacks genes encoding the type III secretion system (T3SS) and its
cognate effector proteins that are normally associated with strong
induction of cell death, a hallmark of acute P. aeruginosa infections
(reviewed by Filloux, 2011). In addition, PA7 does not show high
lytic capacity towards epithelial cells due to exolysin A (ExlA) as
described for the haemorrhagic pneumonia-causing strain of the
same family (Elsen et al, 2014; Reboud et al, 2016). We thus took
advantage of the absence of traditional virulence factors in this
P. aeruginosa strain to study the molecular interactions involved in
TIR-mediated bacterial targeting of events proximal to receptor–
adaptor signalling complexes and to dissect PumA function. We
found that the PumA Pseudomonas TIR domain-containing protein
is essential for PA7 virulence conferring a previously unrecognized
ability to Pseudomonas to down-modulate innate immune responses
during infection. We show that PumA directly interacts with both
TIRAP and MyD88 to control TLR signalling. Uniquely, it also
targets the ubiquitin-associated protein 1 (UBAP1), a recently
discovered component of the endosomal-sorting complex required
for transport I (ESCRT-I; Stefani et al, 2011). UBAP1 is known to
play a key role in selective sorting of ubiquitinated endosomal cargo
on multi-vesicular bodies (MVB), via its interaction with VPS37A
and other components of ESCRT-I namely TSG101 (Wunderley
et al, 2014), as well as with the ESCRT regulator, His domain
protein tyrosine phosphatase (HDPTP; Stefani et al, 2011). UBAP1
has been shown to control endosomal sorting of ubiquitinated
EGFR (Stefani et al, 2011) as well as ubiquitin-dependent degrada-
tion of antiviral surface proteins (Agromayor et al, 2012) and inte-
grins (Kharitidi et al, 2015). More recently, UBAP1 was shown
to modulate steady-state trafficking of cytokine receptors in non-
stimulated cells (Maminska et al, 2016). UBAP1 is expressed in a
wide range of tissues, but when deleted in mice, it is lethal for
embryos (Agromayor et al, 2012).
We propose that this novel Pseudomonas effector modulates
UBAP1 function, hence the name PumA (for Pseudomonas UBAP1
modulator A), which confers to this TIR domain-containing protein
the distinctive ability to also interfere with cytokine receptor signal-
ling. Targeting of both TLR adaptors and UBAP1 by PumA is not
spatially restricted as we found UBAP1 can associate with MyD88 in
host cells. Our results thus highlight a novel role of bacterial TIR
domains and place UBAP1 sorting in the context of TLR signalling.
Results
PumA is required for Pseudomonas aeruginosa PA7
virulence in vivo
In Pseudomonas, TIR domain-containing proteins were first identi-
fied in an in silico study in P. aeruginosa and the plant pathogen
P. syringae (Zhang et al, 2011). Analysis of currently available
genomes shows that several plant strains encode such proteins as
well as additional human pathogenic strains of P. stutzeri and
P. aeruginosa. The closest orthologue is found in the plant pathogen
P. viridiflava. The TIR domain of PumA spans the first 136 amino
acids of PumA (Appendix Fig S1A and B), with no significant
sequence/structure homologies detected for the C-terminal domain
(amino acid 137–303) and no signal peptide. Analysis of the PA7
genome shows pumA (PSPA7_2375) is within the genomic island
RGP56, which displays a G+C content of 58.5% in contrast to the
average 66.5% in the remaining genome. Interestingly, using
Geneious (Kearse et al, 2012), we found the pumA gene itself has
an even larger reduction in G+C content (46.6%) (Appendix Fig
S1C), suggesting that it is not a conserved gene within its immediate
genetic context.
We assessed the potential role of PumA in virulence by infecting
the nematode Caenorhabditis elegans, a well-established model for
P. aeruginosa allowing for rapid assessment of virulence (Garvis
et al, 2009). Infection with the highly virulent strain P. aeruginosa
PA14 which contains virulence factors such as the T3SS but no TIR
protein resulted in 50% lethality at day 5. The PA7 wild-type strain
caused 50% lethality 7 days after inoculation. In contrast, we found
that the PA7 ΔpumA mutant showed a slight but significant attenua-
tion in virulence in C. elegans (Fig 1A). These differences were not
due to an in vitro growth defect of the mutant (Appendix Fig S2A)
nor to a problem in expression of PumA in the wild-type P. aerugi-
nosa PA7 strain (Appendix Fig S2B).
We then used an acute in vivo infection model to evaluate the
involvement of pumA in P. aeruginosa induced lung injury. Mice
infected with DpumA showed a clear increased survival compared
to wild-type strain (Fig 1B). A dose of 4.107 CFU of PA7 induced
100% lethality after 52 h against 62.5% survival after 96 h for the
DpumA mutant. Bacterial clearance and cellular recruitment were
then analysed with a lower inoculum of 3.107 CFU. PA7DpumA
infected mice showed decreased cell recruitment (Fig 1C) and an
enhanced lung bacterial clearance in bronchoalveolar lavages (BAL)
compared to the wild-type strain (Fig 1D). The bacterial dissemina-
tion measured with the spleen bacterial load was equivalent
between the two groups (Fig 1E). Together these results show that
PumA is required for P. aeruginosa PA7 infection.
PumA inhibits NF-jB translocation into the nucleus during
infection in vitro
As bacterial TIR proteins down-modulate NF-jB activation
(Newman et al, 2006; Cirl et al, 2008; Salcedo et al, 2008, 2013;
Spear et al, 2012; Askarian et al, 2014; Zou et al, 2014), we
infected the lung carcinoma epithelial cell line A549, a well-
established cellular model for Pseudomonas infection and analysed
NF-jB translocation into the nucleus after one hour of infection
by confocal microscopy. We developed an automated analysis of
p65/RelA fluorescence in relation to DAPI labelling using a speci-
fic ImageJ plugin from images obtained by confocal microscopy
(Fig EV1A) which allowed us to clearly differentiate between
TNFa-treated and mock-infected cells (Figs 2A and EV1B). Infec-
tion with the three heat-killed P. aeruginosa strains, wild-type
PA7, isogenic mutant DpumA or wild-type PA14 resulted in signif-
icant induction of NF-jB translocation into the nucleus, although
to a lower level than TNFa-treated cells (Fig 2A). When cells
were infected with PA7, there was no significant induction of
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NF-jB when compared with the mock-infected negative control
(Fig 2B), suggesting PA7 blocks NF-jB translocation into the
nucleus. In contrast, DpumA infection promoted NF-jB nuclear
translocation, attaining activation levels similar to those observed
with heat-killed bacteria. The inability of pumA mutants to block
NF-jB nuclear transport was complemented by chromosomal
expression of this gene under an arabinose-inducible promoter
(Fig 2C). Importantly, when pumA expression was repressed with
glucose, no complementation of NF-jB inhibition was observed
(Fig 2B). Addition of arabinose had no effect on NF-jB
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Figure 1. PumA is required for Pseudomonas aeruginosa PA7 virulence in vivo.
A Caenorhabditis elegans survival curve. Fifty C. elegans were infected with E. coli OP50 and with highly virulent strain P. aeruginosa PA14. One hundred C. elegans
were infected with P. aeruginosa PA7 and PA7 ΔpumA. Test of Mantel–Cox was used with ***P = 0.0002.
B To establish an in vivo model of acute infection, mice were intranasally infected with 4 × 107 CFU P. aeruginosa PA7 or PA7DpumA strains (n = 7/group). Lethality
was monitored for 96 h, and a test of Mantel–Cox was used, with **P = 0.0035.
C–E Mice were intranasally infected with 3 × 107 CFU P. aeruginosa PA7 or PA7DpumA strains (n = 7/group). Cells from bronchoalveolar lavage (BAL) were counted (C).
Bacterial load in the lungs (D) and dissemination (E) were assessed through cultured lung or spleen homogenate. Non-parametric two-tailed Mann–Whitney test
was carried out with (C) *P = 0.0173, (D) *P = 00364 and (E) P = 0.3629. All data correspond to mean  standard error.
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Figure 2. PumA is essential for control of NF-jB translocation into the nucleus during Pseudomonas aeruginosa infection of human A549 lung epithelial cells.
A Quantification of fluorescence ratio between nuclear NF-jB (p65) and nuclear DAPI staining. Negative control corresponds to uninfected cells that underwent all
steps of the experiment. Positive control corresponds to full NF-jB activation with TNFa (1 lg/ml). A549 cells were incubated for 1 h with heat-killed (HK) bacteria to
establish maximum activation induced by Pseudomonas infection.
B Cells were infected for 1 h with either P. aeruginosa PA7 wt, ΔpumA, ΔpumA:pumA (Ara) induced with 1% arabinose, ΔpumA:pumA (Glu) repressed with 0.5% glucose,
PA14 wt, PA14:pumA (Ara) induced with 1% arabinose and PA14:pumA (Glu) repressed with 0.5% glucose. For consistency, arabinose was also included for the
infections with wild-type and deletion mutant strains.
C Western blots from representative inocula used for the infection experiments, showing expression of PumA (34 kDa) in the different P. aeruginosa strains visualized
using a polyclonal rabbit anti-PumA with control blot against the standard cytoplasmic protein EF-Tu (45 kDa) below.
Data information: For (A) and (B), between 200 and 400 cells per condition were counted and data correspond to median  standard error from three independent
experiments. Non-parametric one-way ANOVA Kruskal–Wallis test, with Dunn’s multiple comparisons test was performed; ****P < 0.0001, ***P < 0.001, **P < 0.01.
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translocation (Fig 2B versus EV1B). Furthermore, absence of
NF-jB nuclear translocation was not due to reduced immune
detection of the mutant strain as incubation of host cells with
heat-killed DpumA resulted in equivalent levels of NF-jB activa-
tion to the wild-type PA7 (Fig 2A). To further support that the
differences observed relate to PumA and are not indirect, we
verified that all strains showed equivalent levels of membrane
permeability (Fig EV2A), the global protein composition of the
cell envelope was not altered in a pumA mutant (Fig EV2B), and
no differences were observed in cytotoxicity (Fig EV2C and D)
nor host cell adhesion (Fig EV2E) between wild-type PA7 and
isogenic DpumA mutant. Together these results show that PumA
is responsible for P. aeruginosa PA7 inhibition of NF-jB nuclear
translocation during infection.
We then investigated whether expression of PumA alone could
confer the ability to block NF-jB translocation to a different Pseu-
domonas strain. We chose PA14, which does not contain pumA and
is known to be more virulent due to the presence of several viru-
lence factors, namely those secreted by the T3SS. As expected, cells
infected with wild-type PA14 showed high levels of NF-jB translo-
cation into the nucleus (Fig 2B). Induction of pumA from the PA14
chromosome, which did not impact membrane permeability
(Fig EV2A), was sufficient to enable this highly virulent strain to
block NF-jB accumulation in the nucleus of infected cells (Fig 2B).
These data indicate that PumA expression in P. aeruginosa is neces-
sary and sufficient for NF-jB inhibition, highlighting its central role
in immune evasion.
PumA translocation into host cells during infection in vitro
We next sought to determine whether PumA could be secreted by
Pseudomonas. Fractionation of bacterial cells grown in liquid
culture indicates that PumA is mostly cytoplasmic and to a lesser
extent associated with the inner membrane (Appendix Fig S3A).
The protein was not detected in the outer membrane fractions nor
could it be found in the supernatant indicating absence of secretion
into the extracellular milieu in vitro. To determine whether PumA
could be found inside host cells during infection, we fused chromo-
somal PumA with the TEM1 b-lactamase. Although the presence of
other b-lactamases in PA7 and/or potential bacterial lysis resulted in
non-specific cleavage of the CCF2 substrate within host cells
infected with the wild-type strain, significant levels of coumarin
fluorescing cells following infection with a strain containing PumA-
TEM1 (Appendix Fig S3B) suggest that PumA is translocated into
host cells during infection.
PumA is associated with both TIRAP and MyD88 at the plasma
membrane and intracellular compartments
To determine the mechanism by which PumA interferes with NF-jB
activity, PumA was expressed in mammalian cells. We found PumA
localized mostly at the plasma membrane, with some intracellular
distribution, independently of the tag and in both immortal HeLa
cells (Fig EV3A, top panel) and primary mouse embryonic fibro-
blasts (MEFs, Fig EV3B). As this localization was reminiscent of
that of the TLR adaptor TIRAP (Fig EV3A and B), we co-transfected
cells with PumA and TIRAP. We found extensive co-localization, in
particular at the plasma membrane in both HeLa and MEFs (Fig 3A
and B). We observed these results with any combination of tags
(HA, Myc or GFP) for both proteins.
In contrast with TIRAP, MyD88 is mostly localized in intracellu-
lar structures that do not label the plasma membrane. We therefore
co-expressed MyD88 with PumA. Surprisingly, we found enrich-
ment of PumA in a proportion of MyD88-positive structures in both
cell types although to a lesser extent than that observed with TIRAP
(Fig 3A and B). These results were confirmed by structured illumi-
nation microscopy (SIM) to enable imaging at higher resolution
(Fig 3C and D). PumA enrichment was observed with PumA tagged
with Myc or HA and MyD88 fused to either HA, FLAG or Myc. Curi-
ously, this phenotype was exacerbated when GFP-PumA, normally
at the cell surface (Fig EV3) was co-expressed with MyD88, result-
ing in the majority of GFP-PumA being recruited to MyD88-positive
compartments (Fig EV3C).
The TIR domain of PumA is responsible for interaction with both
TIRAP and MyD88
We then investigated whether the TIR domain present in the first
136 amino acids of PumA was responsible for membrane targeting.
PumA1–136 was also efficiently targeted to the plasma membrane
(Fig 4A). However, unlike TIRAP and another bacterial TIR protein
BtpA/TcpB which are known to interact with specific phospholipids
of the plasma membrane (Kagan & Medzhitov, 2006; Radhakrishnan
et al, 2009), PumA and PumA1–136 did not show any lipid binding
properties when incubated with phosphoinositide phosphate strips
(Fig 4B). We then tested whether PumA could interact with TIRAP,
which could explain its membrane localization. We found that
TIRAP-GFP and Myc-PumA co-immunoprecipitated (co-IP) suggest-
ing TIRAP and PumA could be part of the same complex (Fig 4C).
This association was confirmed using purified His-tagged PumA or
PumA1–136 immobilized on Ni-NTA resin, which both retained
HA-TIRAP (Fig 4D).
As we had also observed enrichment of PumA in MyD88-positive
compartments, we investigated whether PumA could interact with
this adaptor protein. Although we did not observe and interaction
between GFP-MyD88 and Myc-PumA (Fig 4C) nor HA-PumA and
Myc-MyD88 (Appendix Fig S4A), using co-IP assays, His-PumA or
PumA1–136 were able to retain HA-Myd88 (Fig 5A), suggesting
PumA is also able to interact with MyD88. To confirm these results,
we took advantage of the strong enrichment in MyD88-positive
compartments when Myd88 is co-expressed with the GFP-tagged
version of PumA (Fig EV3C) and carried out co-IP in these condi-
tions. Indeed, GFP-PumA and Myc-Myd88 could be co-immunopre-
cipitated as well as GFP-PumA and Myc-TIRAP (Fig 5B), suggesting
that PumA can interact with MyD88. As a control for non-specific
TIR–TIR interactions, we tested the ability of PumA to interact with
TLR2, also by co-IP. Indeed, GFP-PumA could interact with FLAG-
TIRAP but not FLAG-TLR2, suggesting some level of specificity in
PumA targeting (Appendix Fig S4B and C).
Finally, we co-expressed in E. coli His-PumA1–136 with His-MBP
(Fig 5C), His-MBP-TIRAP (Fig 5D) or His-MBP-MyD88 (Fig 5E) and
we could clearly see co-elution of both TIRAP and MyD88 in
contrast to the His-MBP control (also see Appendix Fig S4D).
We next sought to determine whether the C-terminus of
PumA137–303 could also participate in these interactions. Lack of
expression of His-PumA137–303 in E. coli prevented us from purifying
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Figure 3. PumA co-localizes with TIRAP at the plasma membrane and to a lesser extent with intracellular MyD88, when ectopically expressed in host cells.
A, B Confocal microscopy of HeLa cells (A) and mouse embryonic fibroblast (MEFs) (B) co-expressing Myc-PumA and adaptor proteins HA-TIRAP (top panel) and HA-
MyD88 (bottom panel). Cells were fixed after 10 h of transfection. Scale bars correspond to 10 lm.
C, D Representative micrographs obtained by super resolution structure illumination microscopy (SIM) of MEFs co-expressing (C) Myc-PumA and TIRAP and (D) Myc-
PumA and HA-MyD88. Wide field (WF) is shown in top panels and structured illumination of wide field (SIM) in bottom panels. Scale bars correspond to 1 lm.
The EMBO Journal Vol 36 | No 13 | 2017 ª 2017 The Authors
The EMBO Journal UBAP1 targeting by Pseudomonas TIR domain protein Paul RC Imbert et al
1874
Published online: May 8, 2017 
? ????
 
this domain. We therefore carried out co-IP experiments with GFP-
PumA137–303 expressed in host cells. We could not detect any inter-
action between PumA137–303 and TIRAP (Fig EV4A) nor between
PumA137–303 and MyD88 (Fig EV4B). However, it is important to
note that expression of PumA137–303 results in loss of plasma
membrane localization. Instead, we observed formation of cellular
aggregates that are positive for FK2 labelling (Fig EV4C), which
recognizes mono- and poly-ubiquitinated proteins and could corre-
spond to misfolded protein. For this reason, we cannot completely
exclude a role of the C-terminus of PumA in these interactions.
Nonetheless, our data identify TIRAP and MyD88 as host cell targets
of PumA, which mediates interaction with these adaptor proteins
via its TIR domain.
PumA interacts with the ESCRT-I component UBAP1
As PumA was able to interact with both TIRAP and MyD88, two key
adaptors in TLR signalling, we hypothesized PumA’s function was
to block all immune pathways dependent on these adaptors. Using
an in vitro luciferase assay, we tested key immune receptors impli-
cated in Pseudomonas infection. Surprisingly, we found PumA could
not only block TLR4, TLR5 and IL-1b but also the TNF receptor,
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Figure 5. PumA is also capable of interacting with MyD88.
A Pull-down assay using extracts from cells expressing HA-MyD88 against His-PumA or His-PumA1–136 immobilized on a Ni-NTA resin. Empty column was used as a
control for non-specific binding. Interactions were visualized by Western blotting using anti-HA antibody, and column binding with anti-His (lower blot). Non-
bound fraction (FT), last wash (W) and elution (E) are shown for each sample and the molecular weights indicated (kDa).
B Co-immunoprecipitation (co-IP) assay from cells expressing GFP-PumA and either Myc-TIRAP or Myc-MyD88. GFP was used as a control for non-specific binding.
The co-IP was revealed using an anti-Myc antibody, the fraction bound to GFP-trapping beads using an anti-GFP antibody and the inputs (shown on the bottom
two images) using both anti-Myc and anti-GFP antibodies.
C–E Co-purification of His-PumA1–136 co-expressed in E. coli BL21 with either (C) His-MBP (control), (D) His-MBP-TIRAP or (E) His-MBP-MyD88. Interactions were
visualized with coomassie blue stained gels. Soluble fraction (SF) and selected elutions (E) are shown for each sample and the molecular weights indicated (kDa).
Source data are available online for this figure.
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which is not dependent on TIR–TIR interactions (Fig EV5A). TNFR1
inhibition was specific to PumA as expression of the Brucella TIR
domain-containing protein BtpA/TcpB did not have any significant
effect (Fig EV5B). We therefore carried a yeast two-hybrid screen to
identify an alternative target of PumA and found UBAP1, a key
component of the ESCRT-I mediating trafficking and sorting of ubiq-
uitinated cargo proteins on MVBs (Stefani et al, 2011; Agromayor
et al, 2012). This interaction was confirmed by co-IP from cells co-
expressing PumA and UBAP1 (Fig 6A and B) as well as by pull-
down using purified PumA or PumA1–136 and cell extracts with
either streptavidin-tagged UBAP1 (Fig 6C) or Myc-UBAP1
(Appendix Fig S5A). These results were specific to PumA as the
Brucella TIR protein BtpA/TcpB did not show any interaction
(Fig 6C). Furthermore, PumA137–303 could not co-IP UBAP1
(Fig EV4D) supporting a role of the TIR domain in targeting UBAP1.
Not surprisingly, microscopy analysis of cells expressing both PumA
and UBAP1 showed significant co-localization at the plasma
membrane and intracellular compartments (Appendix Fig S5C).
We next investigated whether PumA is interacting with UBAP1 in
the context of the ESCRT-I machinery. As over-expression of UBAP1
could result in its mislocalization, we carried out endogenous co-IP
from cells expressing HA-PumA. Full-length PumA not only inter-
acted very efficiently with endogenous UBAP1 but more importantly
also co-immunoprecipitated TSG101 (Fig 6D), confirming PumA is
targeting the ESCRT-I machinery. As expected, PumA also interacted
with endogenous TIRAP (Fig 6D). The TIR domain of PumA only
weakly interacted with endogenous UBAP1 and TIRAP (Fig 6E),
whereas the C-terminus of PumA showed no interactions (Fig 6F).
While we were conducting this work, another study reported
UBAP1 participates in control of TNFR1 and other cytokine receptor
trafficking (Maminska et al, 2016). Our data along with this recently
published study thus suggest that PumA interaction with UBAP1
results in inhibition of the TNF receptor-mediated pathway. To
determine whether PumA was targeting two different types of cellu-
lar compartments, one with UBAP1 controlling the TNFR pathway
and another containing TLR adaptors, we analysed whether UBAP1
was excluded from TIRAP and MyD88 containing compartments.
We first analysed their intracellular localization following transfec-
tion as we were not able to detect endogenous UBAP1 with
currently available antibodies. Extensive co-localization was
observed at the plasma membrane and intracellular structures when
co-expressing UBAP1 and TIRAP (Fig 7A), with no visible impact
on the normal distribution of TIRAP. However, in the case of
MyD88, co-expression with UBAP1 resulted in accumulation of this
adaptor at the plasma membrane, not seen in cells expressing
MyD88 alone (Fig 7A, bottom panel and B). Quantification of
membrane enrichment of MyD88 in cells expressing UBAP1 showed
MyD88 membrane association was even more striking in the pres-
ence of UBAP1 (Fig 7C) than that observed when co-expressing
TIRAP with MyD88 (Kagan & Medzhitov, 2006), suggesting UBAP1
could be participating in MyD88 intracellular sorting.
To determine whether UBAP1 could be interacting with these
TLR adaptors, we carried out biochemical analysis of cells co-
expressing UBAP1 and either TIRAP or MyD88. We could efficiently
detect an interaction between UBAP1 and MyD88 by co-IP
(Appendix Fig S5D and E) but not UBAP1 and membrin
(Appendix Fig S5E), used as a control eukaryotic protein with the
same tag. In the case of TIRAP, the co-IP was much less efficient
(Appendix Fig S5D). These results suggest that UBAP1 may be
associated with MyD88-containing compartments and to a lesser
extent TIRAP, consistent with our microscopy observations. To
confirm these results and ensure these interactions were taking
place with UBAP1 in the context of the ESCRT-I, we determined
whether MyD88 and TIRAP could interact with endogenous UBAP1
and TSG101. We found that HA-MyD88 co-immunoprecipitated
both components of the ESCRT-I as well as endogenous TIRAP
(Fig 7D), as expected. However, we did not observe an interaction
between HA-TIRAP and endogenous UBAP1 nor TSG101 (Fig 7E),
suggesting that only MyD88 can be found associated with the
ESCRT-I.
Overall, these data suggest that PumA mediates interactions with
UBAP1 in the context of ESCRT-I, which can itself associate with the
TLR adaptor MyD88, also targeted by this P. aeruginosa effector
protein.
Pseudomonas aeruginosa PA7 induces a decrease of TNFR1 in a
PumA-dependent manner during infection in vitro
It is well described in the literature that inhibition of UBAP1 induces
intracellular accumulation of EGFR, LTbR and TNFR1 (Stefani et al,
2011; Maminska et al, 2016). To establish a link between PumA
interaction with UBAP1 and the ability of PumA to reduce TNFa-
dependent signalling (Fig EV5A), we analysed the levels of TNFR1
during infection. In wild-type PA7 infected A549 cells, we observed
a decrease of TNFR1 compared to the negative control (Fig 7F). In
contrast, the mutant lacking PumA was not able to reduce the levels
of TNFR1 in infected cells and this phenotype could be fully restored
by expression of PumA in the complemented strain. This is consis-
tent with PumA targeting of UBAP1 and enhancing its activity
during infection in vitro. Interestingly, we did not see any impact on
the overall levels of TIRAP during infection (Fig 7F) suggesting that
PumA is not inducing TIRAP degradation as was previously
reported for BtpA (Sengupta et al, 2010).
Discussion
Many pathogens have developed sophisticated strategies to evade or
modify host immune responses to their advantage. We have found
that the TIR domain-containing protein PumA plays a major role in
the virulence of multi-drug resistant P. aeruginosa PA7 strain.
PumA ensures efficient inhibition of innate immune responses by
interacting with MyD88 and TIRAP, key adaptor proteins for IL-1R
and the main relevant TLRs in Pseudomonas infection (TLR4 and
TLR5), as well as UBAP1 which regulates cytokine receptor path-
ways. These results identify UBAP1 as a novel cellular target for
bacterial pathogens.
Pseudomonas aeruginosa is an important human pathogen asso-
ciated with high level of mortality in nosocomial infections and
cystic fibrosis patients. Most P. aeruginosa strains rely on a multi-
tude of virulence factors to control host cellular pathways, including
effectors delivered by the T3SS. However, in a cystic fibrosis
context, colonizing strains modulate levels of expression of some of
these virulence factors (Hauser et al, 2011), namely down-
regulation of the T3SS (Jain et al, 2004) and undergo a remarkable
accumulation of pathoadaptive mutations (Marvig et al, 2014). The
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Figure 6. Identification of UBAP1 as a novel host protein targeted by the bacterial TIR domain of PumA.
A, B Co-immunoprecipitation (co-IP) assay from cells expressing Myc-UBAP1 (A) or Strep-UBAP1 (B) with either GFP, GFP-PumA or TIRAP-GFP. The co-IPs were revealed
using an anti-Myc (A) or anti-UBAP1 (B) antibodies, the fractions bound to GFP-trapping beads using an anti-GFP antibody and the inputs using anti-Myc, anti-
GFP or anti-UBPA1 antibodies as indicated.
C Pull-down assay using extracts from cells expressing Strep-UBAP1 against His-PumA or His-PumA1–136 immobilized on a Ni-NTA resin. Empty column was used as
a control for non-specific binding. Interactions were visualized by Western blotting using anti-UBAP1 antibody, and column binding with anti-His (middle blot),
followed by anti-V5 (lower blot), necessary for detection of BtpA, which for reasons we do not understand cannot be easily detected with the anti-His antibody
(Appendix Fig S5B).
D–F Endogenous co-IP from cells expressing (D) HA-PumA, (E) HA-PumA1–136 and (F) HA-PumA137–303. The fractions bound to HA-trapping beads were probed with anti-
HA, anti-UBAP1, anti-TIRAP and anti-TSG101 antibodies. Non-bound fraction (FT), last wash (W) and elution (E) are shown for each sample and the molecular
weights indicated (kDa).
Source data are available online for this figure.
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PA7-related P. aeruginosa strains lack the 20-Kb-long genomic
region encoding the T3SS core components and all genes encoding
secreted effectors but contains several additional genomic islands
and potential novel virulence factors (Pirnay et al, 2009; Roy et al,
2010; Cadoret et al, 2014; Freschi et al, 2015). In some of these
strains, such as CLJ1, an exolysin secreted by a two-partner secre-
tion system is responsible for hypervirulence (Elsen et al, 2014).
However, in PA7, this exolysin is detected at only low levels in the
secretome and is not responsible for cytotoxicity (Reboud et al,
2016), suggesting an alternative pathogenicity mechanism. In this
context, we hypothesize that PumA might be underlying an alterna-
tive pathogenicity mechanism to allow PA7 persistence within a
host. Consistently, we observed a clear attenuation in virulence for
a PA7 strain lacking pumA in both C. elegans and in a mouse lung
infection model. Interestingly, no impact in the ability of the pumA
mutant to disseminate systemically was observed suggesting a role
in control of local pathology. This type of P. aeruginosa infection
based on persistence and colonization rather than rapid cytotoxicity
could be relevant in specific clinical contexts such as infection of
wound and burn patients, aggravated by the high level of multi-drug
resistance. It is interesting to note that other Pseudomonas contain a
TIR domain protein, namely several strains pathogenic in plants. In
this context, it will be interesting to analyse the role of the ortholo-
gous TIR protein in the plant pathogens P. syringae or P. viridiflava
with over 90% identity to PumA in amino acid sequence for the TIR
domain, regarding control of plant responses as these functions may
be relevant across taxonomic kingdoms.
Pseudomonas is not the only bacterial pathogen to take advan-
tage of the TIR domain to engage TIR–TIR interactions which are
essential components of innate immune signalling. Bacterial target-
ing of TLRs has been best described for uropathogenic E. coli TcpC
(Cirl et al, 2008) and Brucella BtpA, also known as TcpB (Cirl et al,
2008; Salcedo et al, 2008), even though their molecular mode of
action remains elusive. Brucella relies on an additional TIR protein,
BtpB to down-modulate inflammation during infection (Salcedo
et al, 2013). TcpC was shown to interfere with MyD88-dependent
and independent pathways to down-modulate TLR signalling and
contribute to kidney pathology (Cirl et al, 2008; Yadav et al, 2010).
In the case of Brucella, BtpA/TcpB has been described as a mimic of
TIRAP, since it can directly bind specific phosphoinositides of the
plasma membrane (Radhakrishnan et al, 2009). This is clearly
distinct from PumA that shows no significant lipid binding proper-
ties. In addition, BtpA/TcpB was also shown to bind TIRAP, which
results in its increased ubiquitination and degradation during
infection (Sengupta et al, 2010), which also differs from PumA
which despite TIRAP binding does not induce its degradation.
Several studies have followed disputing the precise target of BtpA/
TcpB with some proposing preferential binding to MyD88 (Chaud-
hary et al, 2011). One key question that remains unanswered is
how these bacterial TIR proteins are entering host cells and where
do they localize during infection? No direct imaging of bacterial
TIR proteins has been described. In the case of TcpC, internaliza-
tion into host cells was observed but the export mechanism was
not identified (Cirl et al, 2008), whereas no data are available
regarding Salmonella, Yersinia, Staphyloccocus and Enteroccoccus.
In the case of Brucella, depending on the fusion tags, translocation
into host cells of BtpA/TcpB or BtpB was dependent or indepen-
dent of the T4SS (Salcedo et al, 2013) whereas a separate group
has proposed that BtpA/TcpB is cell permeable and may enter host
cells in a passive manner (Radhakrishnan & Splitter, 2010). Unfor-
tunately, PumA fusion with CyaA resulted in its cleavage prevent-
ing us from using this system. Using different fluorescent tags and
the specific anti-PumA antibody, we were not able to confidently
visualize it inside host cells during infection. We were however
able to detect intracellular PumA using a TEM1 fusion. Further
work needs to be carried out to confirm translocation of PumA
into host cells and define the intracellular location of PumA during
infection. PumA was also not found in the bacterial culture super-
natant in vitro, suggesting that contact-dependent delivery is
involved. How PumA is entering host cells will have to be further
investigated, but since the T3SS is not present in PumA-encoding
strains, it suggests that host cell delivery would need an alternative
secretion pathway.
It is important to note that TIR domains are widespread in multi-
cellular organisms, such as in plants (role in disease resistance) and
amoebas (dual role in ingestion of bacteria and immune-like func-
tions) as well as in numerous bacterial genera that include
cyanobacteria and other non-pathogenic bacteria (Zhang et al,
2011). This suggests these domains have evolved as an essential
protein–protein interaction platform that could have additional func-
tions. Indeed, recently the TIR domain of TcpC has been shown to
directly interact with the NACHT leucin-rich repeat PYD protein 3
(NLRP3) inflammasome and caspase-1, besides MyD88, to perturb
inflammasome activation (Waldhuber et al, 2016). There are also
additional potential targets yet to be identified for BtpA/TcpB since
it interferes with microtubule dynamics (Radhakrishnan et al, 2011;
Felix et al, 2014) and induces unfolded protein response (Smith
et al, 2013).
◀ Figure 7. Analysis of the impact of UBAP1 on TIRAP and MyD88.A Representative micrographs obtained by confocal microscopy of HeLa cells co-expressing Myc-UBAP1 (red) and adaptor proteins HA-TIRAP (green, top panel) or
HA-MyD88 (green, bottom panel). Cells were fixed after 10 h of transfection. Scale bars correspond to 10 lm.
B Different zoomed images showing HA-MyD88 (green) recruitment to the plasma membrane in the presence of Myc-UBAP1 (red). Scale bars correspond to 10 lm.
C Quantification of plasma membrane localization of MyD88 in cells expressing MyD88 alone or with either UBAP1, TIRAP or PumA. At least 200 cells were
enumerated in three independent experiments, and membrane localization was defined under the strict criteria of clear line at the plasma membrane. Cells with
MyD88-positive vesicles in close proximity to the plasma membrane were not counted as positive. Non-parametric one-way ANOVA Kruskal–Wallis test was
performed, with Dunn’s multiple comparisons test. **P < 0.01.
D, E Endogenous co-IP from cells expressing (D) HA-MyD88 and (E) HA-TIRAP. The fractions bound to HA-trapping beads were probed with anti-HA, anti-UBAP1, anti-
TIRAP and anti-TSG101 antibodies. Non-bound fraction (FT), last wash (W) and elution (E) are shown for each sample and the molecular weights indicated (kDa).
F Western blot of TNFR1 in A549 cells infected for 1 h with either P. aeruginosa PA7 wt, ΔpumA or ΔpumA:pumA (Ara) induced with 1% arabinose. A mock-infected
sample was included as a negative control. The same blot was also probed for TIRAP and actin to control loading.
Source data are available online for this figure.
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This notion that bacterial TIR domains provide a broad inter-
action platform is supported by our observations. We found that
in addition to directly interacting with TIRAP and MyD88, PumA
also targets the ESCRT-I machinery by binding to UBAP1 as
PumA could co-immunoprecipitate endogenous UBAP1 and
TSG101. All these interactions seem to be mediated by the TIR
domain of PumA, but endogenous co-IP experiments showed that
the full-length PumA is required for efficient interactions to occur.
It is likely that TIR–TIR interactions are taking place with TIRAP
and MyD88. In the case of UBAP1, the PumA interacting domain
remains to be identified. All yeast two-hybrid preys identified in
our screen encoded for a region containing amino acid 45–164,
present between two key functional domains: the N-terminal
UBAP1-MVB12-associated (UMA) domain (residues 17–63) that
binds the central stalk of ESCRT-I Vps37 and the central domain
(residues 159–308), containing the recently identified key binding
site for HDPTP which can act as a cargo adaptor (Gahloth et al,
2016). The C-terminal portion of UBAP1 includes a SOUBA
domain (residues 381–502) known to bind ubiquitin (Agromayor
et al, 2012). UBAP1 is a key component of ESCRT-I that enables
sorting of ubiquitinated cargo on MVBs. PumA may be binding
an intermediate region of UBAP1 that could partially overlap with
that interacting with HDPTP. Further work is now necessary to
confirm this hypothesis. In view of the recent work implicating
UBAP1 in restriction of constitutive NF-jB signalling (Maminska
et al, 2016), PumA could be impacting the activation of TNFR
pathway through UBAP1. Depletion of UBAP1 was shown to
induce intracellular accumulation of the cytokine receptors in
endosomal compartments (Maminska et al, 2016), which leads to
increase in constitutive levels of NF-jB, since UBAP1 cannot
ensure proper steady-state cytokine receptor (such as LTbR and
TNFR1) sorting and subsequent degradation. Since in vitro experi-
ments suggest PumA is blocking TNF receptor-mediated pathway,
PumA could be enhancing activity of UBAP1. This phenotype is
specific of PumA since we observed no effect of another bacterial
TIR domain-containing protein BtpA/TcpB which does not interact
with UBAP1 and its ectopic expression does not result in inhibi-
tion of the TNF-induced pathway. Consistent with our hypothesis,
wild-type PA7 decreases the levels of TNFR1 in A549 cells in a
PumA-dependent manner suggesting targeting of UBAP1 is occur-
ring during infection and could enhance its activity.
In an attempt to determine whether distinct intracellular locations
were targeted by PumA to enable interaction with TLR adaptors and
the ESCRT-I component UBAP1, we analysed whether UBAP1 was
excluded from TIRAP or MyD88-enriched compartments. Surpris-
ingly, co-IP experiments revealed endogenous UBAP1 itself and
TSG101 could be found associated with MyD88 but not TIRAP,
suggesting that the ESCRT-I machinery may be interacting with
specific TLR adaptors. We therefore propose that additional crosstalk
between these pathways may exist. MyD88 has been shown to inter-
act with TLRs and with TIRAP via its TIR domain or the death
domain. It remains to be demonstrated whether UBAP1 interacts
directly with MyD88 but our data strongly suggest they can be found
in the same complex, namely at the plasma membrane. Interestingly,
co-expression of MyD88 and UBAP1 resulted in MyD88 enhanced
plasma membrane targeting, to higher levels than that previously
described for TIRAP (Kagan & Medzhitov, 2006). Further work is
required to determine if UBAP1 interaction with MyD88 promotes
activation of TLR signalling and whether PumA could disrupt this
interaction. A few studies have suggested the implication of ESCRT-I
or MVBs in the control of TLR pathways. In Drosophila, ESCRT-0
components modulate endosomal sorting of Toll (Husebye et al,
2006; Huang et al, 2010). ESCRT have been also shown to negatively
regulate TLR7 and 9 to enable recycling of these receptors following
ubiquitination (Chiang et al, 2012). More interestingly, inhibition of
endosomal sorting via ESCRT-I increases LPS-induced signalling
(Husebye et al, 2006), suggesting it is playing a role in sorting and
degradation of activated receptor complexes.
In conclusion, our study describes a P. aeruginosa effector PumA
that targets UBAP1 in the context of ESCRT-I and plays a major role
in virulence. In addition, our data associate UBAP1 to MyD88, high-
lighting a potential larger role of endosomal sorting by ESCRT-I in
regulation of TLR signalling.
Materials and Methods
Strains
Pseudomonas aeruginosa strains used in this study were wild-type
PA7, PA14 or derived strains and were routinely cultured in liquid
Luria Bertani (LB) medium. Antibiotics were added to P. aeruginosa
cultures, when appropriate, at the following concentrations: 150 lg/
ml tetracycline and 750 lg/ml carbenicillin. When indicated, arabi-
nose at 1% or glucose at 0.5% was added to cultures. For Escheri-
chia coli cultures, antibiotics were added when necessary at
the following concentrations: 50 lg/ml kanamycin and 50 lg/ml
ampicillin.
Construction of Pseudomonas DpumA mutant and
complemented strains
The 500 base pairs upstream and 500 base pairs downstream of
pumA gene (PSPA7_2375; NC_009656.1.) were amplified from
P. aeruginosa PA7 genomic DNA to do overlapping PCR, using
primers 50-TTTGGGCCCAAGACGATCAGCGGCACC-30, 50-ATCGGCT
CTGCCCTATGCCATCTTTTTAACTCCATCCTTGTAATTCC-30, 50-GG
ATGGAGTTAAAAAGATGGCATAGGGCAGAGCCGAT-30 and 50-TT
TTGATCACAACTACCCCGATGCGTT-30, respectively. Then, the PCR
product was sub-cloned into pGEM-T Easy Vector (PROMEGA)
and ligated into pKNG208 (Cadoret et al, 2014) following digestion
with SpeI and ApaI to generate pKNG208-ΔpumA. This plasmid was
introduced into P. aeruginosa PA7 by conjugation where it is inca-
pable of autonomous replication. Homologous recombination events
were primary selected using tetracyclin resistance (150 lg/ml) in
Pseudomonas isolation agar (PIA) plates and secondary selected
using sucrose 6% sensitivity in LB agar plates during 2–3 days at
room temperate. PCR and sequencing analyses confirmed the pumA
wild-type gene was deleted and Western blotting showed absence of
PumA production of the PA7 ΔpumA strain (Appendix Fig S2B).
The mini-CTX-PBAD plasmid was constructed by cloning the SalI-
AraC-PBAD-SacI fragment from pJN105 vector (Newman & Fuqua,
1999) into the 6711 bp SalI/SacI DNA fragment from miniCTX-lacZ
vector (Hoang et al, 1998). PSPA7_2375 gene was amplified with an
artificial Shine-Dalgarno (AAGAAG) and cloned into mini-CTX-PBAD
digested by SpeI/SacI using the SLIC method (Jeong et al, 2012).
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Primers used were 50-AGCCCGGGGGATCCACTAGTAGGAGGTGA
GATATACAATGGCGGTCTTCATTAGTTA-30 and 50-ACCATCCAGT
GCAGGAGCTCCTATGCGCGCGGCCACGGG-30.
Construction of PA7 pumA::bla1 strain
The 500 base pairs upstream and downstream of pumA stop codon
from P. aeruginosa PA7 genomic DNA and blaM gene from pJC121
plasmid (Myeni et al, 2013) were PCR amplified using primers
50-ATTACGCGTTAACCCGGGCCCAGGATGTTGACGGCTATC-30, 50-
CAGCGTTTCTGGTGCGCGCGGCCACGG-30, 50-CTGATTAAGTAGGG
CAGAGCCGATCAGCTC-30, 50-ACACTGGCGGCCGTTACTAGTGCTG
GACTGGCGCAACTA-30, 50-TGGCCGCGCGCACCAGAAACGCTGGT
GAAA-30 and 50-ATCGGCTCTGCCCTACTTAATCAGTGAGGCACC
T-30 and used in overlapping PCR. DNA product was then cloned by
the SLIC method (Jeong et al, 2012) into pKNG208 (Cadoret et al,
2014) digested by ApaI/SpeI to generate pKNG208-pumA::bla1
vector.
Construction of eukaryotic expression vectors
The PumA constructs were obtained by cloning in the gateway
pDONRTM (Life Technologies) and then cloned in the pENTRY Myc,
HA or GFP vectors. The following primers were used 50-GGGGA
CAAGTTTGTACAAAAAAGCAGGCTTCGCGGTCTTCATTAGTTATT
CCCACG-30 and 50-GGGGACCACTTTGTACAAGAAAGCTGGGTCC
TATGCGCGCGGCCACGGGGTAGC-30. PumA1–136 was constructed
with the following primers: 50-GGGG ACAAGTTTGTACAAAAAA
GCAGGCTTCATGGCGGTCTTCATTAGTTATTCC -30; 50-GGGGACCA
CTTTGTACAAGAAAGCTGGGTCCTAACGGGACTGATCAGGATTAG
AG-30. PumA137–303 with 50-GGGGACAAGTTTGTACAAAAAAGCA
GGCTTC ATTGAGGATGTTGACGGCTA-30; 50-GGGGACCACTTTG
TACAAGAAAGCTGGGTC CTATGCGCGCGGCCACGGGGTAGC -30.
Construction of prokaryotic expression vectors
The full-length P. aeruginosa PA7 pumA and its TIR domain (resi-
dues 1–136) were cloned into pET151/D-Topo (Invitrogen)—which
carries the T7 promoter, N-terminal 6xHis and V5 tags, protease
recognition site for tobacco etch virus (TEV) protease and ampicillin
resistance gene. The following primers were used: 50-CAC
CATGGCGGTCTTCATTAGTTATTCC-30 and 50-TGATCGGCTCT
GCCCTATGC-30 for pumA; the same forward primer and 50-
CTAACGGGACTGATCAGGATTAGAG-30 for pumA TIR domain.
BtpA was cloned in this same vector. The HA-TIRAP and HA-Myd88
vector was used as a template to clone TIRAP and Myd88, respec-
tively, into pRSF-MBP vector. This vector corresponds to pRSFDuet-1
(Novagen) but modified to insert 6xHis-MBP from pETM-41 vector
(EMBL) behind the cloning multiple site.
Cell culture and transfections
HeLa, HEK 293T and A549 cells (all obtained from ATCC) were
grown in DMEM supplemented with 10% of foetal calf serum (FCS).
Mouse embryonic fibroblasts were prepared as described previously
(Conner, 2001) and maintained in DMEM supplemented with 10%
(FCS). All cells were transiently transfected using Fugene (Roche)
for 24 h, according to manufacturer’s instructions.
Pseudomonas infection of A549 cells
For adhesion assays and microscopy analysis of NF-jB, cells were
first seeded into 24-well tissue culture plates at 2 × 105 cells/well (to
obtain a monolayer) or 5 × 104 cells/well, respectively. Cells were
infected with overnight cultures at a MOI of 10 or 100 of P. aerugi-
nosa in 500 ll of complete medium per well. Plates were centrifuged
at 400 × g for 5 min and then incubated for 1 h at 37°C with 5% CO2
atmosphere. Cells were then washed five times with DMEM and
either lysed or fixed. In the case of the cytotoxicity assays, cells were
incubated for longer periods with complete media. When indicated,
arabinose at 1% or glucose at 0.5% was added.
For NF-jB experiments, exponential phase cultures were also
used, but no differences were detected. After 1 h, medium was
removed and cells were washed two times with ice-cold PBS. Control
samples were always performed by incubating cells with mock inoc-
ula and following the exact same procedure as for the infection.
For adhesion assays, cells were lysed with 500 ll of 0.1% Triton
solution and pipetted vigorously several times. Lysed samples were
harvest, and serial 10-fold dilutions in PBS were plated on LB agar
to enumerate CFUs.
For Western blot analysis of TNFR1, cells were seeded in six-well
plates at 2 × 105 cells/well and infected as described above. At 1 h
post-infection, cells were washed with ice-cold PBS 2 times, were
collected and lysed directly with loading buffer. For each sample,
six wells were pooled.
Cell cytotoxicity exerted by bacteria was quantified with the cyto-
toxicity detection kit-LDH (Roche), which measures the activity of
cellular lactate dehydrogenase released into the supernatants. The
assays were performed according to the instructions of the manufac-
turer.
For propidium iodide staining, A549 cells were maintained in
DMEM media supplemented with 10% FCS. Cells were seeded at
1 × 105 cells/ml in 96-well plate to achieve confluent monolayers.
Cells were then infected with overnight cultures of P. aeruginosa or
mutants supplemented with arabinose to a final concentration of 2%
(as indicated) at a MOI of 100. The plates were centrifuged at 400 × g
for 5 min and incubated for 1 h at 37°C. After 1 h of infection, cells
were washed three times with PBS then incubated with complete
media (without red phenol) containing propidium iodide and labelling
measured during 6 h every 15 min with a Tecan Infinite M1000.
Immunofluorescence labelling and microscopy
Cells were fixed in Antigenfix (DiaPath), at room temperature for
10 min. Cells were then labelled at RT with primary antibody mix
diluted in 0.1% saponin in PBS with 1% BSA and 10% horse serum
for blocking. Primary antibody was incubated for 1 h followed by
two washes in 0.1% saponin in PBS. Secondary antibodies were
then mixed and incubated for a further 30 min, followed by two
washes in 0.1% saponin in PBS, one wash in PBS and one wash in
distilled water before mounting with Prolong Gold. Samples were
examined on a Zeiss LSM710 or Zeiss LSM800 laser scanning confo-
cal microscopes for image acquisition. Images of 1,024 × 1,024
pixels were then assembled using plugin FigureJ from ImageJ.
For immunofluorescence microscopy analysis of NF-jB, cells
were permeabilized for 6 min with 0.1% Triton in PBS, followed by
a blocking for 1 h with 2% BSA in PBS. Primary antibodies were
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incubated for 1 h followed by two washes in 2% BSA in PBS, 30-
min incubation for secondary antibodies, two washes in 2% BSA in
PBS, one wash in PBS and one wash in water before mounting with
Prolong Gold (Life Technologies). Samples were examined on a
Zeiss LSM710 laser scanning confocal microscope for image acquisi-
tion. Images of 2,648 × 2,648 pixels were then passed through a
specific plugin of ImageJ developed by L. Plantevin, based on a
previous study (Noursadeghi et al, 2008); raw images were treated
with a median filter and threshold moments, afterwards total NF-jB
was subtracted from the Dapi channel to obtain cytoplasmic NF-jB.
Total NF-jB was then subtracted from cytoplasmic NF-jB to obtain
nuclear NF-jB (Fig EV1A). Quantification was always done by
counting at least 200 cells per condition in minimum three indepen-
dent experiments, for a total of at least 600 host cells analysed per
condition.
Antibodies and reagents
Primary antibodies used were rabbit anti-p65 from Santa Cruz (clone
C-20, ref. sc-372) at 1/250, mouse anti-myc9E10 (developed by
Bishop, J.M. was obtained from the Developmental Studies Hybri-
doma Bank, created by the NICHD of the NIH and maintained at the
University of Iowa), mouse anti-HA (Eurogentec, clone 16B12, ref.
MMS-101R), rabbit anti-HA (Sigma, ref. H6908), rabbit anti-GFP
(Amsbio, ref. TP401), rabbit anti-UBAP1 (Proteintech, ref. 12385-1-
AP), mouse anti-His (Sigma, clone HIS-1, ref. H1029), mouse anti-
FLAG (Sigma, clone M2, ref. F1804) all at 1/1000 and mouse anti-
TNFR1 (Santa Cruz, clone H-5, ref. sc-8436) and rabbit anti-TSG101
(Atlas Antibodies, ref. HPA006161) both at 1/200. Rabbit polyclonal
anti-PumA serum was obtained by repeated immunization of rabbits
with purified PumA (Eurogentec) and was used at 1/1,000 for
Western blot and for immunofluorescence microscopy. Purified BtpA
was used to obtain chicken anti-BtpA (Eurogentec). Anti-EF-Tu anti-
body (kind gift from R. Voulhoux) was used at 1/10,000.
Secondary antibodies used were anti-rabbit, mouse, chicken or
rat conjugated with Alexas-488, -555 or -647 all from Jackson
ImmunoResearch. When necessary, phalloidin-568 (1/1,000) was
used to label the actin cytoskeleton and DAPI nuclear dye (1/1,000)
for the host cell nucleus. For Western blots, anti-mouse or rabbit-
HRP antibodies were used at 1/5,000.
TEM translocation assay
HeLa cells were seeded in a 96-well plates at 1 × 104 cells/well
overnight. Cells were then infected with an MOI of 100 by
centrifugation at 4°C, 400 g for 5 min and 1 at 37°C 5% CO2.
Cells were washed with HBSS containing 2.5 mM probenecid.
Then, 6 ll of CFF2 mix (as described by Life Technologies proto-
col) and 2.5 mM probenicid were added to each well, and incu-
bated for 1.5 h at room temperature in the dark. Cells were
finally washed with PBS, fixed using Antigenfix and analysed
immediately by confocal microscopy (Zeiss LSM800) or flow
cytometry (MACSQuant10 analyser).
Luciferase activity assay
HEK 293T cells were seeded in a 96-well plates at 2 × 104 cells/well
overnight, and cells were transiently transfected with FuGENE 6
(Promega) for 24 h for a total of 0.4 lg of DNA consisting of 50 ng
TLR plasmids, 200 ng of pBIIXLuc reporter plasmid, 5 ng of control
Renilla luciferase (pRL-null, Promega) and 50 ng of myc-PumA
expression vector. The total amount of DNA was kept constant by
adding empty vector. Where indicated, cells were treated with
E. coli LPS (1 lg/ml) and Flagellin FLA-ST (1 lg/ml), all obtained
from InvivoGen, for 6 h. In the case of IL-1b and TNFR, endogenous
receptors were stimulated with IL-1b (100 ng/ml) and TNFa
(100 ng/ml), respectively. Cells were then lysed and luciferase
activity measured using Dual-Glo Luciferase Assay System
(Promega).
Yeast two-hybrid screen
Full-length pumA cloned in pB27 (N-LexA-bait-C fusion) was used
in a ULTImate screen against a human normal lung-RP1 library
(Hybrigenics).
Protein expression and purification
Escherichia coli BL21 star (DE3) cells carrying pET151D topo-pumA,
pET151D topo-pumA1–136, or pRSFDuet-TIRAP or MyD88 plasmids
were grown in 1 L Luria Bertani (LB) media containing ampicillin or
kanamycin according to the plasmid at 37°C until an OD600 value of
0.5–0.8 was reached. Isopropyl-b-D-thiogalactopyranoside (IPTG)
was added to final concentration of 1 mM, and culture was further
grown overnight at 20°C. Cells were harvested by centrifugation at
6,000×g for 20 min at 4°C.
Bacterial pellets were lysed by sonication in cold lysis buffer
(40 mM Tris–HCl pH8, 250 mM NaCl, 10% (v/v) glycerol, 1%
(v/v) Triton X-100) supplemented with DNase-I, lysozyme and
protease inhibitor tablets (Roche). Extracts were cleared at
16,000 × g for 20 min at 4°C and loaded onto a 5 ml His-Trap
column or 5 ml MBP-Trap column (GE Healthcare) pre-equilibrated
with buffer A (40 mM Tris [pH8], 250 mM NaCl, 5% glycerol). The
column was washed successively with buffer A, 10% v/v buffer B
(buffer A with 500 mM imidazole), 1M NaCl and eluted in a gradi-
ent of buffer B (His-Trap) or wash in buffer A and eluted in buffer A
containing 20 mM maltose (MBP-Trap).
Proteins used for lipid binding assay were incubated with TEV
protease, 1mM DTT and 0.5 mM EDTA, dialysed against buffer A at
4°C overnight. The untagged recombinant protein was purified
through a second His-trap column. Pure fractions were pooled,
concentrated and applied to size exclusion chromatography
(Superdex 75 10/300; GE Healthcare).
Fractions were analysed by SDS–PAGE.
Pull-downs from cell extracts
Human embryonic kidney (HEK) 293T cells were seeded at
5 × 105 in 10-cm cell culture dish in Dulbecco’s modified Eagle’s
medium (Life Technologies) supplemented with 10% foetal
bovine serum. Cells were incubated overnight in a 37°C humidi-
fied atmosphere of 5% CO2. Cells were transiently transfected
with different plasmids (8 lg) using FuGENE 6 (Promega). 22 h
after infection, cells were washed in ice-cold PBS, harvested and
resuspended in 200 ll of RIPA buffer (Sigma) supplemented with
phenylmethylsulfonyl fluoride (Sigma) and protease inhibitor
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cocktail (Roche). Extracts were then centrifuged at 17,000 g at
4°C for 20 min. The supernatant was incubated with 50 lg of
His tag recombinant protein during 2 h at 4°C, then incubated
within gravity flow column (Agilent) containing 80 ll Ni-NTA
agarose beads (Macherey-Nagel) during 1 h beforehand washed
in water and pre-equilibrated in equilibrium buffer 20 mM Tris–
HCl pH7.5, 250 mM NaCl. The column was washed successively
three times in equilibrium buffer supplemented with 25 mM
imidazole, three times in equilibrium buffer and eluted in equi-
librium buffer supplemented with 500 mM imidazole. Proteins
eluted were separated by SDS–PAGE, transferred to a PVDF
membrane, incubated with specific primary antibodies for 1 h
and detected with horseradish peroxidase (HRP)-conjugated
secondary antibodies by using ClarityTM Western ECL Blotting
Substrate (Bio-Rad).
Co-immunoprecipitations
HEK 293T cells were cultured in 100 mm × 20 mm cell culture
dishes at 4 × 105 cells/dish overnight. Cells were transiently trans-
fected with 14.7 ll of Torpedo DNA (Ibidi) for 24 h for a total of 5 lg
of DNA/plate. On ice, after two washes with cold PBS, cells were
collected by with a cell scraper and centrifuged at 80 g at 4°C during
5 min. Cell lysis and processing for co-immunoprecipitation were
done as described by either GFP-Trap_A kit (Chromotek) or with
the PierceTM HA Epitope Antibody Agarose conjugate (Thermo
scientific).
For endogenous co-IP, HeLa cells were cultured in
100 mm × 20 mm cell culture dishes at 1 × 106 cells/dish over-
night. Cells were transiently transfected and collected as described
above. Cell lysis and processing for co-immunoprecipitation were
done following the manufacturers’ instructions (PierceTM HA
Epitope Antibody Agarose conjugate, Thermo scientific) but using
100 ll of beads and increasing the number of washes to 5.
Co-expression analysis
Escherichia coli BL21 star (DE3) cells harbouring both pET151D
topo-pumA1–136 and pRSF-Duet vector-TIRAP (or Myd88 or empty
vector) plasmids were grown in LB media containing ampicillin
and kanamycin at 37°C until an OD600 value of 0.5–0.8 and
induced with 2 mM isopropyl-b-D-thiogalactopyranoside overnight
at 20°C.
Cells were lysed and loaded onto a 5 ml MBP column as
described in the protein expression and purification section.
Fractions were analysed by SDS–PAGE.
Lipid binding assays
Lipid binding assays were performed as described previously
(Marek & Kagan, 2012). Briefly, phosphoinositide phosphate (PIP)
strips (Echelon Biosciences) were saturated in blocking buffer
(10 mM Tris [pH8], 150 mM NaCl, 0.1% Tween 20, 0.1% Ovalbu-
min) for 1 h at room temperate under shacking. Strips were probed
for 2 h at room temperate with each recombinant protein (2.5 lg)
in the presence of the specific anti-protein antibody. PIP strips were
then washed in blocking buffer three times for 10 min each and
probed with an HRP-conjugated anti-rabbit IgG or anti-Hen IgY for
30 min in blocking buffer. Bound protein was detected using
ClarityTM Western ECL Blotting Substrate.
Caenorhabditis elegans infection
The slow killing assay was performed as described previously
(Garvis et al, 2009). Each independent assay consisted of three
replicates. Briefly, five 60 mm NGM plates were inoculated with
60 ll of overnight culture of each bacterial strain and incubated
at 37°C overnight. Plates were seeded with L4 stage hermaphro-
dite fer-15 worms (10 per plate). Plates were then incubated at
25°C and scored each day for live worms. A worm was consid-
ered dead when it no longer responded to touch. Escherichia coli
was used as a control. Animal survival was plotted using
GraphPad Prism version 6.0 for Mac, GraphPad Software, La
Jolla, California, USA. Survival curves are considered signifi-
cantly different from the control when P-values are < 0.05. Prism
calculates survival fractions using the product limit (Kaplan–
Meier) method. Prism compares survival curves by two methods:
the log-rank test (also called the Mantel–Cox test) and the
Gehan–Breslow–Wilcoxon test.
Mouse model of Pseudomonas acute infection
Wild-type C57BL6/J male mice, 8–10 weeks old, were purchased
from Janvier laboratories. Mice were randomized before the experi-
ments and infection were performed blindly. Following a light
anaesthesia with isoflurane (Baxter), a pulmonary infection model
was induced by intranasal instillation with 3 × 107 CFU of P. aerugi-
nosa PA7 or PA7DpumA strains (except for survival studies
conducted with lethal inocula of 4 × 107 CFU/mouse). All mice
were sacrificed at 24 h or survival was monitored for 96 h.
To establish bacterial burden, mouse lungs and spleens were
homogenized in sterile tubes with PBS. Lung and spleen homoge-
nates were sequentially diluted and cultured on Lysogeny Broth
agar plates for 24 h at 37°C to assess bacterial load. Bronchoalveolar
lavage (BAL) was done as follows: lungs from each experimental
group were washed with a total of 1.5 ml sterile phosphate-buffered
saline (PBS). The recovered lavage fluid was centrifuged (200 g for
10 min), and red blood cells from the cellular pellet were lysed with
300 ll of ACK Lysis Buffer (Gibco). Cell counts were performed
directly by optical microscopy.
Ethics statement
All experiments involving animals were carried out in compliance
with French and European regulations on the care and protection of
laboratory animals (European Commission Directive 86/609 and the
French Act #2001–486, issued on June 6, 2001) and performed by
certified personnel. The study and all experimental protocols associ-
ated were registered and approved by the French authorities (Min-
iste`re de l’Enseignement Supe´rieur et de la Recherche—Direction
Ge´ne´rale pour la Recherche et l’Innovation—Secre´tariat Autorisa-
tion de projet, registration number 00481.01). Animals were housed
at the Lille University Animal Research Facility (De´partement Hospi-
talo-Universitaire de Recherche Expe´rimentale de Lille, France)
accredited by the French Ministry of Agriculture for animal care and
use in research (#B59–350009).
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Fractionation of Pseudomonas aeruginosa
Pseudomonas aeruginosa strains were grown in LB for 4 h and
adjusted to OD600 20 in 1 ml cold 50 mM Tris–HCl pH 8.0 with
1 mM EDTA and protease inhibitors (Roche). All subsequent steps
were conducted at 4°C. The cell samples were sonicated three times
at 30-s intervals, with the resulting cellular debris pelleted by
centrifugation three times at 4,000 g for 5 min, taking the upper-
most supernatant for each spin. The total membrane fraction was
separated from the soluble fraction by ultracentrifugation at
100,000 g for 1 h. After washing the membrane pellet thoroughly in
sonication buffer, the inner membrane fraction was solubilized in
200 ll 50 mM Tris–HCl pH 7.6 with 2% (v/v) sodium lauroyl
sarcosinate for 1 h with gentle agitation. The outer membrane frac-
tion was pelleted by ultracentrifugation at 100,000 g for 1 h, washed
and resuspended in sonication buffer. The preparation of super-
natant samples separation by sodium dodecyl sulphate-polyacryla-
mide gel electrophoresis and subsequent immunoblotting has been
described previously (Hachani et al, 2011). Immunodetection was
conducted using monoclonal antibodies against RNA polymerase
(NeoClone) and polyclonal antibodies against PilQ, XcpY (Michel
et al, 1998) and LasB.
Expanded View for this article is available online.
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